ID,CNumber,Aliases
1,177.0,"LL-Z-1640-2 ; 66018-38-0 ; (5Z)-7-Oxozeaenol ; (3S,5E,8S,9S,11E)-8,9,16-Trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione ; [66018-38-0] ; 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione ; 3,4,9,10-tetrahydro-8,9,16-trihydroxy-14-methoxy-3-methyl- ; (3S,5E,8S,9S,11E)- ; (3S,5Z,8S,9S,11E)-3,4,9,10-tetrahydro-8,9,16-trihydroxy-14-methoxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione ; (2E,5S,6S,8E,11S)-5,6,15-trihydroxy-17-methoxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(18),2,8,14,16-pentaene-7,13-dione ; LL-Z1640-1 ; 5E-7-oxozeaenol ; 253863-19-3 ; [253863-19-3] ; ll z1640-2 ; "
2,2.0,"PP1-AG1872 ; K00047 ; 4-Amino-1-tert-butyl-3-(1'-naphthyl)pyrazolo[3,4-d]pyrimidine ; 1H-Pyrazolo[3,4-d]pyrimidin-4-amine ; 1-(1,1-dimethylethyl)-3-(1-naphthalenyl)- ; 1H-Pyrazolo[3,4-d]pyrimidin-4-amine ; 1-(1,1-dimethylethyl)-3-(1-naphthalenyl)- (9CI) ; 221243-82-9 ; 9-naphthalen-1-yl-7-tert-butyl-3,5,7,8-tetrazabicyclo[4.3.0]nona-1,3,5,8-tetraen-2-amine ; 22662-31-3 ; 8275174 ; 1-NA-PP1 ; 1-(1,1-Dimethylethyl)-3-(1-naphthalenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 1-tert-butyl-3-naphthalen-1-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 1-Naphthyl PP1 ; 1-tert-butyl-3-(1-naphthyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine ; [221243-82-9] ; 1-(2-Methyl-2-propanyl)-3-(1-naphthyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 1-NA-PP 1 | ; 1-tert-butyl-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 1-NA-PP 1 ; 1-(tert-Butyl)-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; MFCD03425471 ; 1-tert-butyl-3-naphthalen-1-ylpyrazolo[3,4-d]pyrimidin-4-amine ; 956025-47-1 ; CHEMBL264406 ; 1-TERT-BUTYL-3-(NAPHTHALEN-1-YL)PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE ; 0J9 ; (1-Naphthyl PP1) ; "
3,3.0,"8278642 ; 1-NM-PP1 ; 221244-14-0 ; 1-(1,1-dimethylethyl)-3-(1-naphthalenylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 4-Amino-1-tert-butyl-3-(1'-naphthylmethyl)pyrazolo[3,4-d]pyrimidine ; 1-tert-butyl-3-(naphthalen-1-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 1H-Pyrazolo[3,4-d]pyrimidin-4-amine ; 1-(1,1-dimethylethyl)-3-(1-naphthalenylmethyl)- ; 1-NMPP1 ; PP1 Analog II ; 1NM-PP1 ; 1-Naphthyl PP1 ; 4-amino-1-tert-butyl-3-(1'-naphthylmethyl)pyrazolo(3,4-d)pyrimidine ; Mutant Kinases Inhibitor II and PP1 Analog II ; 1NM-PP1 ; 1-(2-Methyl-2-propanyl)-3-(1-naphthylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; MFCD17010191 ; NM-PP1 ; 1- ; [221244-14-0] ; 1 NM-PP1 ; AC1NP9I6 ; mutant kinases inhibitor II ; NM-PP1 ; PP1 analog II ; AC1NP9I6|mutant kinases inhibitor II|NM-PP1 ; 1-(tert-butyl)-3-(naphthalen-1-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 956025-48-2 ; 1-NM-PP 1 ; 1NM-PP1 ; 1-tert-butyl-3-(naphthalen-1-ylmethyl)pyrazolo[3,4-d]pyrimidin-4-amine ; PP1 Analog II;1-NM-PP 1 ; 4-AMINO-1-TERT-BUTYL-3-(1'-NAPHTHYLMETHYL)PYRAZOLO-[3,4-D]PYRIMIDINE ; 1NM-PP1(PP1 Analog II) ; 1-NM-PP1 ; 1-tert-butyl-3-(1-naphthylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 0JN ; 4-amino-1-t-butyl-3-(1'-naphthylmethyl)pyrazolo[3,4-d]pyrimidine ; 4-amino-1-tert-butyl-3-(1’-naphthylmethyl)pyrazolo[3,4-d]pyrimidine ; MMV676599 ; "
4,293.0,"2-Aminopurine ; Purine ; 2-amino- ; 1H-Purin-2-amine ; 207-197-4 ; 452-06-2 ; Benzoic acid ; 4-(aminomethyl)- (9CI) ; 2-AP ; SQ 22,451 ; EINECS 207-197-4 ; 3H-Purin-2-amine ; 9H-Purin-2-amine ; 9H-Purin-2-ylamine ; purine-2-ylamine ; 2-amino purine ; 7H-Purin-2-amine ; 191236-69-8 ; 41731-39-9 ; 61655-24-1 ; 2H-Purin-2-imine ; 1,9-dihydro- ; 2'-amino-purine ; MFCD00005566 ; 1,3-Dihydro-2H-purin-2-imine ; 2H-Purin-2-imine ; 1,3-dihydro- ; aminopurine ; purin-2-amine ; 2-(dihydroxymethyl)-2,5-dihydrofuran-2,5-diol ; 7H-Purin-2-amine (9CI) ; 2H-Purin-2-imine ; 1,9-dihydro- (9CI) ; 1H-Purin-2-amine (9CI) ; 849611-62-7 ; [452-06-2] ; UO7475000 ; OR-1074 ; 7H-Purin-2-ylamine ; CHEMBL388594 ; BiomolKI_000044 ; BiomolKI2_000050 ; NCGC00163382-01 ; ST5298872 ; UNII-O14B3U97FW ; UNII:O14B3U97FW ; 1H-PURIN-2-AMINE,RADICAL ION(1-) ; 2-Aminopurine (en) ; '452-06-2 ; 2BP ; 7h-purin-2-amine(wxc05878) ; 9h-purin-2-amine(wxc06803) ; O14B3U97FW ; 1H-PURIN-2-AMINE|1H-PURIN-2-AMINE ; 2-AMINO PURINE|9H-PURIN-2-AMINE ; 2-AMINOPURINE|7H-PURIN-2-AMINE ; Famciclovir Related Compound E ; MFCD03853695 ; 2-AP207-197-4MFCD00005566 ; "
5,5.0,(S)-1-(5-(3-Methyl-1H-indazol-5-yl)pyridin-3-yloxy)-3-(1H-indol-3-yl)propan-2-amine ; A-443654 ; A-4436554 ; 1H-Indole-3-ethanamine ; .alpha.-[[[5-(3-methyl-1H-indazol-5-yl)-3-pyridinyl]oxy]methyl]- ; (.alpha.S)- ; 552325-16-3 ; (S)-1-(1H-indol-3-yl)-3-((5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl)oxy)propan-2-amine ; (2S)-1-(1H-indol-3-yl)-3-(5-(3-methyl-1H-indazol-5-yl)pyridin-3-yloxy)propan-2-Amine ; (2S)-1-(1H-Indol-3-yl)-3-{[5-(3-methyl-1H-indazol-5-yl)-3-pyridinyl]oxy}-2-propanamine ; 1H-Indole-3-ethanamine ; alpha-[[[5-(3-methyl-1H-indazol-5-yl)-3-pyridinyl]oxy]methyl]- ; (alphaS)- ; A 443654 ; a-443654 dihydrochloride ; 911305-87-8 ; A 443654 ; A443654 ; (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE ; 5-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole ; 2-(1H-Indol-3-yl)-1-[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yloxymethyl]ethylamine ; (2S)-1-(1H-indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan-2-amine ; A 443654|A443654 ; [552325-16-3] ; MFCD11840663 ; A443654 ; (2S)-1-(1H-indol-3-yl)-3-[[5-(3-methyl-2H-indazol-5-yl)-3-pyridinyl]oxy]-2-propanamine ; Î±S-[[[5-(3-methyl-1H-indazol-5-yl)-3-pyridinyl]oxy]methyl]-1H-indole-3-ethanamine ; 
6,6.0,"4-hydroxy-3-(2'-hydroxybiphenyl-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile ; Thieno[2,3-b]pyridine-5-carbonitrile ; 6,7-dihydro-4-hydroxy-3-(2'-hydroxy[1,1'-biphenyl]-4-yl)-6-oxo- ; A 769662 ; [844499-71-4] ; 4-hydroxy-3-[4-(2-hydroxyphenyl)phenyl]-6-oxo-7-hydrothiopheno[2,3-b]pyridine-5-carbonitrile ; 4-Hydroxy-3-(2'-hydroxy-1,1'-biphenyl-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile ; 844499-71-4 ; 6,7-Dihydro-4-hydroxy-3-(2'-hydroxy[1,1'-biphenyl]-4-yl )-6-oxo-thieno[2,3-b]pyridine-5-carbonitrile ; 6,7-Dihydro-4-hydroxy-3-(2'-hydroxy[1,1'-biphenyl]-4-yl)-6-oxo-thieno[2,3-b]pyridine-5-carbonitrile ; A-769662 ; 4-hydroxy-3-[4-(2-hydroxyphenyl)phenyl]-6-oxo-7H-thieno[2,3-b]pyridine-5-carbonitrile ; 4-hydroxy-3-(2'-hydroxy-[1,1'-biphenyl]-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile ; Hismanal | ; MFCD11977269 ; 4-Hydroxy-3-(2'-hydroxy-4-biphenylyl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile ; A769662 ; CHEMBL512504 ; 6-hydroxy-3-[4-(2-hydroxyphenyl)phenyl]-4-oxo-7H-thieno[2,3-b]pyridine-5-carbonitrile ; UNII-P68477CD2C ; UNII:P68477CD2C ; A-769662;A769662 ; Not available ; 3-[4-(2-Hydroxyphenyl)phenyl]-4-Oxidanyl-6-Oxidanylidene-7h-Thieno[2,3-B]pyridine-5-Carbonitrile ; C1V ; P68477CD2C ; 6,7-Dihydro-4-hydroxy-3-(2'-hydroxy[1,1'-biphenyl]-4-yl)-6-oxothieno[2,3-b]pyridine-5-carbonitrile ; A 769662|A-769662 ; "
7,162.0,"A-83-01 ; A 83-01 ; 909910-43-6 ; 3-(6-methylpyridin-2-yl)-N-phenyl-4-(quinolin-4-yl)-1H-pyrazole-1-carbothioamide ; [909910-43-6] ; 1H-Pyrazole-1-carbothioamide ; 3-(6-methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)- ; 3-(6-methylpyridin-2-yl)-N-phenyl-4-quinolin-4-yl-1H-pyrazole-1-carbothioamide ; 3-(6-Methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)-1H-pyrazole-1-carbothioamide ; A83-01 ; R-L3 | ; 3-(6-methylpyridin-2-yl)-N-phenyl-4-(quinolin-4-yl)-1H-pyrazole-1-carbothio amide ; A83-01;A-83-01 ; MFCD08705403 ; 3-(6-methylpyridin-2-yl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide ; TGF-beta inhibitor A-83-01 ; A 8301 ; TGFá inhibitor A-83-01 ; 1H-Pyrazole-1-carbothioamide,3-(6-methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)- ; 3-(6-Methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl) -1H-pyrazole-1-carbothioamide ; A-83-01 ; 3-(6-METHYL-PYRIDIN-2-YL)-N-PHENYL-4-(4-QUINOLINYL)-1H-PYRAZOLE-1-CARBOTHIOAMIDE ; 3-(6-METHYLPYRIDIN-2-YL)-N-PHENYL-4-(QUINOLIN-4-YL)PYRAZOLE-1-CARBOTHIOAMIDE ; A-83-01 ; 3-(6-Methylpyridin-2-yl)-N-phenyl-4-(quinolin-4-yl)-1H-pyrazol-1-carbothioamide ; Not available ; a8301 ; culturesure a-83-01 ; "
8,144.0,"6,7-dimethoxy-3-phenylquinoxaline ; Quinozaline ; 6,7-dimethoxy-2-phenyl- ; 146535-11-7 ; 1489-12-9 ; 6,7-Dimethoxy-2-phenylquinoxaline ; AG1296 ; C106250 ; 6,7-Dimethoxy-2-phenyl-quinoxaline ; Quinoxaline ; 6,7-dimethoxy-2-phenyl- ; Tyrphostin AG 1296 (AG 1296) ; [146535-11-7] ; MFCD00270913 ; 2-phenyl-6,7-dimethoxyquinoxaline ; COc1cc2nc(cnc2cc1OC)c1ccccc1 ; "
9,154.0,"N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine ; 153436-53-4 ; PD153035 ; 4-(3-Chloroanilino)-6,7-dimethoxyquinazoline ; 170449-18-0 ; N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine ; RTKI cpd ; N-(3-chlorophenyl)-N-(6,7-dimethoxy-4-quinazolinyl)amine ; AG1478 ; C101044 ; 4-Quinazolinamine ; N-(3-chlorophenyl)-6,7-dimethoxy- ; n-(3-chlorphenyl)-6,7-dimethoxy-4-chinazolinamin ; (3-Chloro-phenyl)-(6,7-dimethoxy-quinazolin-4-yl)-amine ; 4-(3'-chloroanilino)-6,7-dimethoxyquinazoline hydrochloride ; 175178-82-2 ; PD-153,035 ; 6,7-Dimethoxy-4-[N-(3-chlorophenyl)amino]quinazoline hydrochloride ; 4-(3-Chloro-benzyl)-6,7-dimethoxy-quinazoline ; AG-1478 (Tyrphostin AG-1478) ; 153436-53-4 ; 170449-18-0 (HCl) ; N-(3-chlorophenyl)-6,7-dimethoxy-quinazolin-4-amine ; MFCD00270914 ; Tyrphostin ; [175178-82-2] ; 4-Quinazolinamine,N-(3-chlorophenyl)-6,7-dimethoxy- ; '175178-82-2 ; 0TO ; ag-1478 (tyrphostin ag1478) ; atoms 22 bonds 24 ; "
10,7.0,"2-Propenamide ; Tyrphostin deriv. 42 ; Tyrphostin  AG  490 ; N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)acrylamide ; Tyrphostin- AG- 490 ; tyrphostin AG-490 ; 133550-30-8 ; (E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)acrylamide ; AG 490 ; AG-490 ; AG490 ; C095512 ; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide ; n-benzyl-3,4-dihydroxy-benzylidenecyanoacetamide ; Tyrphostin B42 ; 134036-52-5 ; (E)-2-Cyano-3-(3,4-dihydrophenyl)-N-(phenylmethyl)-2-propenamide ; (2E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)acrylamide ; (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxy-phenyl)-acrylamide ; N-Benzyl-2-cyano-3-(3,4-dihydroxy-phenyl)-acrylamide ; Tyrphostin AG 490 ; 2-Propenamide ; 2-cyano-3-(3,4-dihydroxyphenyl)-N-(phenylmethyl)- ; A-Cyano-(3,4-dihydroxy)-N-benzylcinnamide ; [133550-30-8] ; (2E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide ; (2E)-3-(3,4-dihydroxyphenyl)-2-cyano-N-benzylprop-2-enamide ; Tyrphostin AG490 ; AG 490 (Tyrphostin AG 490) ; Tyrphostin AG 490 | ; 2-cyano-3-(3,4-dihydroxyphenyl)-N-(phenylmethyl)-2-propenamide ; Tyrphostin AG 490 ; Tyrphostin B42 ; (E)-N-Benzyl-2-cyano-3-(3,4-dihydro ; xy-phenyl)-acrylamide ; MFCD00209833 ; a-cyano-(3,4-dihydroxy)-n-benzylcinnamamide ; (E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide ; Tyrphostin B 42 ; (E)-N-Benzyl-2-cyano-3-(3,4-dihydro ; xy-phenyl)-acrylamide ; MFCD00236452 ; TyrphostinB42 ; UC6316197 ; 2-Propenamide,2-cyano-3-(3,4-dihydroxyphenyl)-N-(phenylmethyl)- ; 2-Propenamide,2-cyano-3-(3,4-dihydroxyphenyl)-N-(phenylmethyl)-,(2E)- ; N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide ; Tyrphostin B42 ; AG-490 ; (E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-(phenylmethyl)-2-propenamide ; AG-490|tyrphostin AG490|tyrphostin B42 ; 2-Cyano-3-(3,4-dihydroxyphenyl)-N-(benzyl)-2-propenamide ; AG-490 (Tyrphostin B42) ; 2-cyano-3-(1-cyclohexa-1,5-dienyl)-N-(phenylmethyl)-2-propenamide ; AG 490;Tyrphostin AG 490;AG490 ; NOCAS_40960 ; '134036-52-5 ; ag 490(tyrphostin b42) ; ag-490(tyrphostin b42) ; ag490(tyrphostinb42) ; AG 490|Tyrphostin B 42 ; "
11,8.0,"Tyrphostin AG 879 ; alpha-cyano-(3,5-di-t-butyl-4-hydroxy)thiocinnamide ; 2-Propenethioamide ; 3-(3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)-2-cyano- ; 148741-30-4 ; (2E)-2-Cyano-3-(3,5-di-tert-butyl-4-hydroxyphenyl)prop-2-enethioamide ; 2-Propenethioamide ; 3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-cyano- ; (2E)-3-[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-cyano-2-propenethioamide ; Tyrphostin AG 879 (AG 879) ; Tyrphostin AG 879 | ; 3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-cyano-2E-propenethioamide ; 2-Propenethioamide,3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-cyano- ; (2E)-2-Cyano-3-[4-hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl]-2-propenethioamide ; 2-CYANO-3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROP-2-ENETHIOAMIDE ; 2-Propenethioamide,3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-cyano-,(2E)- ; '148741-30-4 ; (E)-3-amino-2-[(3,5-ditert-butyl-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]-3-sulfanylprop-2-enenitrile ; AG879 ; tyrphostin AG879 ; AG 879|AG-879|tyrphostin AG879 ; [148741-30-4] ; MFCD00236450 ; Î±-Cyano-(3,5-di-t-butyl-4-hydroxy)thiocinnamide ; (E)-2-Cyano-3-(3,5-di-tert-butyl-4-hydroxyphenyl)prop-2-enethioamide ; 2-Propenethioamide ; 3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-cyano- ; TYRPHOSTIN  AG 879 ; "
12,148.0,"5-(1,3-benzothiazol-2-yl)-3-ethyl-2-{2-[methyl(phenyl)amino]vinyl}-1-phenyl-1H-benzimidazol-3-ium iodide ; 5-(1,3-benzothiazol-2-yl)-3-ethyl-2-{(E)-2-[methyl(phenyl)amino]ethenyl}-1-phenyl-1H-3,1-benzimidazol-3-ium iodide ; 6-benzothiazol-2-yl-1-ethyl-2-[2-(methyl-phenylamino)-vinyl]-3-phenyl-3H-benzoimidazol-1-ium iodid ; 1H-3,1-benzimidazolium ; 5-(2-benzothiazolyl)-3-ethyl-2-[(E)-2-(methylphenylamino)ethenyl]-1-phenyl- ; iodide (1:1) ; GNF-PF-254 ; GNF-PF-3619 ; 681281-88-9 ; B2311 ; 1H-Benzimidazolium ; 5-(2-benzothiazolyl)-3-ethyl-2-[(E)-2-(methylphenylamino)ethenyl]-1-phenyl- ; iodide (1:1) ; 5-(1,3-Benzothiazol-2-yl)-3-ethyl-2-{(E)-2-[methyl(phenyl)amino]vinyl}-1-phenyl-1H-benzimidazol-3-ium iodide ; 5-(1,3-benzothiazol-2-yl)-3-ethyl-2-[(E)-2-[methyl(phenyl)amino]ethenyl]-1-phenyl-1H-1,3-benzodiazol-3-ium iodide ; 5-(2-BENZOTHIAZOLYL)-3-ETHYL-2-(-(METHY ; cid_5719375 ; [681281-88-9] ; MFCD00570739 ; Akt Inhibitor IV ; 5-(Benzo[d]thiazol-2-yl)-3-ethyl-2-(2-(methyl(phenyl)amino)vinyl)-1-phenyl-1H-benzo[d]imidazol-3-ium iodide ; 959841-49-7 ; 6-(2-benzothiazolyl)-1-ethyl-2-[2-(methylphenylamino)ethenyl]-3-phenyl-1H-benzimidazolium ; monoiodide ; AKTIV ; "
13,9.0,"1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one ; 1-{1-[4-(7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one ; 2H-benzimidazol-2-one ; 1,3-dihydro-1-[1-[[4-(7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]-4-piperidinyl]- ; 1-(1-((4-(7-Phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)phenyl)methyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one ; 1-{1-[4-(7-Phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)-benzyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one ; 612847-09-3 ; 1,3-Dihydro-1-(1-((4-(6-phenyl-1h-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2h-benzimidazol-2-one ; 1-(1-(4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one ; Desvenlafaxine | ; 1-(1-(4-(6-Phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl)-piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one ; MFCD23843802 ; 1-{1-[4-(6-Phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl]-4-piperidinyl}-1,3-dihydro-2H-benzimidazol-2-one ; 2H-Benzimidazol-2-one ; 1,3-dihydro-1-[1-[[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methyl]-4-piperidinyl]- ; MFCD09026909 ; Akt Inhibitor VIII ; 1,3-Dihydro-1-[1-[[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methyl]4-piperidinyl]-2H-benzimidazol-2-one ; 1,3-dihydro-1-[1-[[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methyl]-4-piperidinyl]-2H-benzimidazol-2-one ; 1-{1-[4-(7-Phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl]-4-piperidinyl}-1,3-dihydro-2H-benzimidazol-2-one ; imidazoquinoxaline 16h ; 3-[1-[[4-(7-phenyl-3H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one ; 3-[1-[4-(7-phenyl-3H-imidazo[4,5-g]quinoxalin-6-yl)benzyl]-4-piperidyl]-1H-benzimidazol-2-one ; 1-{1-[(4-{6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl}phenyl)methyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one ; [612847-09-3] ; 1-(1-(phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one ; MFCD08705407 ; 3-[1-[[4-(7-phenyl-3H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]-4-piperidinyl]-1H-benzimidazol-2-one ; 1-{1-[(4-{7-PHENYL-3H-IMIDAZO[4,5-G]QUINOXALIN-6-YL}PHENYL)METHYL]PIPERIDIN-4-YL}-3H-1,3-BENZODIAZOL-2-ONE ; Not available ; IQO ; 1-(1-(4-(7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one ; aktinhibitorviii,isozyme-selective ; Akt Inhibitor ; Isozyme-Selective ; "
14,10.0,"Alsterpaullone ; 9-Nitropaullone ; Paullone Analog 1 ; 9-Nitro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one ; 9-NITRO-5,12-DIHYDRO-7H-BENZO[2,3]AZEPINO[4,5-B]INDOL-6-ONE ; 9-Nitro-7,12-dihydroindolo-[3,2-d][1]benzazepin-6(5)-one ; 9-nitro-7,12-dihydroindolo(3,2-d)(1)benzazepin-6(5H)-one ; C120793 ; 237430-03-4 ; Indolo[3,2-d][1]benzazepin-6(5H)-one ; 7,12-dihydro-9-nitro- ; Kinome_3754 ; 9-nitro-7,12-dihydro-indolo[3,2-d][1]benzazepin-6(5H)-one ; 7,12-dihydro-9-nitro-indolo[3,2-d][1]benzazepin-6(5H)-one ; 14-nitro-8,18-diazatetracyclo[9.7.0.02,7.012,17]octadeca-1(11),2(7),3,5,12,14,16-heptaen-9-one ; 9-nitro-7,12-dihydro-5H-indolo[3,2-d][1]benzazepin-6-one ; Alsterpaullone derivative ; 2 ; 14-nitro-8,18-diazatetracyclo[9.7.0.02,7.012,17]octadeca-1(11),2,4,6,12,14,16-heptaen-9-one ; 9-nitropaullone|NSC-705701 ; MFCD02683579 ; 14-nitro-8,18-diazatetracyclo[9.7.0.0²,⁷.0¹²,¹⁷]octadeca-1(11),2(7),3,5,12(17),13,15-heptaen-9-one ; Indolo[3,2-d][1]benzazepin-6(5H)-one,7,12-dihydro-9-nitro- ; 14-nitro-8,18-diazatetracyclo[9.7.0.0({2,7}).0({12,17})]octadeca-1(11),2,4,6,12(17),13,15-heptaen-9-one ; 9-nitro-7,12-dihydrobenzo[2,3]azepino[4,5-b]indol-6(5h)-one ; "
15,311.0,"Solfa ; Amlexanox ; Aphthasol ; amoxanox ; Amlenanox ; Aptheal ; Apthera ; Elics ; OraRinse ; OraDisc A ; Aphthasol (TN) ; Solfa (TN) ; Amlexanox [USAN:INN:JAN] ; 68302-57-8 ; 2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid ; 5H-(1)Benzopyrano(2,3-b)pyridine-3-carboxylic acid ; 2-amino-7-(1-methylethyl)-5-oxo- ; 2-Amino-7-isopropyl-1-azaxanthone-3-carboxylic Acid ; 2-Amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic Acid ; 2-Amino-7-(1-methylethyl)-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylicAcid ; Amlexanoxo [Spanish] ; Amlexanoxum [Latin] ; 2-amino-7-(1-methylethyl)-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid ; 5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid ; 2-amino-7-(1-methylethyl)-5-oxo- ; 2-amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3b)pyridine-3-carboxylic acid ; C045742 ; GlaxoSmithKline brand of amlexanox ; 2-amino-5-oxo-7-(propan-2-yl)-5H-chromeno[2,3-b]pyridine-3-carboxylic acid ; 2-Amino-6-isopropyl-10-oxo-10H-9-oxa-1-aza-anthracene-3-carboxylic acid ; 2-Amino-7-isopropyl-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid ; 2-amino-7-(methylethyl)-5-oxochromeno[2,3-b]pyridine-3-carboxylic acid ; amlexanoxum [INN_la] ; DDUG | ; amlexanox ; amlexanoxo ; amlexanoxum ; 2-amino-7-(1-methylethyl)5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid ; MFCD00864790 ; 2-Amino-7-(1-methylethyl)-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid ; Amlexanoxo ; Amlexanoxum ; 2-Amino-7-isopropyl-5-oxo-5H-chromeno-[2,3-b]pyridine-3-carboxylic acid ; Aphthasol (Trade name) ; Elics (Trade name) ; OraDisc A (Trade name) ; 2-amino-5-oxo-7-propan-2-yl-chromeno[3,2-e]pyridine-3-carboxylic acid ; 2-amino-5-oxo-7-propan-2-ylchromeno[3,2-e]pyridine-3-carboxylic acid ; 2-amino-7-isopropyl-5-keto-chromeno[3,2-e]pyridine-3-carboxylic acid ; 2-amino-7-isopropyl-5-oxo-3-chromeno[3,2-e]pyridinecarboxylic acid ; 2-amino-7-isopropyl-5-oxo-chromeno[3,2-e]pyridine-3-carboxylic acid ; [68302-57-8] ; AA673 ; Aphthasol ; OraDisc A ; 2-amino-5-oxo-7-propan-2-yl-3-[1]benzopyrano[2,3-b]pyridinecarboxylic acid ; 2-amino-5-oxo-7-propan-2-ylchromeno[2,3-b]pyridine-3-carboxylic acid ; Solfa (Amlexanox) ; '68302-57-8 ; 2-Amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b] pyridine-3-carboxylic acid ; ANW ; Amlexanox|AA-673 ; DB01025 ; "
16,11.0,"GSK-3b Inhibitor VIII ; 487021-52-3 ; AR-A 014418 ; 1-(4-Methoxybenzyl)-3-(5-nitro-1,3-thiazol-2-yl)urea ; [487021-52-3] ; Urea ; N-[(4-methoxyphenyl)methyl]-N'-(5-nitro-2-thiazolyl)- ; Kinome_1268 ; N-[(4-Methoxyphenyl)methyl]-N'-(5-nitro-2-thiazolyl)urea ; AR-A014418 ; 1-[(4-methoxyphenyl)methyl]-3-(5-nitro-1,3-thiazol-2-yl)urea ; 1-(4-methoxybenzyl)-3-(5-nitrothiazol-2-yl)urea ; GSK-3Î’ INHIBITOR VIII ; GSK-3beta Inhibitor VIII ; SN 4521 ; AR-AO 14418 ; GSK 3B inhibitor VIII ; AR 0133418 ; AR-A0-14418 ; N-[(4-methoxyphenyl)methyl]-N'-(5-nitro-2-thiazolyl)-urea ; MFCD08277040 ; AR-AO-14418 ; CHEMBL259850 ; -(5-nitro-1,3-thiazol-2-yl)urea ; 1-[(4-methoxyphenyl)methyl]-3-(5-nitro-2-thiazolyl)urea ; 1-[(4-methoxyphenyl)methyl]-3-(5-nitrothiazol-2-yl)urea ; HSCI1_000278 ; AR-A014418|GSK-3b inhibitor VIII ; Inhibitor VIII ; N-(4-Methoxybenzyl)-Nâ€²-(5-nitro-1,3-thiazol-2-yl)urea ; AR 014418 ; A inhibitor ; GSK 3 ; IN1309 ; IN1316 ; N-[(4-Methoxyphenyl)methyl]-N'-(5-nitro-thiazol-2-yl)urea ; GSK3Î² Inhibitor VIII ; ar-a014418(gsk3β inhibitor viii) ; GSK3β Inhibitor VIII ; GSK-3 Inhibitor ; AR-A014418 ; "
17,12.0,"AS601245 ; 345987-15-7 ; 861411-83-8 ; JNK Inhibitor V ; 4-Pyrimidineacetonitrile,a-2(3H)-benzothiazolylidene-2-[[2-(3-pyridinyl)ethyl]amino]-,(aZ)- ; (2E)-1,3-Benzothiazol-2(3H)-ylidene(2-{[2-(3-pyridinyl)ethyl]amino}-4-pyrimidinyl)acetonitrile ; 4-Pyrimidineacetonitrile ; alpha-2(3H)-benzothiazolylidene-2-[[2-(3-pyridinyl)ethyl]amino]- ; (alphaE)- ; "
18,182.0,"2-[(Cyclopropylcarbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide ; Benzo[b]thiophene-3-carboxamide ; 2-[(cyclopropylcarbonyl)amino]-4,5,6,7-tetrahydro- ; 2-(cyclopropylcarbonylamino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide ; PknG Inhibitor ; 329221-38-7 ; 2-(cyclopropanecarboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide ; 2-C-cyclopropane-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido ; Benzo[b]thiophene-3-carboxamide,2-[(cyclopropylcarbonyl)amino]-4,5,6,7-tetrahydro- ; MFCD00785286 ; CHEMBL379367 ; 2-cyclopropaneamido-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide ; AX-20017 ; AX 20017 ; AXX ; 2-(Cyclopropanecarbonyl-amino)-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid amide ; 2-(cyclopropanecarbonylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide ; ax20017 ; "
19,212.0,"AZD8055 ; 1009298-09-2 ; AZD 8055 ; AZD-8055 ; (5-{2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl}-2-methoxyphenyl)methanol ; (5-(2,4-Bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol ; AZD8055£¬AZD-8055 ; [5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol ; (5-(2,4-Bis((S)-3-methylmorpholino)pyrido-[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol ; MFCD16660191 ; Benzenemethanol ; 5-[2,4-bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy- ; (5-{2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl}-2-methoxyphenyl)methanol ; [5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]- 2-methoxyphenyl]methanol ; 5-[2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol ; [5-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol ; 1201799-04-3 ; 5-[2,4-bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-benzenemethanol ; [5-[2,4-bis[(3S)-3-methyl-4-morpholinyl]-7-pyrido[2,3-d]pyrimidinyl]-2-methoxyphenyl]methanol ; AZD 8055|AZD-8055 ; LM1148 ; [1009298-09-2] ; (5-(2,4-Bis((S)-3-methylmorpholino)pyrido2 ; 3-dpyrimidin-7-yl)-2-methoxyphenyl)methanol ; 5-2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido2,3-dpyrimidin-7-yl-2-methoxyphenylmethanol ; AZD8055 ; AZD 8055 ; {5-[2,4-bis(3S)(3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl}methanol ; 5-[2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy benzenemethanol ; "
20,280.0,"BAY 61-3606 ; Kinome_3125 ; 732983-37-8 ; Syk Inhibitor IV ; BAY 61-3606 ; 2-{[7-(3,4-Dimethoxyphenyl)imidazo[1,2-c]pyrimidin-5-yl]amino}nicotinamide ; 3-Pyridinecarboxamide ; 2-[[7-(3,4-dimethoxyphenyl)imidazo[1,2-c]pyrimidin-5-yl]amino]- ; BAY61-3606 ; BAY-61-3606 FREE BASE ; BAY-61-3606 ; 2-[[7-(3,4-dimethoxyphenyl)-5-imidazo[2,1-f]pyrimidinyl]amino]-3-pyridinecarboxamide ; 2-[[7-(3,4-dimethoxyphenyl)imidazo[2,1-f]pyrimidin-5-yl]amino]nicotinamide ; 2-[[7-(3,4-dimethoxyphenyl)imidazo[2,1-f]pyrimidin-5-yl]amino]pyridine-3-carboxamide ; 2-{[7-(3,4-DIMETHOXYPHENYL)IMIDAZO[1,2-C]PYRIMIDIN-5-YL]AMINO}PYRIDINE-3-CARBOXAMIDE ; 2-[[7-(3,4-dimethoxyphenyl)-5-imidazo[1,2-c]pyrimidinyl]amino]-3-pyridinecarboxamide ; MFCD18641826 ; 2-[[7-(3,4-dimethoxyphenyl)imidazo[1,2-c]pyrimidin-5-yl]amino]pyridine-3-carboxamide ; "
21,14.0,"7-[2-(CYCLOPROPYLMETHOXY)-6-HYDROXYPHENYL]-1,4-DIHYDRO-5-[(3S)-3-PIPERIDINYL]-2H-PYRIDO[2,3-D][1,3]OXAZIN-2-ONE HYDROCHLORIDE ; 7-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-5-(piperidin-3-yl)-1H-pyrido[2,3-d][1,3]oxazin-2(4H)-one hydrochloride ; 406208-34-2 ; Bay 65-1942 hydrochloride ; 2H-Pyrido[2,3-d][1,3]oxazin-2-one ; 7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-1,4-dihydro-5-(3-piperidinyl)- ; hydrochloride (1:1) ; 7-[2-(Cyclopropylmethoxy)-6-hydroxyphenyl]-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one hydrochloride (1:1) ; MFCD11040976 ; 7-(2-(CYCLOPROPYLMETHOXY)-6-HYDROXYPHENYL)-5-(PIPERIDIN-3-YL)-1H-PYRIDO-[2,3-D][1,3]-OXAZIN-2(4H)-ONE HYDROCHLORIDE ; "
22,15.0,"3-(p-Tolylsulfonyl)acrylonitrile ; 3-(4-Tolylsulfonyl)acrylonitrile ; 3-(p-Toluenesulfonyl)acrylonitrile ; CP 15749-3 ; 3-((4-Methylphenyl)sulfonyl)-2-propenenitrile ; 2-Propenenitrile ; 3-((4-methylphenyl)sulfonyl)- ; Acrylonitrile ; 3-(p-tolylsulfonyl)- (7CI,8CI) ; 1424-48-2 ; 3-(4-methylphenylsulfonyl)-2-propenenitrile ; 19542-67-7 ; (E)-3-(4-Methylphenylsulfonyl)-2-propenenitrile ; BAY 11-7082 ; 1440-61-5 ; BAY-11-7082 ; BAY-117082 ; BAY11 compound ; BAY11-7082 ; C434003 ; Bay 11-7821 ; (2E)-3-[(4-Methylphenyl)sulfonyl]-2-propenenitrile ; 3-[(4-methylphenyl)sulfonyl]prop-2-enenitrile ; (2E)-3-[(4-methylphenyl)sulfonyl]prop-2-enenitrile ; 2-Propenenitrile ; 3-[(4-methylphenyl)sulfonyl]- ; 3-tosylacrylonitrile ; (2E)-3-[(4-Methylphenyl)sulfonyl]acrylonitrile ; (E)-3-(4-Methylphenyl)sulfonylprop-2-enenitrile ; [19542-67-7] ; (E)-3-tosylacrylonitrile ; (2E)-3-[(4-methylbenzene)sulfonyl]prop-2-enenitrile ; (E)-3-(4-methylphenyl)sulfonyl-2-propenenitrile ; Bay 11-7082 | ; 195462-67-7 ; (E)-3-(P-TOLUENESULFONYL)ACRYLONITRILE ; (E)3-[(4-Methylphenyl)sulfonyl]-2-propenenitrile ; BAY 11-7082 (BAY 11-7821) ; 3-[(4-methylphenyl)sulfonyl]-(2E)-propenenitrile ; MFCD00712162 ; (E)-3-(p-tolylsulfonyl)prop-2-enenitrile ; (E)-3-(p-tolylsulfonyl)acrylonitrile ; UD1430000 ; 3-(4-methylphenyl)sulfonylprop-2-enenitrile ; 3-(Toluene-4-sulfonyl)-acrylonitrile ; (E)-3-(4-methylphenyl)sulfonylacrylonitrile ; 3-(4-methylphenyl)sulfonylacrylonitrile ; 3-(P-TOLUENESULFONYL)ACRYLONITRILE ; BiomolKI_000065 ; BiomolKI2_000006 ; BSPBio_001197 ; Curator_000002 ; IDI1_002184 ; IDI1_008259 ; NCGC00025272-02 ; NCGC00025272-03 ; Oprea1_624859 ; ST5036097 ; UNII-4Y5G2A4F6O ; (3E)3-(p-toluenesulfonyl)acrylonitrile ; (E)-3-(4-methylphenylsulfonyl)-2-propenenenitrile ; BAY-117821 ; BAY-11-7821 ; beta-(cyanovinyl)-p-tolylsulfone ; (E)-3-tosylacrylonitrile|BAY-117082 ; UNII:4Y5G2A4F6O ; (2E)-3-(4-METHYLBENZENESULFONYL)PROP-2-ENENITRILE ; ketanserin.tartrate ; "
23,16.0,"SFN ; Sorafenib ; Nexavar ; Xarelto ; Sorafenib [INN] ; K00597a ; BAY-54-9085 ; BAX ; 2-Pyridinecarboxamide ; 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl- ; 284461-73-0 ; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide ; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide ; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE ; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea ; Sorafenib tosylate ; 19932-27-5 ; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methyl-2-pyridinecarboxamide ; 2-Pyridinecarboxamide ; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl- ; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide ; 475207-59-1 ;  284461-73-0 ; 4-{4-[3-(4-Chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid methylamide ; 4750207-59-1 ; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide ; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide ; Sorafenib tosylate ; Kinome_766 ; CAS: 284461-73-0 ; Sorafenib (Nexavar) ; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide ; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methyl-2-pyridinecarboxamide 4-methylbenzenesulfonate (1:1) ; (4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide ; MFCD06411450 ; [475207-59-1] ; QA-5261 ; 1130115-44-4 ; Sorafenib-d3 ; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide ; 4-[4-[[[4-chloro-3-(trifluoromethyl)anilino]-oxomethyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide ; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]-oxomethyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide ; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-picolinamide ; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate ; NSC-724772 ; UNII-9ZOQ3TZI87 ; sorafenibum ; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]ureaSorafenibbase ; [284461-73-0] ; Sorafenib (free base) ; 4-[4-[[[4-chloro-3-(trifluoromethyl)anilino]-oxomethyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide ; 4-methylbenzenesulfonic acid ; CHEBI:50924 ; UNII:9ZOQ3TZI87 ; Nexavar;Bay 43-9006 ; SORAFENIB-D4 ; 2-PYRIDINECARBOXAMIDE  4-[4-[[[[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO]CARBONYL]AMINO]PHENOXY]-N-METHYL- ; BAY-43-9006,Sorafenib,Nexavar,sorafenibum ; MnTMPyP Pentachloride ; CM-4307 ; 9ZOQ3TZI87 ; 100012-18-8 ; sorafenib ; sorafenibum ; c21h16clf3n4o3 ; sorafenib free base ; sorafenib free base (bay-43-9006) ; 8234 ; N-(3-trifluoromethyl-4-chlorophenyl)-N'-(4-(2-methylcarbamoyl pyridin-4-yl)oxyphenyl)urea ; 索拉非尼 ; BAY 43-9006 ; Free base ; DB00398 ; "
24,17.0,"BI-2536 ; 4-{[(7R)-8-Cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydro-2-pteridinyl]amino}-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide ; Benzamide ; 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)- ; BI 2536 ; 755038-02-9 ; 4-[[(7R)-8-Cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide ; (R)-4-((8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)amino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide ; BL 2536 ; 4-((R)-8-Cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydro-pteridin-2-ylamino)-3-methoxy-N-(1-methyl-piperidin-4-yl)-benzamide ; (R)-4-(8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-ylamino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide ; MFCD10565924 ; 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide ; 4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide ; BI2536 ; (R)-BI-2536 ; 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide ; 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methyl-4-piperidyl)benzamide ; 4-[[(7R)-8-cyclopentyl-7-ethyl-6-keto-5-methyl-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methyl-4-piperidyl)benzamide ; R78 ; UNII-4LJG22T9C6 ; BI 2536|BI2536 ; 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide ; [755038-02-9] ; UNII:4LJG22T9C6 ; BI-2536;BI2536 ; 4LJG22T9C6 ; 4-{[(7R)-8-CYCLOPENTYL-7-ETHYL-5-METHYL-6-OXO-7H-PTERIDIN-2-YL]AMINO}-3-METHOXY-N-(1-METHYLPIPERIDIN-4-YL)BENZAMIDE ; (R)-4-[(8-Cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide ; "
25,131.0,"4-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[(5-nitro-1,3-thiazol-2-yl)sulfanyl]-4,5-dihydro-1H-1,2,4-triazol-5-one ; 883065-90-5 ; BI-78D3 ; BI 78D3 ; 4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-[(5-nitro-1,3-thiazol-2-yl)sulfanyl]-2,4-dihydro-3H-1,2,4-triazol-3-one ; [883065-90-5] ; 3H-1,2,4-Triazol-3-one ; 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,4-dihydro-5-[(5-nitro-2-thiazolyl)thio]- ; 4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2,4-dihydro-5-[(5-nitro-2-thiazolyl)thio]-3H-1,2,4-triazol-3-one ; 4-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-((5-nitrothiazol-2-yl)thio)-1H-1,2,4-triazol-5(4H)-one ; 4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-((5-nitro-thiazol-2-yl)thio)-1H-1,2,4-triazol-5(4H)-one ; MFCD01313575 ; 4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-[(5-nitro-1,3-thiazol-2-yl)sulfanyl]-4H-1,2,4-triazol-3-ol ; 4H-1,2,4-Triazol-3-ol ; 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-[(5-nitro-2-thiazolyl)thio]- ; 4-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-((5-nitrothiazol-2-yl)thio)-2,4-dihydro-3H-1,2,4-triazol-3-one ; 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[(5-nitro-2-thiazolyl)thio]-1H-1,2,4-triazol-5-one ; 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[(5-nitro-1,3-thiazol-2-yl)sulfanyl]-1H-1,2,4-triazol-5-one ; Ro 47-0203 | ; 4-(2,3-Dihydrobenzol[b][1,4]dioxin-6-yl)-5-(5-nitrothiazol-2-ylthio)-4H-1,2,4-triazol-3-ol ; MFCD12912396 ; "
26,18.0,"501437-28-1 ; 2-(3,5-Difluoro-4-hydroxyphenylamino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one ; 2-[(3,5-Difluoro-4-hydroxyphenyl)amino]-5,7-dimethyl-8-(3-methylbutyl)-7,8-dihydropteridin-6(5H)-one ; 6(5H)-Pteridinone ; 2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)- ; 2-[(3,5-difluoro-4-hydroxyphenyl)amino]-5,7-dimethyl-8-(3-methylbutyl)-5,7,8-trihydropteridin-6-one ; 2-[(3,5-Difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)-6(5H)-pteridinone ; BI-D1870 ; 2-((3,5-difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one ; 2-(3,5-Difluoro-4-hydroxy-phenylamino)-5,7-dimethyl-8-(3-methyl-butyl)-7,8-dihydro-5H-pteridin-6-one ; 2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)-6(5H)-pteridinone, ; 2-[(3,5-Difluoro-4-hydroxyphenyl)amino]-5,7-dimethyl-8-(3-methylbutyl)-7,8-dihydro-6(5H)-pteridinone ; MFCD11223662 ; 2-(3,5-difluoro-4-hydroxyanilino)-5,7-dimethyl-8-(3-methylbutyl)-7H-pteridin-6-one ; [501437-28-1] ; BI-D 1870 ; 2-[(3,5-DIFLUORO-4-HYDROXYPHENYL)AMINO]-5,7-DIMETHYL-8-(3-METHYLBUTYL)-7H-PTERIDIN-6-ONE ; 2-(3,5-Difluoro-4-hydroxyanilino)-5,7-dimethyl-8-(3-methylbutyl)-7,8-dihydropteridin-6(5H)-one ; bid1870 ; "
27,201.0,"Thieno[2,3-b]pyridine-2-carboxamide ; 3-amino-4-(1,1-difluoropropyl)-6-[4-(methylsulfonyl)-1-piperidinyl]- ; 960293-88-3 ; Thieno[2,3-b]pyridine-2-carboxamide,3-amino-4-(1,1-difluoropropyl)-6-[4-(methylsulfonyl)-1-piperidinyl]- ; BI605906 ; BI-605906 ; MFCD22665698 ; [960293-88-3] ; BI 605906 ; Not available ; 3-Amino-4-(1,1-difluoro- propyl)-6-(4-methanesulfonyl- piperidin-1-yl)-thieno[2,3- b]pyridine-2-carboxylic acid amide ; compound 115 [US20070293533] ; 3-amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide ; 3-amino-4-(1,1-difluoropropyl)-6-[4-(methylsulfonyl)-1-piperidinyl]-thieno[2,3-b]pyridine-2-carboxamide ; "
28,19.0,"indirubin deriv. 7a ; 6-Bromoindirubin-3'-oxime ; (2'Z,3'E)-6-Bromoindirubin-3'-oxime ; (3E)-6'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-OXIME ; (2'Z,3'E)-6-Bromoindirubin-3′-oxime ; 6-Bromoindirubin-3-oxime ; GSK-3 Inhibitor IX ; 667463-62-9 ; (3Z)-6-Bromo-3-[(3E)-3-(hydroxyimino)-1,3-dihydro-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one ; [667463-62-9] ; 2H-Indol-2-one ; 6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro- ; 6-bromo-3-[(3E)-3-(hydroxyimino)-2,3-dihydro-1H-indol-2-ylidene]-2,3-dihydro-1H-indol-2-one ; (2Z,3E)-6'-bromo-3-(hydroxyimino)-[2,3'-biindolinylidene]-2'-one ; (E)-2,3',4,5'-tetramethoxystilbene | ; 6BIO | ; 2H-Indol-2-one,6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-,(3Z)- ; (Z)-6'-Bromo-1H,1'H-[2,3']biindolylidene-3,2'-dione 3-oxime ; 6BIO ; GSK-3InhibitorIX ; MFCD08705318 ; 6-BIO ; GSK 3 Inhibitor IX ; GSK 3 IX ; MLS 2052 ; MLS2052 ; (2Z,3E)-6-Bromoindirubin-3'-oxime ; (3Z)-6-Bromo-3-[(3E)-3-hydroxyimino-1H-indol-2-ylidene]-1H-indol-2-one ; 6-bromo-3-[(2Z,3E)-3-(hydroxyimino)-1H-indol-2-ylidene]-1H-indol-2-one ; 6-bromo-3-[(2Z,3E)-3-(hydroxyimino)-2,3-dihydro-1H-indol-2-ylidene]-2,3-dihydro-1H-indol-2-one ; (2Z,3E)-6-Bromoindirubin-3â€²-oxime ; 6BIO;6-BIO;GSK 3 IX;GSK 3 Inhibitor IX;MLS 2052;MLS2052 ; (2Z,3E)-6'-bromo-2,3'-biindole-2',3(1H,1'H)-dione 3-oxime ; BIO|(2'Z,3'E)-6-Bromoindirubin-3'-oxime ; "
29,20.0,"134-58-7 ; doramapimod ; Doramapimod (USAN) ; Doramapimod [USAN:INN] ; 285983-48-4 ; B96 ; 1-(3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)-3-(4-(2-(morpholin-4-yl)ethoxy)naphthalen-1-yl)urea ; 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3(4-(2-morpholin-4-yl-ethoxy)naphthalen-1-yl)urea ; 1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA ; Urea ; N-(3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)-N'-(4-(2-(4-morpholinyl)ethoxy)-1-naphthalenyl)- ; 3-[3-tert-Butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-1-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea ; 1-[1-(4-Methylphenyl)-3-(2-methyl-2-propanyl)-1H-pyrazol-5-yl]-3-{4-[2-(4-morpholinyl)ethoxy]-1-naphthyl}urea ; N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]- ; 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea ; 850312-12-8 ; 1-[3-tert-Butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-{4-[2-(morpholin-4-yl)ethoxy]-1-naphthyl}urea ; Kinome_2137 ; BIRB 796(Doramapimod) ; BIRB 796 (Doramapimod) ; Doramapimod ; Free Base ; Doramapimod ; BIRB-796 ; 285983-48-4 ; 1283526-53-3 (HCl) ; MFCD09752957 ; N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]-urea ; 1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea ; cid_156422 ; [285983-48-4] ; 1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea ; 1-[5-tert-butyl-2-(4-methylphenyl)-3-pyrazolyl]-3-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]urea ; BIRB 796BS ; 1-[5-tert-butyl-2-(4-methylphenyl)-3-pyrazolyl]-3-[4-(2-morpholinoethoxy)-1-naphthyl]urea ; 1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-morpholinoethoxy)-1-naphthyl]urea ; UNII-HO1A8B3YVV ; BIRB 796BS|BIRB-796 ; 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea ; Doramapimod,BIRB-796 ; BIRB796 ; 1-[2-(4-methylphenyl)-5-tert-butyl-pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea ; BIBR-796 ; UNII:HO1A8B3YVV ; 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naphthalen-1-yl]-urea ; BIRB 796;BIRB-796;BIRB796 ; Doramapimod | ; YT0099000 ; 1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea ; N-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea ; HO1A8B3YVV ; 8325 ; atoms 39 bonds 43 ; doramapimod (birb 796) ; doramapimod (birb-796) ; "
30,21.0,"3a-Hydroxy-6-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one ; 4H-Pyrrolo[2,3-b]quinolin-4-one ; 1,2,3,3a-tetrahydro-3a-hydroxy-6-methyl-1-phenyl- ; C472645 ; Blebbistatin ; (±)-1,2,3,3a-Tetrahydro-3a-hydroxy-6-methyl-1-phenyl-4H-pyrrolo[2,3-b]quinolin-4-one ; 674289-55-5 ; (±)-Blebbistatin ; [674289-55-5] ; (S)-(-)-Blebbistatin ; 3a-hydroxy-6-methyl-1-phenyl-1H,2H,3H,3aH,4H-pyrrolo[2,3-b]quinolin-4-one ; 856925-71-8 ; Blebbistatin (±)- ; 2,2'-Pyridylisatogen tosylate | ; (+)-Blebbistatin ; 1177356-70-5 ; (¡À)-Blebbistatin ; (-)-Blebbistatin ; (ñ)-Blebbistatin ; 1,2,3,3a-tetrahydro-3a-hydroxy-6-methyl-1-phenyl-4H-pyrrolo[2,3-b]quinolin-4-one ; BLEBBISTATIN ; BLEBBISTATIN ; (3aS)-3a-hydroxy-6-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one ; (-)-Blebbistcitin ; MFCD08460907 ; MFCD04113775 ; MFCD08460906 ; 3a-hydroxy-6-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one ; 3A-HYDROXY-6-METHYL-1-PHENYL-2H,3H-PYRROLO[2,3-B]QUINOLIN-4-ONE ; 8WII7624I5 ; XWG1958E8I ; (±)bebbistatin ; "
31,176.0,"1072443-89-0 ; 1,2,4-Trideoxy-4-(methylamino)-1-(4-pentylphenyl)-D-erythro-pent-1-enitol hydrochloride ; (1E)-1,2,4-Trideoxy-4-(methylamino)-1-(4-pentylphenyl)-D-erythro-pent-1-enitol hydrochloride (1:1) ; D-erythro-Pent-1-enitol ; 1,2,4-trideoxy-4-(methylamino)-1-(4-pentylphenyl)- ; hydrochloride (1:1) ; "
32,22.0,"BMS-345541 ; N-(1,8-Dimethylimidazo[1,2-a]quinoxalin-4-yl)-1,2-ethanediamine hydrochloride ; 547757-23-3 ; N-(2-aminoethyl)-1,8-dimethylimidazo[1,2-a]quinoxalin-4-amine hydrochloride ; N-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine hydrochloride (1:1) ; BMS 345541 ; N1-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine hydrochloride ; 1,2-Ethanediamine ; N1-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)- ; hydrochloride (1:1) ; N-(1,8-Dimethylimidazo[1,2-a]quinoxalin-4-yl)-1,2-ethanediamine hydrochloride (1:1) ; BMS-345541 hydrochloride;BMS 345541 hydrochloride ; MFCD07784499 ; UNII-BXU277OCN5 ; [547757-23-3] ; BMS 345541 hydrochloride ; BMS345541 hydrochloride ; BMS-345541 hydrochloride ; UNII:BXU277OCN5 ; BMS345541 hydrochloride;BMS-345541 hydrochloride;BMS 345541 hydrochloride ; N1-{1,8-DIMETHYLIMIDAZO[1,2-A]QUINOXALIN-4-YL}ETHANE-1,2-DIAMINE HYDROCHLORIDE ; Not available ; BXU277OCN5 ; N'-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine;hydrochloride ; "
33,329.0,"Bosutinib ; Bosutinib (USAN) ; Bosutinib [USAN] ; K00615a ; 380843-75-4 ; 3-Quinolinecarbonitrile ; 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)- ; 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile ; 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile ; 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile ; 3-Quinolinecarbonitrile ; 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]- ; 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile ; 9100307 ; SKI 606 ; Bosutinib(SKI-606) ; 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazinyl)propoxy]quinoline-3-carbonitrile ; SKI-606 | ; BOSULIF ; Bosutinib monohydrate ; Bosutinib (SKI-606) ; 4-(2,4-Dichloro-5-methoxy-phenylamino)-6-methoxy-7-[3-(4-methyl-piperazin-1-yl)propoxy]quinoline-3-carbonitrile ; 4-(2,4-dichloro-5-methoxyphenylamino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile ; MFCD07367846 ; 4-(3,5-Dichloro-4-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile ; VB0990000 ; [380843-75-4] ; 4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile ; 4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile ; SK 606 ; SK-606 ; Bosulif® ; Bosutinib (SKI606) ; 4-[(2,4-dichloro-5-methoxy-phenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile ; CHEBI:39112 ; UNII-5018V4AEZ0 ; MFCD22418831 ; SKI606 ; Bosulif® ; Bosutinib Monohydrate ; SKI-606 ; WAY-173606 ; 1391063-17-4 ; UNII:5018V4AEZ0 ; SKI-606;SKI606;SKI 606 ; Bosutinib Isomer 1 ; Free Base ; 5018V4AEZ0 ; DB8 ; 博舒替尼 ; "
34,23.0,"N-(3-{[5-BROMO-2-({3-[(PYRROLIDIN-1-YLCARBONYL)AMINO]PHENYL}AMINO)PYRIMIDIN-4-YL]AMINO}PROPYL)-2,2-DIMETHYLMALONAMIDE ; 702676-93-5 ; N-(3-(4-(3-(3-amino-2,2-dimethyl-3-oxopropanamido)propylamino)-5-bromopyrimidin-2-ylamino)phenyl)pyrrolidine-1-carboxamide ; BX-320 ; Propanediamide ; N-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-dimethyl- (9CI) ; N1-(3-((5-bromo-2-((3-(pyrrolidine-1-carboxamido)phenyl)amino)pyrimidin-4-yl)amino)propyl)-2,2-dimethylmalonamide ; BX320 ; N-(3-{[5-Bromo-2-({3-[(1-pyrrolidinylcarbonyl)amino]phenyl}amino)-4-pyrimidinyl]amino}propyl)-2,2-dimethylmalonamide ; N'-[3-[[5-bromo-2-[[3-(pyrrolidin-1-ylcarbonylamino)phenyl]amino]pyrimidin-4-yl]amino]propyl]-2,2-dimethyl-propanediamide ; N'-[3-[[5-bromo-2-[[3-(pyrrolidine-1-carbonylamino)phenyl]amino]pyrimidin-4-yl]amino]propyl]-2,2-dimethyl-malonamide ; N'-[3-[[5-bromo-2-[[3-(pyrrolidine-1-carbonylamino)phenyl]amino]pyrimidin-4-yl]amino]propyl]-2,2-dimethylpropanediamide ; N'-[3-[[5-bromo-2-[[3-(pyrrolidine-1-carbonylamino)phenyl]amino]pyrimidin-4-yl]amino]propyl]-2,2-dimethyl-propanediamide ; N'-[3-[[5-bromo-2-[[3-[(oxo-1-pyrrolidinylmethyl)amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-dimethylpropanediamide ; UNII-B504GXS5SM ; UNII:B504GXS5SM ; B504GXS5SM ; "
35,26.0,N-(3-(4-(3-(Thiophene-2-carbonylamino)propylamino)-5-iodopyrimidin-2-ylamino)phenyl)pyrrolidine-1-carboxamide ; N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide ; 702675-74-9 ; BX-795 ; n-(3-((5-iodo-4-((3-((2-thienylcarbonyl)amino)propyl)amino)-2-pyrimidinyl)amino)phenyl)-1-pyrrolidinecarboxamide ; BX 795 ; BX795 ; Pyrrolidine-1-carboxylic acid [3-(5-iodo-4-{3-[(thiophene-2-carbonyl)-amino]-propylamino}-pyrimidin-2-ylamino)-phenyl]-amide ; 1-Pyrrolidinecarboxamide ; N-[3-[[5-iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]- ; N-(3-{[5-Iodo-4-({3-[(2-thienylcarbonyl)amino]propyl}amino)-2-pyrimidinyl]amino}phenyl)-1-pyrrolidinecarboxamide ; N-(3-((5-iodo-4-((3-(thiophene-2-carboxamido)propyl)amino)pyrimidin-2-yl)amino)phenyl)pyrrolidine-1-carboxam ; MFCD12546134 ; N-[3-[[5-iodo-4-[3-(thiophene-2-carbonylamino)propylamino]pyrimidin-2-yl]amino]phenyl]pyrrolidine-1-carboxamide ; N-[3-[[5-iodo-4-[3-[[oxo(thiophen-2-yl)methyl]amino]propylamino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide ; BX 795|BX795 ; N-(3-((5-iodo-4-((3-(thiophene-2-carboxamido)propyl)amino)pyrimidin-2-yl)amino)phenyl)pyrrolidine-1-carboxamide ; [702675-74-9] ; N-(3-(4-(2-(2-Formamidothiophen-3-yl)propanamido)-5-iodopyrimidin-2-ylamino)phenyl)pyrrolidine-1-carboxamide ; BX 795;BX-795 ; N-{3-[(5-IODO-4-{[3-(THIOPHEN-2-YLFORMAMIDO)PROPYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}PYRROLIDINE-1-CARBOXAMIDE ; N-(3-((5-iodo-4-((3-((2-thienylcarbonyl)amino)propyl)amino)-2-pyrimidinyl)-amino)phenyl)-1-pyrrolidinecarboxamide ; Not available ; BX7 ; N-(3-{[5-Iodo-4-({3-[(Thiophen-2-Ylcarbonyl)amino]propyl}amino)pyrimidin-2-Yl]amino}phenyl)pyrrolidine-1-Carboxamide ; N-(3-{[5-IODO-4-({3-[(THIOPHEN-2-YL)FORMAMIDO]PROPYL}AMINO)PYRIMIDIN-2-YL]AMINO}PHENYL)PYRROLIDINE-1-CARBOXAMIDE ; Untitled Document ; 
36,320.0,"N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-yl)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide ; 702674-56-4 ; BX-912 ; Pyrrolidine-1-carboxylic acid (3-{5-bromo-4-[2-(1H-imidazol-4-yl)-ethylamino]-pyrimidin-2-ylamino}-phenyl)-amide ; BX 912 ; 1-Pyrrolidinecarboxamide ; N-[3-[[5-bromo-4-[[2-(1H-imidazol-4-yl)ethyl]amino]-2-pyrimidinyl]amino]phenyl]- ; N-(3-((4-((2-(1H-imidazol-5-yl)ethyl)amino)-5-bromopyrimidin-2-yl)amino)phenyl)pyrrolidine-1-carboxamide ; BX912 ; MFCD10565925 ; N-{3-[(5-Bromo-4-{[2-(1H-imidazol-4-yl)ethyl]amino}-2-pyrimidinyl)amino]phenyl}-1-pyrrolidinecarboxamide ; 1-Pyrrolidinecarboxamide ; N-[3-[[5-bromo-4-[[2-(1H-imidazol-5-yl)ethyl]amino]-2-pyrimidinyl]amino]phenyl]- ; N-{3-[(5-Bromo-4-{[2-(1H-imidazol-5-yl)ethyl]amino}-2-pyrimidinyl)amino]phenyl}-1-pyrrolidinecarboxamide ; N-(3-((4-((2-(1H-imidazol-4-yl)ethyl)amino)-5-bromopyrimidin-2-yl)amino)phenyl)pyrrolidine-1-carboxamide ; N-[3-[[5-bromo-4-[2-(1H-imidazol-5-yl)ethylamino]pyrimidin-2-yl]amino]phenyl]pyrrolidine-1-carboxamide ; N-[3-[[5-bromo-4-[2-(1H-imidazol-5-yl)ethylamino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide ; N-[3-[[5-bromo-4-[2-(3H-imidazol-4-yl)ethylamino]pyrimidin-2-yl]amino]phenyl]pyrrolidine-1-carboxamide ; BX 912|BX912 ; [702674-56-4] ; Pyrrolidine-1-carboxylic acid (3-(5-bromo-4-[2-(1H-imidazol-4-yl)-ethylamino]-pyrimidin-2-ylamino)-phenyl)-amide ; BX912;BX 912 ; N-{3-[(5-BROMO-4-{[2-(3H-IMIDAZOL-4-YL)ETHYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}PYRROLIDINE-1-CARBOXAMIDE ; N-(3-((5-bromo-4-((2-(1H-imidazol-4-yl)ethyl)amino)-2-pyrimidinyl)amino)phenyl)-1-pyrrolidinecarboxamide ; bx9121-pyrrolidinecarboxamide,n-[3-[[5-bromo-4-[[2-(1h-imidazol-4-yl)ethyl]amino]-2-pyrimidinyl]amino]phenyl]- ; c20h23brn8o ; N-{3-[(5-BROMO-4-{[2-(1H-IMIDAZOL-4-YL)ETHYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}PYRROLIDINE-1-CARBOXAMIDE ; N-{3-[(5-BROMO-4-{[2-(1H-IMIDAZOL-5-YL)ETHYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}PYRROLIDINE-1-CARBOXAMIDE ; "
37,312.0,"3-(2-(methylsulfonyl)benzyloxy)-5-(5,6-dimethoxy-1H-benzo[d]imidazol-1-yl)thiophene-2-carbonitrile ; 2-Thiophenecarbonitrile ; 5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(methylsulfonyl)phenyl]methoxy]- ; 862812-98-4 ; 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarbonitrile ; 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(methylsulfonyl)benzyl]oxy}-2-thiophenecarbonitrile ; benzimidazole-thiophene carbonitrile ; 12e ; IKK-3 Inhibitor ; GSK319347A ; [862812-98-4] ; MFCD10567700 ; 5-(5,6-dimethoxybenzimidazol-1-yl)-3-[(2-methylsulfonylphenyl)methoxy]thiophene-2-carbonitrile ; 5-(5,6-DIMETHOXY-1H-BENZIMIDAZOL-1-YL)-3-((2-(METHYLSULFONYL)PHENYL)METHOXY)-2-THIOPHENECARBONITRILE ; 5-(5,6-dimethoxy-1-benzimidazolyl)-3-[(2-methylsulfonylphenyl)methoxy]-2-thiophenecarbonitrile ; GSK 319347A ; Not available ; "
38,327.0,"Tripterine ; 34157-83-0 ; D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid ; 3-hydroxy-2-oxo- ; (20alpha)- ; 2-Picenecarboxylic acid ; 1,2,3,4,4a,5,6,6a ; 11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b ; 14a-hexamethyl-11-oxo- ; (20alpha)-3-hydroxy-2-oxo-D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid ; 1,2,3,4,4a,5,6,6a ; 11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b ; 14a-hexamethyl-11-oxo-2-Picenecarboxylic acid ; (2R,4aS,6aS,12bR,14aS,14bR)-10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-picene-2-carboxylic acid ; (2R,4aS,6aS,12bR,14aS,14bR)-10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid ; 2-Picenecarboxylic acid ; 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo- ; (2R,4aS,6aS,12bR,14aS,14bR)- ; Celastrol ; Celastrus scandens ; [34157-83-0] ; (9b,13a,14b,20a)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid ; (2R,4aS,6aS,12bR,14aS,14bR)-10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-2-picenecarboxylic acid ; 3-hydroxy-9beta,13alpha-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid ; (2R,4aS,6aS,12bR,14aS,14bR)-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-2-picenecarboxylic acid ; 3-hydroxy-9.beta.,13.alpha.-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid ; 2-Picenecarboxylic acid ; 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo- ; Tripterin ; 3-Hydroxy-2-oxo-24-nor-D:A-friedooleana-1(10),3,5,7-tetraen-29-oic acid ; (20alpha)-3-hydroxy-2-oxo-D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oate ; (2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid ; MFCD03424073 ; (2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid ; (2R,4aS,6aS,6aR,14aS,14bR)-10-hydroxy-11-keto-2,4a,6a,6a,9,14a-hexamethyl-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid ; (2R,4aS,6aS,6aR,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid ; 3-Hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic Acid ; BSPBio_001905 ; Celastrol ; <i>Celastrus scandens ; IDI1_000718 ; SPECTRUM201664 ; Spectrum5_000805 ; UNII-L8GG98663L ; 10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-picene-2-carboxylic acid ; 10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid ; UNII:L8GG98663L ; CELASTROL (TRIPTERIN) ; TRITERPENE ; L8GG98663L ; Celastrol|Tripterin ; "
39,28.0,"CGP 57380 ; CGP57380 ; N3-(4-fluorophenyl)-1h-pyrazolo[3,4-d]pyrimidine-3,4-diamine ; C466997 ; CGP-57380 ; N3-(4-Fluorophenyl)-1H-pyrazolo-[3,4-d]pyrimidine-3,4-diamine ; 522629-08-9 ; [522629-08-9] ; 3-N-(4-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidine-3,4-diamine ; N-(4-Fluorophenyl)-1H-pyrazolo-[3,4-d]pyrimidine-3,4-diamine ; MNK1 Inhibitor ; 4-Amino-5-(4-fluoroanilino)-pyrazolo[3,4-d]pyrimidine ; 1H-Pyrazolo[3,4-d]pyrimidine-3,4-diamine ; N3-(4-fluorophenyl)- ; MFCD03861062 ; 3-N-(4-fluorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-3,4-diamine ; CGP 57380|CGP-57380 ; CHEMBL1240885 ; IN1236 ; S7421,522629-08-9 ; "
40,31.0,"Chelerythrine ; Toddalin ; Chelerythrine chloride ; 251-930-0 ; 34316-15-9 ; 1,2-Dimethoxy-N-methyl(1,3)benzodioxolo(5,6-c)phenanthridinium chloride ; 3895-92-9 ; Chelerythrine ; chloride ; Chelerythrine hydrochloride ; 223-444-9 ; Chelerythrine ; hydroxide ; hydrochloride (8CI) ; 1,2-Dimethoxy-12-methyl(1,3)benzodioxolo(5,6-c)phenanthridinium chloride ; (1,3)Benzodioxolo(5,6-c)phenanthridinium ; 1,2-dimethoxy-12-methyl- ; chloride (9CI) ; CHAPS ; 75621-03-3 ; Chelerythrine ; hydroxide ; hydrochloride ; 1,2-Dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridinium chloride ; EINECS 223-444-9 ; 1,2-Dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium chloride ; [1,3]Benzodioxolo[5,6-c]phenanthridinium ; 1,2-dimethoxy-12-methyl- ; chloride (1:1) ; Chlorure de 1,2-diméthoxy-12-méthyl[1,3]benzodioxolo[5,6-c]phénanthridin-12-ium ; 1,2-Dimethoxy-12-methyl[1,3]dioxolo[4,5]benzo[1,2-c]phenanthridin-12-iumchlorid ; 1,2-Dimethoxy-N-methyl(1,3)benzodioxolo(5,6-c) phenanthridinium chloride ; [34316-15-9] ; 1,2-dimethoxy-12-methyl-9H-phenanthridino[4',3'-5,4]benzo[d]1,3-dioxolane ; chloride ; MK 678 | ; 1,2-Dimethoxy-12-methyl-[1,3]dioxolo[4',5':4,5]benzo[1,2-c]phenanthridin-12-ium chloride ; 1,2-Dimethoxy-12-methyl-[1,3]dioxolo[4',5':4,5]-benzo[1,2-c]phenanthridin-12-ium chloride ; MFCD00060717 ; 1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridinium ; monochloride ; CHELERYTHRINECHLORIDE ; FL9200000 ; [3895-92-9] ; Chelerythrine (chloride) ; [1,3]Benzodioxolo[5,6-c]phenanthridinium ; 1,2-dimethoxy-12-methyl- ; chloride ; 1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium ; CHEMBL258893 ; 1,2-dimethoxy-12-methyl-[1,3]Benzodioxolo[5,6-c]phenanthridinium ; Chelerythrin Chloride ; 1,2-dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridiniumchloride ; 1,2-DIMETHOXY-N-METHYL-[1,3]BENZODIOXOLO[5,6-C]PHENANTHRIDINIUM CHLORIDE ; 1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium;chloride ; 1,2-dimethoxy-12-methyl-[1,3]dioxolo[4,5:4,5]-benzo[1,2-c]phenanthridin-12-ium chloride ; Toddalin|Chelerythrine chloride ; "
41,33.0,"acetic acid ; ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy) ; 6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile ; 3-pyridinecarbonitrile ; 6-[[2-[[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]- ; 6-(2-(4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino)ethylamino)nicotinonitrile ; CHIR-99021 ; 252917-06-9 ; Kinome_3785 ; CHIR-99021(CT99021) ; CT 99021 ; CHIR 99021 ; CHIR99021(CT99021) ; CT99021 ; 6-[2-[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino]ethylamino]pyridine-3-carbonitrile ; CHIR99021 ; Free Base ; CHIR99021 ; 3-PYRIDINECARBONITRILE,6-[[2-[[4-(2,4-DICHLOROPHENYL)-5-(5-METHYL-1H-IMIDAZOL-2-YL)-2-PYRIMIDINYL]AMINO]ETHYL]AMINO]- ; CHIR-99021 (CT99021) HCl ; 6-[[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile ; 6-{2-[4-(2,4-Dichloro-phenyl)-5-(5-methyl-1H-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-nicotinonitrile ; 3-Pyridinecarbonitrile ; 6-[[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]- ; 6-[(2-{[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino}ethyl)amino]nicotinonitrile ; 6-((2-((4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile ; GSK-3 Inhibitor XVI ; MFCD12546133 ; 6-(2-(4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino)ethylamino)nicotinonitrile hydrochloride ; 6-(2-(4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)-pyrimidin-2-ylamino)ethyl-amino)-nicotinonitrile ; MFCD11846251 ; 6-[(2-{[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino}ethyl)amino]nicotinonitrile ; 6-[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile ; CHIR 911 ; GSK-3 Inhibitor XVI ; CHIR 911 ; GSK-3 Inhibitor XVI ; 6-[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethylamino]-3-pyridinecarbonitrile ; CT-99021 ; UNII-234CMT4GK4 ; CHIR 99021|CHIR99021|CT-99021|CT99021 ; 6-((2-((4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile ; [252917-06-9] ; MFCD23704170 ; 6-[2-[[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile ; CHIR-99021 (CT99021) ; UNII:234CMT4GK4 ; CT99021;CHIR99021;CHIR 99021;CT-99021 ; 6-[(2-{[4-(2,4-DICHLOROPHENYL)-5-(4-METHYL-3H-IMIDAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}ETHYL)AMINO]PYRIDINE-3-CARBONITRILE ; CHIR99021 ; CHIR-99021 ; CHIR 99021 ; CT99021,GSK-3 Inhibitor XVI ; CHIR-911 ; Not available ; 65C ; 6-[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-2-imidazolyl)-2-pyrimidinyl]amino]ethylamino]-3-pyridinecarbonitrile ; 234CMT4GK4 ; culturesure® chir99021 ; CHIR99021|CHIR 911 ; GSK-3 Inhibitor XVI ; "
42,35.0,"Compound C ; 6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine ; 6-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]-3-PYRIDIN-4-YLPYRAZOLO[1,5-A]PYRIMIDINE ; AMPK Inhibitor ; Dorsomorphin ; 4-(6-{4-[2-(Piperidin-1-yl)ethoxy]phenyl}pyrazolo[1,5-a]pyrimidin-3-yl)pyridine ; 6-{4-[2-(1-Piperidinyl)ethoxy]phenyl}-3-(4-pyridinyl)pyrazolo[1,5-a]pyrimidine ; Pyrazolo[1,5-a]pyrimidine ; 6-[4-[2-(1-piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)- ; 6-{4-[2-(1-Piperidinyl)ethoxy]phenyl}-3-(4-pyridinyl)pyrazolo[1,5-a]pyrimidin ; BML-275 ; 866405-64-3 ; [866405-64-3] ; 4-(6-{4-[2-(Piperidin-1-yl)ethoxy]phenyl}pyrazolo[1,5-alpha]pyrimidin-3-yl)pyridine ; 1219168-18-9 ; 1062368-24-4 ; AMPK Inhibitor ; Compound C ; 6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-3-pyridin-4-yl-pyrrazolo[1,5-a]-pyrimidine ; MFCD08705402 ; 6-[4-[2-(1-piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)-pyrazolo[1,5-a]pyrimidine ; BML275 ; 6-{4-[2-(piperidin-1-yl)ethoxy]phenyl}-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine ; MFCD0870540 ; 6-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]-3-P ; BML 275 ; BML-275 free base ; Dorsomorphin (Compound C) ; BML-275;Compound C;BML275;BML 275 ; dorsomorphin(bml-275) ; dorsomorphin(compoundc) ; "
43,204.0,"3-{(3R,4R)-4-Methyl-3-[methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile ; 1-piperidinepropanenitrile ; 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo- ; (3R,4R)- ; 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile ; 477600-75-2 ; 3-{(3R,4R)-4-Methyl-3-[methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanonitril ; 3-{(3R,4R)-4-methyl-3-[methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile ; 3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile ; 3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4YL)AMINO)PIPERIDIN-1-YL)-3-OXOPROPANENITRILE ; 937669-80-2 ; CP-690550(Tasocitinib) ; Tasocitinib ; Tofacitinib ; Tofacitinib citrate ; CP690550(Tasocitinib) ; (Discontiuned due to Pfizer patent) 3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXOPROPANENITRILE ; tofacitinib ; tofacitinibum ; 3-((3R,4r)-4-methyl-3-(methyl (7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile ; Tofacitinib (CP-690550 ; Tasocitinib) ; 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile ; Tasocitinib ; Tofacitinib ; 3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile ; 1-Piperidinepropanenitrile ; 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-b-oxo- ; (3R,4R)- ; 3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile ; MFCD11035919 ; 1259404-17-5 ; 3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrilato ; racemic-Tasocitinib ; MFCD22628813 ; (3r,4r)-Tofacitinib ; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile ; racemic-tofacitinib ; 1259404-17-5 ; 477600-75-2 ; 540737-29-9 ; 3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)-1-piperidinyl]-3-oxopropanenitrile ; 3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)-1-piperidyl]-3-oxo-propanenitrile ; 3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)piperidin-1-yl]-3-oxopropanenitrile ; 3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)piperidin-1-yl]-3-oxo-propanenitrile ; 3-keto-3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)-1-piperidyl]propionitrile ; UNII-87LA6FU830 ; tofacitinibum ; [477600-75-2] ; Tofacitinib (CP-690550,Tasocitinib) ; 3-((3R,4R)-rel-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile ; UNII:87LA6FU830 ; Tasocitinib;CP-690550;CP 690550;CP690550 ; 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr ; 87LA6FU830 ; Tasocitinib ; Tofacitinibum ; MI1 ; 3-((3r,4r)-4-methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile(wxc01414) ; ck2inhibitor10 ; cp6905503-((3r,4r)-4-methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile ; tasocitinib (cp 690550) ; tofacitinib(cp-690550) ; tofacitinib(cp-690550,tasocitinib) ; 1-piperidinepropanenitrile ; 4-methyl-3-(methyl-7h-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo- ; (3r,4r)- ; tofacitinib,cp-690550 ; "
44,341.0,670220-88-9 ; 1-(2-{5-[(3-methyloxetan-3-yl)methoxy]-1H-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine ; 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl]-8-quinolinyl]-4-piperidinamine ; CP868569 ; Crenolanib ; CP868569 ; CP-868596 ; Crenolanib (CP-868596) ; CP-868569 ; 1-(2-{5-[(3-Methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl}-8-quinolinyl)-4-piperidinamine ; 4-Piperidinamine ; 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl]-8-quinolinyl]- ; cp868596 ; 1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine ; 1-(2-(5-((3-Methyloxetan-3-yl)methoxy)-1H-benzo-[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine ; CP 868596 ; [1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]-8-quinolyl]-4-piperidyl]amine ; 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolyl]-4-piperidinamine ; 1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]-8-quinolyl]piperidin-4-amine ; UNII-LQF7I567TQ ; ARO-002|CP 868596|CP-868596 ; 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine ; [670220-88-9] ; MFCD21609260 ; 1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine ; UNII:LQF7I567TQ ; CP-868596;CP 868596;CP868596 ; Crenolanib(CP-868569) ; cp-868596 (crenolanib) ; 9459 ; LQF7I567TQ ; 1-â€‹[2-â€‹[5-â€‹[(3-â€‹methyl-â€‹3-â€‹oxetanyl)â€‹methoxy]â€‹-â€‹1H-â€‹benzimidazol-â€‹1-â€‹yl]â€‹-â€‹8-â€‹quinolinyl]â€‹-4-â€‹piperidinamine ; crenolanib(cp-868596) ; Crenolanib|CP 868596 ; 1-​[2-​[5-​[(3-​methyl-​3-​oxetanyl)​methoxy]​-​1H-​benzimidazol-​1-​yl]​-​8-​quinolinyl]​-4-​piperidinamine ; 
45,41.0,"458-37-7 ; Flubendazole ; Fluvermal ; Flubenol ; Flumoxal ; Flumoxane ; Flicum ; Flubendazole [USAN:BAN:INN] ; 250-624-4 ; Methyl 5-(p-fluorobenzoyl)-2-benzimidazolecarbamate ; R 17,889 ; 31430-15-6 ; Methyl N-(5-(p-fluorobenzoyl)-2-benzimidazolyl)carbamate ; 2-Benzimidazolecarbamic acid ; 5- (p-fluorobenzoyl)- ; methyl ester ; (5-(4-Fluorobenzoyl)-1H-benzimidazole-2-yl)carbamic acid methyl ester ; 2-Benzimidazolecarbamic acid ; 5-(p-fluorobenzoyl)- ; methyl ester ; carbamic acid ; (5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl)- ; methyl ester ; Carbamic acid ; [5- (4-fluorobenzoyl)-1H-benzimidazol-2-yl]- ; methyl ester ; N-{5-[(4-Fluorophenyl)carbonyl]benzimidazol-2-yl}methyloxymethanamide ; 37893-02-0 ; 5-(p-Fluorobenzoyl)-2-benzimidazolecarbamic Acid Methyl Ester ; [5-(4-Fluorobenzoyl)-1H-benzimidazol-2-yl]carbamic Acid Methyl Ester ; methyl {6-[(4-fluorophenyl)carbonyl]-1H-benzimidazol-2-yl}carbamate ; carbamic acid ; [6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]- ; methyl ester ; Carbamic acid ; N-[5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]- ; methyl ester ; Methyl-{5-[(4-fluorphenyl)carbonyl]-1H-benzimidazol-2-yl}carbamat ; Methyl {5-[(4-fluorophenyl)carbonyl]-1H-benzimidazol-2-yl}carbamate ; Flumoxanal ; Methyl [5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate ; EINECS 250-624-4 ; Flubendazol [INN-Spanish] ; fluoromebendazole ; methyl(5-(4-fluorobenzoyl)-1H-benzimidazol- 2-yl)carbamate ; methyl-[5-(4-fluorbenzoyl)-1h-benzimidazol-2-yl]carbamat ; [5-(4-Fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate de méthyle ; TL8002403 ; C018945 ; Carbamicacid ; [5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]-methylester ; carbamic acid ; N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]- ; methyl ester ; Methyl [6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate ; N-{6-[(4-fluorophenyl)carbonyl]benzimidazol-2-yl}methoxycarboxamide ; Biovermin ; Flutelmium ; Methyl (5-(4-fluorobenzoyl)-1H-benzo[d]imidazol-2-yl)carbamate ; Flubendazole (Flutelmium) ; Methyl (5-(4-fluorobenzoyl)-1H-benzo-[d]imidazol-2-yl)carbamate ; flubendazol ; flubendazole ; flubendazolum ; methyl N-[5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate ; [31430-15-6] ; DD6497500 ; Flubendazole ; Antibiotic for Culture Media Use Only ; Carbamic acid ; [5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]- ; methyl ester ; OR-0982 ; methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate ; Flubendazol ; D04200 ; Flubendazole (USAN) ; Flubendazolum [INN-Latin] ; methyl N-[6-(4-fluorophenyl)carbonyl-1H-benzimidazol-2-yl]carbamate ; MLS000759477 ; N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamic acid methyl ester ; N-[6-[(4-fluorophenyl)-oxomethyl]-1H-benzimidazol-2-yl]carbamic acid methyl ester ; SMR000466360 ; UNII-R8M46911LR ; flubendazolum ; N-[6-(4-fluorobenzoyl)-1H-1,3-benzodiazol-2-yl]methoxycarboximidic acid ; UNII:R8M46911LR ; Flumoxanal;Flutelmium ; '31430-15-6 ; R8M46911LR ; flubendazole standard ; 3904 ; Flubendazole for system suitability ; N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]-carbamic acid ; methyl ester ; Flubendazol ; Ph. Eur. grade ; "
46,42.0,"K00227 ; 4-[4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl]benzamide ; Benzamide ; 4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]- ; 4-(4-(2,3-Dihydrobenzo[1,4]dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide ; D 4476 ; [301836-43-1] ; 301836-43-1 ; 4-[4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide ; D4476 ; 4-(4-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide ; CASEIN KINASE I INHIBITOR ; 4-[4-(2,3-dihydro-1,4-benzodioxin-7-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide ; 4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)1H-imidazol-2-yl]-benzamide ; 4-[4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)1H-imidazol-2-yl]benzamide ; Casein Kinase I Inhibitor;D 4476;D-4476 ; 4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide ; CHEMBL410456 ; casein kinase I inhibitor ; CK1 inhibitor ; CK1 inhibitor|D 4476 ; MFCD09037526 ; D-4476 ; Not available ; 4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)-1h-imidazol-2-yl]-benzamide ; d4476 (d-4476) ; "
47,328.0,"Erlotinib hydrochloride ; 183319-69-9 ; Dasatinib ; Sprycel ; Dasatinib (USAN) ; Dasatinib [USAN] ; SPRYCEL (TN) ; 302962-49-8 ; 1N1 ; 5-Thiazolecarboxamide ; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)- ; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide ; N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide ; 5-Thiazolecarboxamide ; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]- ; N-(2-Chlor-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazol-5-carboxamid ; N-(2-Chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl}amino)-1,3-thiazole-5-carboxamide ; (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide ; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide ; 960114-13-0 ; 863127-77-9 ; BMS Dasatinib ; Dasatinib Hydrate ; Dasatinib ; BMS 354825 ; 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide ; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide ; BMS-354825 ; Sprycel ; BMS354825 ; Dasatinib monohydrate ; 2-{6-[4-(2-Hydroxy-ethyl)-piperazin-1-yl]-2-methyl-pyrimidin-4-ylamino}-thiazole ; dasatinibum [INN_la] ; 302962-49-8£¬863127-77-9 ; Dasatinib (anhydrous) ; anh. dasatinib ; anhydrous dasatinib ; dasatinib (anh.) ; dasatinib ; dasatinibum ; MFCD11046566 ; MFCD08704581 ; Dasatinib (BMS-354825) ; BMS 354825 ; Sprycel ; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide ; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide monohydrate ; [302962-49-8] ; N-(2-Chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide ; Dasatinib anhydrous ; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide ; monohydrate ; BCB03_000715 ; N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide ; NSC732517 ; NSC-732517 ; UNII-X78UG0A0RN ; dasatinibum ; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5- ; Spyrcel ; UNII:X78UG0A0RN ; BMS-354825;Sprycel;BMS354825;BMS 354825 ; DASATINIB-D8 ; 1132093-70-9 ; Sprycel,dasatinibum,Dasatinib,BMS-354825 ; BMS354825 ; BMS 354825 ; anh. dasatinib ; Anhydrous dasatinib ; BMS dasatinib ; Dasatinib ; Dasatinib (anh.) ; dasatinib (anhydrous) ; Dasatinibum ; N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide ; X78UG0A0RN ; Dasatinib ; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide ; BMS-354825 ; 9966762 ; T6N DNTJ A2Q D- DT6N CNJ B1 FM- BT5N CSJ DVMR BG F1 ; dasatinib d8 ; dasatinib(bms-354825) ; 8712 ; 达沙替尼(无水) ; Dasatinib (BMS-354825 ; Sprycel) ; DB01254 ; "
48,283.0,"Fumaric acid ; 78-44-4 ; DMF ; 624-48-6 ; trans-1,2-ethylenedicarboxylic acid ; Dimethyl fumarate ; Methyl fumarate ; Fumaric acid ; dimethyl ester ; Boletic acid dimethyl ester ; Dimethyl but-2-enedioate ; Dimethyl fumarate (usan) ; Allomaleic acid dimethyl ester ; FUMARIC ACID DIMETHYL ESTER ; Dimethyl (2E)-2-butenedioate ; Dimethyl trans-ethylenedicarboxylate ; 2-BUTENEDIOIC ACID (E)- ; DIMETHYL ESTER ; trans-Butenedioic acid dimethyl ester ; 2-Butenedioic acid ; dimethyl ester ; 210-849-0 ; But-2-enedioic acid ; dimethyl ester ; Fumaric acid ; dimethyl ester (8CI) ; 2-Butenedioic acid (2E)- ; dimethyl ester ; 2-Butenedioic acid ; dimethyl ester ; 2-Butenedioic acid ; dimethyl ester ; Ethylene ; 1,2-bis(methoxycarbonyl)- ; trans- ; Ethylene ; 1 ; 2-bis(methoxycarbonyl)- ; trans- ; 4-02-00-02205 (Beilstein Handbook Reference) ; TRANS-1,2-ETHYLENEDICARBOXYLIC ACID DIMETHYL ESTER ; trans-1 ; 2-Ethylenedicarboxylic acid dimethyl ester ; CIS-BUTENEDIOIC ACID,DIMETHYL ESTER   MALEIC ACID,DIMETHYLESTER ; Dimethyl maleate ; Dimethyl 2-butenedioate ; 624-49-7 ; trans-butanedioic acid dimethyl ester ; 4-02-00-02205 ; Dimethylester kyseliny fumarove [Czech] ; EINECS 210-849-0 ; 1,4-dimethyl (2E)-but-2-enedioate ; dimethyl (2E)-but-2-enedioate ; Dimethyl-(2E)-but-2-endioat ; dimethyl (Z)-but-2-enedioate ; (E)-2-Butenedioic acid dimethyl ester ; But-2-enedioicaciddimethylester ; dimethyl (2E)but-2-ene-1,4-dioate ; dimethylfumarate ; 23055-10-9 ; Dimethyl fumarate | ; DIMETHYL FUMALATE ; (2E)-1,4-dimethyl ester 2-butenedioic acid ; But-2-enedioic aciddimethyl ester ; Dimethylester kyseliny fumarove ; (E)-But-2-enedioic acid dimethyl ester ; 2-Butenedioic acid (2E)- ; 1,4-dimethyl ester ; dimethyl (2E)-but-2-enedioate (en)2-Butenedioic acid ; dimethyl ester (en) ; (E)-Dimethyl fumarate ; 1,2-Bis(methoxycarbonyl)-trans-Ethylene ; Dimethyl (E)-but-2-enedioate ; Tecfidera ; dimethyl_fumarate ; MFCD00064438 ; 774590 ; EM6125000 ; MFCD00008459 ; WLN: 1OV1U1VO1 -T ; Pharmakon1600-01506154 ; 1,4-dimethyl but-2-enedioate ; BG-12 ; FR-1080 ; SBB008222 ; UNII-FO2303MNI2 ; [624-49-7] ; Dimethyl furmarate ; UNII:FO2303MNI2 ; 34516-76-2 ; dimethyl fumarate radical-anion ; 2E-butenedioic acid ; 1,4-dimethyl ester ; But-2-enedioic acid dimethyl ester ; dimethyl fumarate d6 ; dimethyl fumarate standard ; FO2303MNI2 ; Fumaric acid-dimethyl ester ; Dimethyl fumarate|Fumaric acid dimethyl ester ; Dimethyl fumarate|2E-butenedioic acid ; 1,4-dimethyl ester ; DB08908 ; "
49,43.0,"Teavigo ; TEA CATECHIN ; EGCG ; Epigallocatechin 3-gallate ; Epigallocatechin gallate ; (-)-Epigallocatechin gallate ; Galloyl-L-epigallocatechol ; Epigallocatechin-3-gallate ; (-)-Epigallocatechol gallate ; (-)-EGCG ; (-)-Epigallocatechin-3-o-gallate ; (-)-epigallocatechin 3-gallate ; Epigallocatechol ; 3-gallate ; 989-51-5 ; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate ; Benzoic acid ; 3,4,5-trihydroxy- ; (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester ; (-)-Epigallocatechin 3-O-gallate ; 3,4,5-Trihydroxybenzoic acid (2R-cis)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester ; (-)-Epigallocatehin gallate ; Epigallocatcchin Gallate ; Epigallocate ; Epigallocic acid ; Green tea extract ; (−)-Epigallocatechin gallate ; (−)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate ; (−)-cis-3,3′,4′,5,5′,7-Hexahydroxy-flavane-3-gallate ; EGCG cpd ; epigallo-catechin gallate ; Gallocatechin gallate ; C045651 ; EPIGALLOCATECHIN-3-MONOGALLATE ; 3658838 ; (-)epigallocatechin gallate ;  989-51-5  ; 3,4-DIHYDRO-5,7-DIHYDROXY-2R-(3,4,5-TRIHYDROXYPHENYL)-2H-1-BENZOPYRAN-3R-YL-3,4,5-TRIHYDROXY-BENZOATE ; (-)-Epigallocatechin gallate (EGCG) ; (-)-Epigallocatechin Gallate Hydrate ; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate ; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate ; (-)EPIGALLOCATECHIN GALLATE with HPLC ; Epigallocatechin (-)- gallate ; (±)-epigallocatechin gallate ; ()-epigallocatechin ; -Epigallocatechingallate ; Epigallocatechin gallate | ; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate ; Benzoic acid ; 3,4,5-trihydroxy- ; 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester ; (2R-cis)- ; Epigallocatechol ; 3-gallate ; Epigallocatechol ; gallate ; Gallic acid ; 3-ester with epigallocatechol ; (-)-epi-Gallocatechin 3-O-gallate ; 3-O-Galloyl-(-)-epigallocatechin ; Epigallocatechin 3-O-gallate ; L-Epigallocatechin gallate ; NVP-XAA 723 ; PF-EGCg 90 ; epi-Gallocatechin 3-O-gallate ; epi-Gallocatechin gallate ; 3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate ; 3-O-(4-Hydroxybenzoyl)epigallocatechin ; EGCG (Epigallocatechin gallate ) ; (-)-cis-3,3',4,5,5,7-Hexahydroxy-flavane-3-gallate ; (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate ; (-)-Epigallocatechin gallat ; Catechin deriv. ; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate ; (-)-Epigallocatechingallate ; KB5200000 ; [989-51-5] ; MFCD00075940 ; CHEMBL297453 ; (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate) ; )-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate ; )-Epigallocatechin gallate ; ,7-Hexahydroxy-flavane-3-gallate ; 3,4,5-trihydroxybenzoic acid [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3-chromanyl] ester ; 3,4,5-trihydroxybenzoic acid [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] ester ; ACon1_001054 ; BSPBio_001628 ; MEGxp0_001166 ; MLS000758300 ; SMR000449288 ; SPECTRUM210239 ; Spectrum5_000102 ; UNII-BQM438CTEL ; EGCG|epigallocatechin gallate ; Epigallocatechol Gallate ; (âˆ’)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate ; (âˆ’)-cis-3,3â€²,4â€²,5,5â€²,7-Hexahydroxy-flavane-3-gallate ; (âˆ’)-Epigallocatechin gallate ; 2,3,4-trihydroxybenzoic acid [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl] ester ; UNII:BQM438CTEL ; EGCG;Epigallocatechol Gallate ; KDH ; (-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate ; (-)-epigallocatechin gallate standard ; catechins ; epigallocatechin gallate(egcg) ; 表没食子儿茶素没食子酸酯 ; Epigallocatechin gallate|EGCG ; "
50,350.0,"N'-[(3,5-Difluorophenyl)(hydroxy)acetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide ; EMD638683 ; 1181770-72-8 ; EMD 638683;EMD-638683 ; 1184940-47-3 ; EMD 638683 (R-Form);EMD-638683 (R-Form) ; 1184940-46-2 ; EMD 638683 (S-Form);EMD-638683 (S-Form) ; EMD 638683 ; EMD-638683 ; EMD638683 R-Form ; EMD638683 S-Form ; MFCD25541743 ; N'-[2-(3,5-difluorophenyl)-2-hydroxyacetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide ; N'-(2-(3,5-difluorophenyl)-2-hydroxyacetyl)-2-ethyl-4-hydroxy-3-methylbenzohydrazide ; "
51,143.0,"10-(3-Aminopropyl)-3,4-dimethyl-9-acridone oxalate ; ER-27319 ; 201010-95-9 ; 10-(3-Aminopropyl)-3,4-dimethyl-9(10H)-acridinone ethanedioate (1:1) ; 9(10H)-Acridinone ; 10-(3-aminopropyl)-3,4-dimethyl- ; ethanedioate (1:1) ; 10-(3-aminopropyl)-3,4-dimethyl-9-acridinone ; 10-(3-aminopropyl)-3,4-dimethyl-acridin-9-one ; 10-(3-aminopropyl)-3,4-dimethylacridin-9-one ; UNII-218W96J218 ; UNII:218W96J218 ; 3,4-Dimethyl-10-(3-aminopropyl)-9-acridone oxalate ; 218W96J218 ; MFCD07784502 ; "
52,200.0,"Fluorene-9-carboxylic acid ; Febuxostat ; Febuxostat [USAN] ; 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid ; 144060-53-7 ; 2-(3-Cyano-4-(2-methylpropoxy)phenyl)-4-methylthiazole-5-carboxylic acid ; 2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-5-THIAZOLE-CARBOXYLIC ACID ; TEI ; 5-Thiazolecarboxylic acid ; 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl- ; 27048-04-0 ; 5-Thiazolecarboxylic acid ; 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl- ; 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid ; 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid ; MX-67 ; Adenuric ; Uloric ; 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid ; 2-(3-Cyano-4-isobutoxy-phenyl)-4-methyl-thiazole-5-carboxylic acid ; Uloric ; 2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid ; Febuxostat(Uloric) ; Uloric ; TMX-67 ; 2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid ; TMX-67;Adenuric;Uloric ; TEI 6720 | TMX 67 | ; Febuxostat(TEI 6720) ; Adenuric ; Febuxostat (Uloric) ; 2-(3-Cyano-4-isobutoxy-phenyl)-4-me ; thyl-thiazole-5-carboxylic acid ; MFCD00871598 ; 2-(3-Cyano-4-isobutoxy-phenyl)-4-me ; thyl-thiazole-5-carboxylic acid ; XJ3675310 ; [144060-53-7] ; Pharmakon1600-01504286 ; OR-2324 ; UNII-101V0R1N2E ; 2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylicacid ; Febuxostat-D9 ; FBX ; 1246819-50-0 ; Adenuric; ; Uloric; ; Goturic; ; Feburic ; UNII:101V0R1N2E ; TEI 6720 ; TMX 67 ; Uloric ; FEBUXOSTAT-D7 ; 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylic Acid (en) ; '144060-53-7 ; 101V0R1N2E ; 2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid ; Febuxostatum ; Atenuri ; DB04854 ; "
53,44.0,"634911-81-2 ; 187389-52-2 ; 211918-97-7 ; L-Alaninamide ; N-[(phenylmethoxy)carbonyl]-L-valyl-N-[(1R)-3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]- (9CI) ; N-[(Benzyloxy)carbonyl]valyl-N-(5-fluoro-1-methoxy-1,4-dioxo-3-pentanyl)alaninamide ; METHYL (3S)-5-FLUORO-3-[[(2S)-2-[[(2S)-3-METHYL-2-PHENYLMETHOXYCARBONYLAMINO-BUTANOYL]AMINO]PROPANOYL]AMINO]-4-OXO-PENTANOATE ; Benzyloxycarbonyl-Val-Ala-Asp(OMe)-­fluoromethylketone ; Alaninamide ; N-[(phenylmethoxy)carbonyl]valyl-N-[3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]- ; methyl (3S)-5-fluoro-3-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]propanoyl]amino]-4-oxopentanoate ; 5-fluoro-3-[[2-[[3-methyl-1-oxo-2-(phenylmethoxycarbonylamino)butyl]amino]-1-oxopropyl]amino]-4-oxopentanoic acid methyl ester ; Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone,Z-Val-Ala-Asp(OMe)-FMK ; Z-Val-Ala-DL-Asp(OMe)-fluoromethylketone ; "
54,45.0,"GDC-941 ; 2-(1H-Indazol-4-yl)-6-{[4-(methylsulfonyl)-1-piperazinyl]methyl}-4-(4-morpholinyl)thieno[3,2-d]pyrimidine ; Thieno[3,2-d]pyrimidine ; 2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)- ; 957054-30-7 ; 2-(1H-Indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin ; 2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-(morpholin-4-yl)thieno[3,2-d]pyrimidine ; 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine ; 4-(2-(1H-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine ; GDC-0941 ; GDC0941 ; 2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-yl-methyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine ; 2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine ; Kinome_3719 ; 957054-50-1 ; 4-{6-[(4-methanesulfonylpiperazin-1-yl)methyl]-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-2-yl}-1H-indazole ; GDC 0941 ; Pictilisib ; pictrelisib ; 2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine ; MFCD11616196 ; 2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)-thieno[3,2-d]pyrimidine ; GDC-0941bismesylate ; 4-(2-(1H-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d] ; 4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine ; 4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonyl-1-piperazinyl)methyl]-4-thieno[3,2-d]pyrimidinyl]morpholine ; GDC 941 ; GNE 0941 ; UNII-ICY00EMP8P ; GDC-0941|GDC0941|GNE 0941|pictrelisib ; [957054-30-7] ; GDC-0941 (free base) ; Pictilisib (GDC-0941) ; UNII:ICY00EMP8P ; Pictilisib;GDC 0941;GDC0941 ; 2-(1h-Indazol-4-Yl)-6-{[4-(Methylsulfonyl)piperazin-1-Yl]methyl}-4-Morpholin-4-Yl-Thieno[3,2-D]pyrimidine ; GD9 ; gdc0941(pictilisib) ; thieno[3,2-d]pyrimidine,2-(1h-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)- ; 9417 ; ICY00EMP8P ; 2-(1H-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidine ; GDC 0941|Pictilisib ; "
55,46.0,"446-95-7 ; Genistein ; Genisteol ; Genisterin ; Prunetol ; Sophoricol ; Differenol A ; Lactoferrin-genistein ; 4',5,7-trihydroxyisoflavone ; 5,7,4'-Trihydroxyisoflavone ; 4,6,7-Trihydroxyisoflavone ; 4',5 ; 7-Trihydroxyisoflavone ; 4',5,7-Trihydroxy isoflavone ; NPI 031L ; STO514 ; PTI G4660 ; SIPI 807-1 ; 207-174-9 ; Isoflavone ; 4',5,7-trihydroxy- ; 4′,5,7-Trihydroxyisoflavone ; 446-72-0 ; K00046 ; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone ; 5-18-04-00594 (Beilstein Handbook Reference) ; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one ; 4H-1-Benzopyran-4-one ; 5,7-dihydroxy-3-(4-hydroxyphenyl)- ; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one ; 4H-1-Benzopyran-4-one ; 5 ; 7-dihydroxy-3- (4-hydroxyphenyl)- ; GEN ; 5-18-04-00594 ; 4,5,7-Trihydroxy Iso-Flavone ; Genistein (4',5,7-Trihydroxyisoflavone) ; BOC-DL-ALA-OH ; C15H10O5 ; EINECS 207-174-9 ; Genestein ; D019833 ; 4,5,7-Trihydroxyisoflavone ; 79379-05-8 ; 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one ; 5,7-Dihydroxy-3-(4-hydroxyphényl)-4H-chromén-4-one ; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-on ; 263823 ; 5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-one ; [446-72-0] ; 4' 5 7-trihydroxyisoflavone ; 4H-1-Benzopyran-4-one ; 5,7-dihydroxy-3-(4-hydrox ; 4,5,7-Trihydroxyisoflavone(Genistein) ; Toxic Solid ; Organic ; N.O.S (Tacalcitol) ; NSC-36586 ; genistein (0.451 g) ; Prunetol ; Sophoricol ; 315204-48-9 ; 187960-08-3 ; GENISTEIN-2',3',5',6'-D4 ; MFCD00016952 ; Gens ; 4',5,7-Trihydroxy-isoflavone ; Baichanin A ; Bonistein ; GeniVida ; 4H-1-benzopyran-4-one ; 5,7-dihydroxy-3-(4-hydroxyphenyl) ; 4',5,7-.Trihydroxyisoflavone ; NR2392000 ; OR-2321 ; Prunetol (Trade name) ; ,5,7-Trihydroxyisoflavone ; ACon1_001065 ; BSPBio_002375 ; cMAP_000086 ; Lopac0_000520 ; MEGxp0_000568 ; MLS000738127 ; NCGC00025005-04 ; NCGC00025005-05 ; NCGC00025005-07 ; Oprea1_224620 ; Oprea1_437815 ; SMP1_000133 ; SMR000112580 ; SPECTRUM210296 ; Spectrum5_000106 ; ST056352 ; UNII-DH2M523P0H ; 4â€²,5,7-Trihydroxyisoflavone ; UNII:DH2M523P0H ; GENISTEIN ; [3H(G)] ; GENISTEIN-D4 ; GENISTEIN-D2 ; 5,7,4'-Trihydroxyisoflavone [446-72-0] ; DH2M523P0H ; 3-(4-hydroxyphenyl)-5,7-bis(oxidanyl)chromen-4-one ; 5,7-dihydroxy-3-(4-hydroxyphenyl)chromone ; Genistein|4',5,7-.Trihydroxyisoflavone ; Genistein|4,5,7-Trihydroxyisoflavone ; "
56,47.0,"Bisindolylmaleimide I ; RBT205 INHIBITOR ; GF 109203X ; 2-(1-(3-dimethylaminopropyl)indol-3-yl)-3-(indol-3-yl)maleimide ; 133052-90-1 ; BI1 ; 1H-Pyrrole-2,5-dione ; 3-(1-(3-(dimethylamino)propyl)-1H-indol-3-yl)-4-(1H-indol-3-yl)- ; 3-(1-(3-(dimethylamino)propyl)-1H-indol-3-yl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione ; 3-{1-[3-(Dimethylamino)propyl]-1H-indol-3-yl}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione ; bisindolylmaleimide ; BEK ; 13401-96-2 ; GF-109203X ; 2-[1-(3-Dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)-maleimide ; GF109203X ; GFX 203290 ; Go-6850 ; BIS-1 cpd ; C070515 ; bisindoylmaleimide I ; 1H-Pyrrole-2,5-dione ; 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)- ; 2-[1-(3-Dimethylaminopropyl)indol-3-yl]-3-(indol-3-yl) maleimide ; [133052-90-1] ; BisindolylmaleimideI ; 3-{1-[3-(dimethylamino)propyl]-1H-indol-3-yl}-4-(1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione ; GF-109203X   Bisindolylmaleimide I ; GF-109203 ; BIM-1 ; BISINDOLYLMALEIMIDE 1 ; Gö 6850 | Bisindolylmaleimide I | ; Bisindolylmaleimide I (GF 109203X) ; 3-[1-(3-dimethylaminopropyl)indol-3-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione ; Gö 6850 and Bisindolylmaleimide I ; bisindolylmaleimide I and Gö 6850 ; 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione ; Gö 6850 ; 2-(1-(3-Dimethylaminopropyl)-indol-3-yl)-3-(indol-3-yl)maleimide ; UX9590000 ; 3-[1-[3-(dimethylamino)propyl]indol-3-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione ; 3-[1-[3-(dimethylamino)propyl]-3-indolyl]-4-(1H-indol-3-yl)pyrrole-2,5-dione ; 3-[1-(3-dimethylaminopropyl)-3-indolyl]-4-(1H-indol-3-yl)pyrrole-2,5-dione ; 3-[1-(3-dimethylaminopropyl)indol-3-yl]-4-(1H-indol-3-yl)-3-pyrroline-2,5-quinone ; 6850 ; BiomolKI_000031 ; BiomolKI2_000039 ; BSPBio_001160 ; HSCI1_000290 ; IDI1_002175 ; NCGC00024760-02 ; NCGC00024760-03 ; UNII-L79H6N0V6C ; MFCD00236428 ; Bisindolylmaleimide ; 2-(1-(3-Dimethylaminopropyl)-indol-3-yl)-3-(indol-3-yl)maleimide ; 2-[1-(3-dimethylaminopropyl)indol-3-yl]-3-(indol-3-yl)maleimide ; UNII:L79H6N0V6C ; BISINDOLYLMALEIMIDE (I) ; 1H-Pyrrole-2,5-dione,3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)- ; Bisindolylmaleimide2-(1-(3-Dimethylaminopropyl)-indol-3-yl)-3-(indol-3-yl)maleimide ; L79H6N0V6C ; 3-{1-[3-(Dimethylamino)propyl]-1h-Indol-3-Yl} -4-(1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione ; bisindolylmaleimide i (gf109203x) ; bisin-dolylmaleimide ; 3-(N-[Dimethylamino]propyl-3-indolyl)-4-(3-indolyl)maleimide ; 3-[1-[3-(Dimethylamino)propyl]1H-indol-3-yl]-4-(1Hindol-3-yl)1H-pyrrole-2,5dione ; Bisindolylmaleimide I|GF 109203X ; "
57,48.0,"Imatinib ; Glivec ; Gleevec ; CGP 57148B ; STI571 ; 152459-95-5 ; Benzamide ; 4-((4-methyl)-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)- ; STI ; 4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide ; Benzamide ; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- ; Benzamide ; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- (9CI) ; 512-69-6 ; Imatinib mesilate ; Imatinib mesylate ; 220127-57-1 ; Tetrakis(neopentyl)hafnium ; 4-(Bromomethyl)pyrimidine ; 4-((4-methylpiperazin-1-yl)methyl)-n-(4-methyl-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)phenyl)benzamide ; 9050-31-1 ; imatinib methansulfonate ; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate ; 4-[(4-Methyl-1-piperazinyl)methyl]-N-(4-methyl-3-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}phenyl)benzamide ; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide ; 7671333 ; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide ; alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide ; N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide ; Gleevec;Glivec ; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide ; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide ; Imatinib free base ; ST1571 ; Kinome_3724 ; N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide ;  220127-57-1  ; 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide ; Pyrimidine,4-(bromomethyl)-2-chloro- ; MFCD05662257 ; STI571 ; Glivec ; Imatinib (Gleevec) ; Imatinib Meta-methyl-piperazine Impurity ; N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide ; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3- pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide ; Imantinib base ; cid_5291 ; Imatinibmesylate ; [152459-95-5] ; Celonib ; Enliven ; Imatib ; Imatinibum ; Mesylonib ; Mitinab ; Plivatinib ; Shantinib ; Imatinib base(IMA-3) ; Celonib (Trade name) ; Enliven (Trade name) ; Glivec (Trade name) ; Imatib (Trade name) ; Mesylonib (Trade name) ; Mitinab (Trade name) ; Plivatinib (Trade name) ; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]phenyl]benzamide ; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide ; CHEBI:45783 ; NCGC00159456-02 ; NCGC00159456-03 ; UNII-BKJ8M8G5HI ; Celonib ; Enliven ; Glivec ; Imatib ; Mesylonib ; Mitinab ; Plivatinib ; Shantinib ; Imatinib ; Imatinibum ; Imatinib (STI571) ; 1iep ; 1xbb ; UNII:BKJ8M8G5HI ; STI571;STI 571;STI-571 ; BKJ8M8G5HI ; imatinib d4 ; imatinib(free base) ; 8031 ; CGP-57148B ; STI-571 ; Imatinib base ; Imatinib|CGP-57148B ; STI-571 ; Imatinib ; Free base ; DB00619 ; "
58,49.0,"136194-77-9 ; 12H-Indolo(2,3-a)pyrrolo(3,4-c)carbazole-12-propanenitrile ; 5,6,7,13-tetrahydro-13-methyl-5-oxo- ; 12H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-12-propanenitrile ; 5,6,7,13-tetrahydro-13-methyl-5-oxo- ; 13-Methyl-5-oxo-5,6,7,13-tetrahydro-12H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-12-propanenitrile ; 137731-05-6 ; 3-(13-Methyl-5-oxo-6,7-dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-12(13H)-yl)propanenitrile ; C081021 ; 8588138 ; 12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo[2,3-a]pyrolo[3,4-c]carbazole ; 3-(13-Methyl-5-oxo-5,6,7,13-tetrahydro-12H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-12-yl)propanenitrile ; [136194-77-9] ; 3-(9-methyl-1-oxo-2,3-dihydro-1H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-8(9H)-yl)propanenitrile ; Kinome_3630 ; 5,6,7,13-Tetrahydro-13-methyl-5-oxo-12H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-12-propanenitrile ; 12H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-12-propanenitrile,5,6,7,13-tetrahydro-13-methyl-5-oxo- ; 3-[1-[3-(dimethylamino)propyl]-5-methoxyindol-3-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione ; 3-{23-methyl-14-oxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1(16),2(10),4,6,8,11(15),17,19,21-nonaen-3-yl}propanenitrile ; 12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole ; Go 6976 ; Solution ; MFCD00236434 ; 12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole ; GÃ¶ 6976 ; Gö 6976 ; "
59,158.0,"(3S,6R)-1-[6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-3-piperidinecarboxamide ; 3-Piperidinecarboxamide ; 1-[6-(3-amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl- ; (3S,6R)- ; GSK-2334470 ; LTB4 | 5,12-DiHETE | ; GSK 2334470 ; 1227911-45-6 ; (3S,6R)-1-(6-(3-amino-1H-indazol-6-yl)-2-(methylamino)pyrimidin-4-yl)-N-cyclohexyl-6-methylpiperidine-3-carboxamide ; GSK2334470 ; [1227911-45-6] ; (3S,6R)-1-[6-(3-amino-1H-indazol-6-yl)-2-(methylamino)pyrimidin-4-yl]-N-cyclohexyl-6-methylpiperidine-3-carboxamide ; GSK 2334470|GSK-2334470 ; MFCD21608525 ; GSK 2334470;GSK-2334470 ; DSK2334470 ; Not available ; "
60,153.0,"Benzamide ; N-[3-[[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]- ; GSK 269962 ; 850664-21-0 ; GSK269962A ; 925213-63-4 ; N-{3-[2-(4-Amino-furazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yloxy]-phenyl}-4-(2-morpholin-4-yl-ethoxy)-benzamide ; GSK 269962A ; N-(3-((2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl)oxy)phenyl)-4-(2-morpholinoethoxy)benzamide ; MFCD09970310 ; Aminofurazanyl-azabenzimidazole 6n ; N-[3-[[2-(4-Aminofurazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[[2-(4-morpholinyl)ethyl]oxy]benzamide ; GSK269962A(GSK269962) ; [850664-21-0] ; N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide ; GSK269962 ; GSK-269962A ; N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide ; GSK-269962 ; GSK 269962A;GSK-269962A;GSK269962;GSK 269962;GSK-269962 ; N-(3-{[2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYLIMIDAZO[4,5-C]PYRIDIN-6-YL]OXY}PHENYL)-4-[2-(MORPHOLIN-4-YL)ETHOXY]BENZAMIDE ; N-[3-[[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]-benzamide ; Not available ; gsk269962 hcl ; gsk269962a hcl ; "
61,152.0,"N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydropyridine-3-carboxamide ; N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-(4-(trifluoromethyl)phenyl)-1,4,5,6-tetrahydropyridine-3-carboxamide ; 3-Pyridinecarboxamide ; N-(6-fluoro-1H-indazol-5-yl)-1,4,5,6-tetrahydro-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]- ; GSK 429286 ; 864082-47-3 ; N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide ; 4-[4-(Trifluoromethyl)phenyl]-N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxamide ; RHO-15 ; D 9998 | ; GSK 429286A ; GSK429286A | ; RHO-15(GSK429286A) ; N-(6-Fluoro-1H-indazol-5-yl)-1,4,5,6-tetrahydro-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-3-pyridinecarboxamide ; dihydropyridone indazole amide 15 ; [864082-47-3] ; N-(6-fluoro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide ; 2-APV | D-APV | D-2-Amino-5-phosphonovalerate | ; MFCD16618404 ; GSK 429286 A;RHO-15 ; GSK-429286A ; 2-Methyl-6-oxo-4-(4-trifluoromethyl-phenyl)-1,4,5,6-tetrahydro-pyridine-3-carboxylic acid (6-fluoro-1H-indazol-5-yl)-amide ; AGN-PC-007TDK ; CHEMBL375312 ; MolPort-021-804-959 ; S1474_Selleck ; SCHEMBL2801740 ; GSK 429286A;GSK-429286A ; N-(6-FLUORO-1H-INDAZOL-5-YL)-2-METHYL-6-OXO-4-[4-(TRIFLUOROMETHYL)PHENYL]-4,5-DIHYDRO-1H-PYRIDINE-3-CARBOXAMIDE ; compound 15 [PMID: 17201405] ; n-(6-fluoro-1h-indazol-5-yl)-2-methyl-6-oxo-4-(4-(trifluoromethyl)-phenyl)-1,4,5,6-tetrahydropyridine-3-carboxamide ; "
62,250.0,"5-{6-[(4-Methylpiperazin-1-yl)methyl]-1H-benzimidazol-1-yl}-3-{(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy}thiophene-2-carboxamide ; 2-Thiophenecarboxamide ; 5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]- ; (R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide ; 929095-18-1 ; CB62473747 ; GSK461364 ; GSK-461364 ; 5-[6-[(4-Methylpiperazin-1-yl)methyl]-1H-benzimidazol-1-yl]-3-[[(1R)-1-[2-(trifluoromethyl)phenyl]ethyl]oxy]thiophene-2-carboxamide ; 5-[6-[(4-Methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-Thiophenecarboxamide ; 5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-((R)-1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxAmide ; GSK 461364 ; MFCD12755419 ; 5-{6-[(4-Methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl}-3-{(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy}-2-thiophenecarboxamide ; 5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide ; [929095-18-1] ; 5-{6-[(4-methylpiperazin-1-yl)methyl]-1H-1,3-benzodiazol-1-yl}-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide ; GSK461364A ; GSK-461364A ; 5-[6-[(4-methyl-1-piperazinyl)methyl]-1-benzimidazolyl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-thiophenecarboxamide ; GSK 461364|GSK-461364|GSK461364|GSK461364A ; GSK 461364A ; GSK 461364;GSK-461364;GSK-461364A;GSK461364A;GSK 461364A ; gsk-461364 ; gsk-461364a ; gsk-461364;gsk-461364a ; "
63,146.0,"2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid ; [890842-28-1] ; Benzoic acid ; 2-cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)- ; 890842-28-1 ; 2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl-benzoic acid ; 2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-benzoic acid ; MFCD12828779 ; GSK-650394 ; GSK650394 ; GSK650394;GSK-650394 ; 2-CYCLOPENTYL-4-(5-PHENYL-1H-PYRROLO[2,3-B]PYRIDIN-3-YL-BENZOICACID ; "
64,207.0,"GW 441756 ; 1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one ; 504433-23-2 ; (3Z)-3-[(1-methyl-1H-indol-3-yl)methylidene]-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one ; 3-(1-Methyl-1H-indol-3-ylmethylene)-1,3-dihydro-pyrrolo[3,2-b]pyridin-2-one ; 2H-Pyrrolo[3,2-b]pyridin-2-one ; 1,3-dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]- ; [504433-23-2] ; (Z)-3-((1-methyl-1H-indol-3-yl)methylene)-1H-pyrrolo[3,2-b]pyridin-2(3H)-one ; 1,3-dihydro-3-((1-methyl-1h-indol-3-yl)methylene)-2h-pyrrolo(3,2-b)pyridin-2-one ; Ro 15-1788 | ; GW-441756 ; 504433-24-3 ; 3-[1-(1-Methyl-1H-indol-3-yl)-meth-(Z)-ylidene]-1,3-dihydro-pyrrolo[3,2-b]pyridin-2-one ; 2H-Pyrrolo[3,2-b]pyridin-2-one ; 1,3-dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]- ; (3Z)-3-[(1-Methyl-1H-indol-3-yl)methylene]-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one ; MFCD08703104 ; GW441756X ; GW441756 ; (3Z)-3-[(1-methylindol-3-yl)methylidene]-1H-pyrrolo[3,2-b]pyridin-2-one ; CHEMBL176544 ; 3-[(1-methyl-3-indolyl)methylidene]-1H-pyrrolo[3,2-b]pyridin-2-one ; (Z)-3-((1-methyl-1H-indol-3-yl)methylene)-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one ; MFCD17010281 ; 3-((1-Methyl-1H-indol-3-yl)methylene)-1H-pyrrolo[3,2-b]pyridin-2(3H)-one ; 1,3-Dihydro-3-(1-methyl-1H-indol-3-yl)methylene-2H-pyrrolo3,2-bpyridin-2-one ; Gw 4,41756 ; GW441756;GW-441756 ; 3-[(1-METHYLINDOL-3-YL)METHYLIDENE]-1H-PYRROLO[3,2-B]PYRIDIN-2-ONE ; "
65,137.0,"317318-70-0 ; {2-Methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic acid ; 2-(2-methyl-4-((4-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-5-yl)methylthio)phenoxy)acetic acid ; {2-Methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid ; Acetic acid ; 2-[2-methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]- ; 2-(4-((2-(4-(TRIFLUOROMETHYL)phenyl)-5-methylthiazol-4-yl)methylthio)-2-methylphenoxy)acetic acid ; GW501516 ; 2-(4-((2-(4-(Trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methylthio)-2-methylphenoxy)acetic acid ; GW 501516 ; 2-(2-methyl-4-(((4-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-5-yl)methyl)thio)phenoxy)acetic acid ; 2-(2-Methyl-4-(((5-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-4-yl)methyl)thio)phenoxy)acetic acid ; GW1516 ; Endurobol ; MFCD09033000 ; GW 1516 ; GW 501,516 ; GW-1516 ; GW-501,516 ; GW501,516 ; UNII-7I2HA1NU22 ; 2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid ; 2-{2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic acid ; 2-[2-Methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]acetic acid ; GW501516 (Endurobol) ; GSK-516|GW 501516|GW-501516|GW1516 ; [317318-70-0] ; AI9105500 ; 2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxyacetic acid ; CHEBI:73726 ; UNII:7I2HA1NU22 ; GW 1516 ; GSK-516 ; GW-501516 ; {2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)thio]phenoxy}acetic acid ; 2-(2-METHYL-4-((4-METHYL-2-(4-TRIFLUOROMETHYL)PHENYL)THIAZOL-5-YL)METHYLTHIO)PHENOXY)ACETIC ACID ; NOCAS_41037 ; 2-[2-methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]-acetic acid ; {2-Methyl-4-{{4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl}methylthio}phenoxy}acetic acid ; 7I2HA1NU22 ; 7T1 ; 18515150 ; gw501516(gsk-516) ; gw501516(gsk-516;gw1516) ; GW 501516|GW 501516 ; Cardarine ; "
66,52.0,"STO521 ; K00053 ; 3-(3,5-Dibromo-4-hydroxybenzyliden)-5-iodo-1,3-dihydroindol-2-one ; 5-iodo-3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-2-indolinone ; 5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone ; GW 5074 ; 3-(3,5-Dibromo-4-hydroxy-benzylidene)-5-iodo-1,3-dihydro-indol-2-one ; 220904-83-6 ; (3Z)-3-(3,5-Dibromo-4-hydroxybenzylidene)-5-iodo-1,3-dihydro-2H-indol-2-one ; 3-(3,5-dibromo-4-hydroxybenzylidene)-5-iodoindolin-2-one ; 3-[1-(3,5-Dibromo-4-hydroxy-phenyl)-meth-(Z)-ylidene]-5-iodo-1,3-dihydro-indol-2-one ; 2H-Indol-2-one ; 3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-1,3-dihydro-5-iodo- ; 33468-35-8 ; [220904-83-6] ; (Z)-3-(3,5-dibromo-4-hydroxybenzylidene)-5-iodoindolin-2-one ; 3-(3,5-Dibromo-4-hydroxybenzylidene)-5-iodo-1,3-dihydroindol-2-one ; 2H-Indol-2-one ; 3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-1,3-dihydro-5-iodo- ; 3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-1,3-dihydro-5-iodo-2H-indol-2-one ; GW305074X ; (3Z)-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one ; CHEMBL72365 ; 3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one ; Raf1 kinase inhibitor I ; GW-5074|Raf1 kinase inhibitor I ; MFCD09971042 ; MFCD03453076 ; GW-5074;GW5074 ; Gw 5074 ; 3-(3,5-Dibromo-4-hydroxybenzylidene)-5-iodo-1,3-dihydro-1H-indol-2-one ; 3-[(3,5-Dibromo-4-hydroxyphenyl)methylene]-1,3-dihydro-5-iodo-2H-indol-2-one ; 1233748-60-1 ; "
67,217.0,"GW 843682X ; 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)benzyl]oxy}thiophene-2-carboxamide ; [660868-91-7] ; 2-Thiophenecarboxamide ; 5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]- ; Kinome_3462 ; 660868-91-7 ; 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide ; 5-(5,6-dimethoxy-1H-benzo[d]imidazol-1-yl)-3-((2-(trifluoromethyl)benzyl)oxy)thiophene-2-carboxamide ; 3-(2-(trifluoromethyl)benzyloxy)-5-(5,6-dimethoxy-1h-benzo(d)imidazol-1-yl)thiophene-2-carboxamide ; GW843682,5- -3-{[2- -benzyl]oxy}thiophene-2-carboxamide ; 5-(5,6-Dimethoxy-benzoimidazol-1-yl-3-(2-trifluoromethyl-benzyloxy)-thiophene-2-carboxylic acid amide ; 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)benzyl]oxy}-2-thiophenecarboxamide ; MFCD09971143 ; GW-843682X ; thiophene deriv. ; 20 ; GW 843682X;GW843682;GW-843682X ; GW843682X ; 5-(5,6-dimethoxybenzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]thiophene-2-carboxamide ; GW843682 ; 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide ; 5-(5,6-dimethoxy-1-benzimidazolyl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide ; 5-(5,6-DIMETHOXY-1,3-BENZODIAZOL-1-YL)-3-{[2-(TRIFLUOROMETHYL)PHENYL]METHOXY}THIOPHENE-2-CARBOXAMIDE ; GW 843628X ; "
68,53.0,"H52 ; 451462-58-1 ; H-1152P ; 4-Methyl-5-{[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl}isoquinoline ; Isoquinoline ; 5-[[(2S)-hexahydro-2-methyl-1H-1,4-diazepin-1-yl]sulfonyl]-4-methyl- ; 4-methyl-5-[(2S)-2-methyl-1,4-diazepane-1-sulfonyl]isoquinoline ; (S)-(+)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLYNYL)SULFONYL]HOMOPIPERAZINE ; [451462-58-1] ; H-1152 ; MFCD07357272 ; H 1152 ; H1152 ; (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl]homopiperazine ; (S)-2-methyl-1-(4-methylisoquinoline-5-sulfonyl)-1,4-diazepane ; dimethyl fasudil ; (S)-4-Methyl-5-((2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline ; 4-methyl-5-[(2S)-2-methyl-1,4-diazepan-1-ylsulfonyl]isoquinoline ; 4-methyl-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline ; H 1152;H1152 ; "
69,54.0,1-(5-Isoquinolinylsulfonyl)-2-methylpiperazine ; PIPERAZINE ; 1-(5-ISOQUINOLINYLSULFONYL)-2-METHYL- ; Isoquinoline-5-sulfonic 2-methyl-1-piperazide ; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine ; Piperazine ; 1-(5-isoquinolinylsulfonyl)-2-methyl- (9CI) ; 84477-87-2 ; H7 ; H 7 ; H-7 ; 108930-17-2 ; 90323-46-9 ; 5482740 ; 5-(2-methylpiperazine-1-sulfonyl)isoquinoline ; 5-[(2-Methylpiperazin-1-yl)sulfonyl]isoquinoline ; Isoquinoline ; 5-[(2-methyl-1-piperazinyl)sulfonyl]- ; 5-[(2-Methyl-1-piperazinyl)sulfonyl]isoquinoline ; 1-(5-ISOQUINOLINYLSULFONYL)-2-METHYL-PIPERAZINE ; TL9305000 ; MFCD00063403 ; 5-(2-methylpiperazin-1-yl)sulfonylisoquinoline ; 5-((2-Methylpiperazin-1-yl)sulfonyl)isoquinoline ; H-7 2HCL ; ()-1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE 2HCL ; 5-(2-METHYLPIPERAZIN-1-YLSULFONYL)ISOQUINOLINE ; 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine ; 1-(5-Isoquinolinylsulfonyl)-2-methylpiperazine ; 
70,55.0,"84478-11-5 ; H8 ; 1137-42-4 ; N-(2-(Methylamino)ethyl)-5-isoquinolinesulfonamide dihydrochloride ; N-[2-(Methylamino)ethyl]-5-isoquinolinesulfonamide hydrochloride ; 5-Isoquinolinesulfonamide ; N-(2-(methylamino)ethyl)- ; dihydrochloride ; 113276-94-1 ; N-[2-(Methylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride ; H-8 (hydrochloride) ; H-8 dihydrochloride ; N-[2-(Methylamino)ethyl]isoquinoline-5-sulfonamide dihydrochloride ; 5-Isoquinolinesulfonamide ; N-[2-(methylamino)ethyl]- ; hydrochloride (1:2) ; H-8 ; Dihydrochloride ; H-8.Dihydrochloride ; H-8 â€¢ 2HCL ; N-[2-(Methylamino)ethyl]-5-isoquinolinesulfonamide ; 2HCl ; N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide ; dihydrochloride ; N-(2-(Methylamino)ethyl)isoquinoline-5-sulfonamide dihydrochloride ; 5-Isoquinolinesulfonamide,N-[2-(methylamino)ethyl]- ; hydrochloride (1:2) ; [113276-94-1] ; MFCD00036962 ; H-8 • 2HCL ; hydron and N-[2-(methylamino)ethyl]isoquinoline-5-sulfonamide and dichloride ; H-8 . dihydrochloride ; "
71,56.0,H-89 ; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide ; N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE ; IQB ; 5-Isoquinolinesulfonamide ; N-(2-((3-(4-bromophenyl)-2-propenyl)amino)ethyl)- ; N-(2-((3-(4-Bromophenyl)-2-propenyl)amino)ehtyl)-5-isoquinolinesulfonamide dihydrochloride ; 127243-85-0 ; N-[2-(p-Bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride ; h89 ; C063509 ; N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide ; N-(2-{[3-(4-bromophenyl)prop-2-en-1-yl]amino}ethyl)isoquinoline-5-sulfonamide ; 5-Isoquinolinesulfonamide ; N-[2-[[(2E)-3-(4-bromophenyl)-2-propen-1-yl]amino]ethyl]- ; N-(2-{[(2E)-3-(4-bromophenyl)prop-2-en-1-yl]amino}ethyl)isoquinoline-5-sulfonamide ; Isoquinoline-5-sulfonic acid {2-[3-((E)-4-bromo-phenyl)-allylamino]-ethyl}-amide ; N-(2-(4-bromocinnamylamino)ethyl)isoquinoline-5-sulfonamide ; N-[2-((p-Bromocinnamyl)amino)ethyl]-5-isoquinolinesulfonamide ; N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide ; H 89 dihydrochloride ; [127243-85-0] ; 130964-39-5 ; H-89 dihydrochloride ; H89 dihydrochloride ; H-89 2HCl ; N-[2-[3-(4-bromophenyl)prop-2-enylamino]ethyl]-5-isoquinolinesulfonamide dihydrochloride ; Dihydrochloride ; N-(2-{[(2E)-3-(4-Bromophenyl)-2-propen-1-yl]amino}ethyl)-5-isoquinolinesulfonamide ; MFCD00214119 ; N-[2-(p-Bromocinnamylamino)ethyl]-5-isoquinoline sulfonamide ; N-[2-[[3-(4-Bromophenyl)-2-propen-1-yl]amino]ethyl]-5-isoquinolinesulfonamide ; N-[2-[p-Bromocinnamylamino]ethyl]-5-isoquinolinesulfonmide ; MFCD00214120 ; N-[2-[3-(4-bromophenyl)prop-2-enylamino]ethyl]isoquinoline-5-sulfonamide ; 5-Isoquinolinesulfonamide ; N-(2-((3-(4-bromophenyl)-2- propenyl)amino)ethyl)- ; N-[2-[[(E)-3-(4-bromophenyl)prop-2-enyl]amino]ethyl]-5-isoquinolinesulfonamide ; N-[2-[[(E)-3-(4-bromophenyl)prop-2-enyl]amino]ethyl]isoquinoline-5-sulfonamide ; N-[2-[3-(4-bromophenyl)prop-2-enylamino]ethyl]-5-isoquinolinesulfonamide ; NCGC00162073-02 ; NCGC00162073-03 ; (E)-N-(2-((3-(4-bromophenyl)allyl)amino)ethyl)isoquinoline-5-sulfonamide ; Protein kinase inhibitor H-89 ; Protein kinase inhibitor H-89;H89;H 89 ; 1000995-75-4 ; N-(2-((3-(4-Bromophenyl)allyl)amino)ethyl)isoquinoline-5-sulfonamide ; H-89 free base ; 
72,57.0,"Fasudil ; Fasudil [INN] ; Fasudil Hydrochloride ; 1-(5-Isoquinolinesulfonyl)homopiperazine ; 1-(5-Isoquinolinesulphonyl)homopiperazine ; 1-(5-Isoquinolinylsulfonyl)homopiperazine ; 105628-07-7(HYDROCHLORIDE) ; (5-ISOQUINOLINESULFONYL)HOMOPIPERAZINE ; 1-(5-isoquinolylsulfonyl)-1,4-diazaperhydroepine ; 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE ; Hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine ; 1H-1,4-Diazepine ; hexahydro-1-(5-isoquinolinylsulfonyl)- ; Hexahydro-1-(5-isoquinolylsulfonyl)-1H-1,4-diazepine ; 1H-1,4-Diazepine ; hexahydro-1-(5-isoquinolinylsulfonyl)- (9CI) ; 103745-39-7 ; M77 ; FH ; 106094-83-1 ; 105628-07-7 ; N-(5-Isoquinolinesulfonyl)-1,4-perhydrodiazepine ; AT877 ; 5-(1,4-Diazepan-1-ylsulfonyl)isoquinoline ; Isoquinoline ; 5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]- ; HA-1077 (hydrochloride) ; (5-ISOQUINOLINESULFONYL)HOMOPIPERAZINE ; 2HCL ; [103745-39-7] ; Kinome_3390 ; MFCD00866182 ; 5-(1,4-diazepane-1-sulfonyl)isoquinoline ; 203911-27-7 ; hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine ; dihydrochloride ; Fasudil (HA-1077) ; HA 1077 ; dihydrochloride fasudil ; Fasudilum [INN-Latin] ; dihydrochloride fasudil|HA 1077|HA1077 ; 5-((1,4-diazepan-1-yl)sulfonyl)isoquinoline ; 5-(1,4-diazepan-4-ium-1-ylsulfonyl)isoquinoline ; dihydrochloride fasudil ; "
73,147.0,"1-(1-hydroxy-5-isoquinolinesulfonyl)homopiperazine ; HFS ; 1H-1,4-Diazepine ; hexahydro-1-((1,2-dihydro-1-oxo-5-isoquinolinyl)sulfonyl)- ; Hexahydro-1-((1,2-dihydro-1-oxo-5-isoquinolinyl)sulfonyl)-1H-1,4-diazepine ; 105628-72-6 ; 1-[(1,2-Dihydro-1-oxo-5-isoquinolinyl)sulfonyl]hexahydro-1H-1,4-diazepine ; [105628-72-6] ; 5-((1,4-diazepan-1-yl)sulfonyl)isoquinolin-1(2H)-one ; 1(2H)-Isoquinolinone,5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]- ; 1-Isoquinolinol ; 5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]- ; 5-(1,4-Diazepan-1-ylsulfonyl)-1-isoquinolinol ; 1(2H)-Isoquinolinone ; 5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]- ; 5-(1,4-Diazepan-1-ylsulfonyl)-1(2H)-isoquinolinone ; HA-1100;HA 1100;HA1100 ; 5-(1,4-diazepane-1-sulfonyl)-1,2-dihydroisoquinolin-1-one ; 5-(1,4-diazepane-1-sulfonyl)isoquinolin-1-ol ; 5-(1,4-diazepan-1-ylsulfonyl)-2H-isoquinolin-1-one ; MFCD01752417 ; HA1100 ; HA-1100 ; Ha 1100 HCl ; 1-[(1,2-Dihydro-1-oxo-isoquinolin-5-yl)sulfonyl]hexahydro-1H-1,4-diazepine HCl ; Hydroxy-Fasudil ; FASUDIL IMPURITY 5 ; "
74,58.0,"6027-98-1 ; HARMALINE ; Dihydroharmine ; Harmidine ; Armalin ; Harmine ; dihydro- ; O-Methylharmalol ; 3,4-Dihydroharmine ; Harmalol methyl ether ; 3 ; 4-Dihydroharmine ; 206-152-6 ; 1-Methyl-7-methoxy-3,4-dihydro-beta-carboline ; 3H-Pyrido[3,4-b]indole ; 4,9-dihydro-7-methoxy-1-methyl- ; 1-Methyl-7-methoxy-3 ; 4-dihydro-.beta.-carboline ; 7-Methoxy-1-methyl-4,9-dihydro-3H-beta-carboline ; 4-Dihydro-7-methoxy-1-methyl-9-pyrid[3,4-b]indole ; 3,4-Dihydro-7-methoxy-1-methyl-9-pyrid(3,4-b)indole ; 3,4-Dihydro-7-methoxy-1-methyl-9-pyrido(3,4-b)indole ; 3H-Pyrido(3,4-b)indole ; 4,9-dihydro-7-methoxy-1-methyl- ; 4,9-Dihydro-7-methoxy-1-methyl-3H-pyrido(3,4-b)indole ; 304-21-2 ; 3H-Pyrido[3,4-b]indole ; 4 ; 9-dihydro-7-methoxy-1-methyl- ; 3H-Pyrido[3,4-b]indole ; 9-dihydro-7-methoxy-1-methyl- ; monohydrochloride ; 363-11-1 ; 5-23-12-00148 ; 794448-68-3 ; 7-methoxy-1-methyl-3,4-dihydro-2H-pyrido[3,4-b]indole ; 2H-Pyrido[3,4-b]indole ; 3,4-dihydro-7-methoxy-1-methyl- (9CI) ; 3,4-Dihydroharmin ; 2H-Pyrido[3,4-b]indole ; 3,4-dihydro-7-methoxy-1-methyl- ; 7-Methoxy-1-methyl-3,4-dihydro-2H-beta-carboline ; 7-methoxy-1-methyl-2H,3H,4H-pyrido[3,4-b]indole ; "
75,59.0,"6028-00-8 ; 227-898-9 ; Harmalol hydrochloride dihydrate ; 4,9-Dihydro-1-methyl-3H-pyrido[3,4-b]indol-7-ol hydrochloride ; H-1110 ; 3H-Pyrido[3,4-b]indol-7-ol ; 4,9-dihydro-1-methyl- ; hydrochloride ; hydrate (1:1:2) ; 1-Methyl-4,9-dihydro-3H-beta-carbolin-7-ol hydrochloride dihydrate ; [6028-00-8] ; MFCD00150053 ; UV 1047000 ; 1-Methyl-7-hydroxy-3,4-dihydro-beta-carboline hydrochloride ; 51360_ALDRICH ; AC1O4WGJ ; AGN-PC-0LT9XX ; CHEMBL1369266 ; 1-Methyl-4,9-dihydro-3H-pyrido[3,4-b]indol-7-ol hydrochloride dihydrate ; Harmalol HCl dihydrate ; Harmalol HCl 2H20 ; 4,9-Dihydro-1-methyl-3H-pyrido[3,4-b]-indol-7-ol HCl hydrate (1:1:2) ; HARMALOL DIHYDRATE HYDROCHLORIDE ; "
76,60.0,"30282-14-5 ; 1-Naphthyl Isocyanate ; 86-84-0 ; Harman ; Aribin ; Passiflorin ; Locuturine ; Locuturin ; Loturine ; Aribine ; 1-Methylnorharman ; Harmane ; 3-Methyl-4-carboline ; 2-Methyl-beta-carboline ; 1-Methyl-.beta.-carboline ; 9H-Pyrido[3,4-b]indole ; 1-methyl- ; 1-Methyl-9H-beta-carboline ; 1-Methyl-9H-pyrid[3,4-b]indole ; 1-METHYL-9H-PYRIDO(3,4-B)INDOLE ; 1-methyl-9H-pyrido[3,4-b]indole ; 207-642-2 ; 486-84-0 (FREE BASE) ; 9H-Pyrido(3,4-b)indole ; 1-methyl- ; CAS-21655-84-5 ; 21655-84-5 (HCL) ; 486-84-0 ; 2-Methyl-b-carboline ; 5-23-08-00261 ; pyridobindole ; L-methyl- ; 1-Méthyl-9H-bêta-carboline ; 1-Methyl-9H-beta-carbolin ; MFCD00004957 ; Harmane ( 1-Methyl-9H-pyrido[3,4-b]indole) ; 1-Methyl-9H-beta-carboline (Harman) ; [486-84-0] ; methylbeta-carboline ; L-methylpyridobindole ; 1-methyl-2-carboline ; 1-methyl-beta-carboline ; Harmane ; Aribine ; 1-Methyl-9H-pyrid(3,4-b)indole ; 486840 ; 1-Methyl-9H-pyrido[3,4-b]indole ; 9CI ; L-Methyl-Pyridobindole ; Passiflorine ; Zygofabagine ; 143898 ; Harmane ; free base ; T B656 EN HMJ F ; UNII-82D6J0535P ; Harmane free base ; 1-methyl-3,4-dihydro-2H-pyrido[3,4-b]indole ; 9H-Pyrido[3,4-b]indole,1-methyl- ; 82D6J0535P ; 1-methyl-9H-beta-carboline|9H-pyrido[3,4-b]indole, 1-methyl-|Harmane ; Aribine ; 1-methyl-9H-beta-carboline|9H-pyrido[3,4-b]indole ; 1-methyl- ; "
77,61.0,"Harmine ; Banisterine ; Leucoharmine ; Telepathine ; Yageine ; Yajeine ; 6-Methoxyharman ; 1-Methyl-7-methoxy-beta-carboline ; 7-Methoxy-1-methyl-9H-beta-carboline ; 207-131-4 ; 9H-Pyrido[3,4-b]indole ; 7-methoxy-1-methyl- ; 442-51-3 (FREE BASE) ; CAS-343-27-1 ; 343-27-1 (HCL) ; 7-Methoxy-1-methyl-9H-pyrido(3,4-b)indole ; 9H-Pyrido(3,4-b)indole ; 7-methoxy-1-methyl- ; 5-23-12-00237 (Beilstein Handbook Reference) ; 442-51-3 ; 6-Methoxyharmane ; Harmine derivative ; 7-methoxy-1-methyl-9H-pyrido[3,4-b]indole ; acetic acid ; ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy) ; 7-Methoxy-1-methyl-9H-beta-carbolin ; 5-23-12-00237 ; EINECS 207-131-4 ; TL8003082 ; H-1200 ; 7-Méthoxy-1-méthyl-9H-bêta-carboline ; 7-Methoxy-1-methyl-9H-beta-carboline (harmine) ;  442-51-3  ; Telepathine; ; BANISTERINE MONOHYDRATE ; Telepathine;Yageine;Banisterine ; Harmin hydrochloride ; 7-methoxy-1-methylbeta-carboline ; 9H-Pyrido[3,4-b]indole- ; 7-methoxy-1-methyl- ; BANISTERINEMONOHYDRATE ; 178813 ; MFCD00004958 ; Banisterin ; Harmin ; Telepathin ; Yagein ; 1-Methyl-7-methoxy-.beta.-carboline ; 1-Methyl-7-methoxy-b-carboline ; 442513 ; 1-Methyl-7-methoxy-beta -carboline ; 7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole ; 9CI ; Garmin ; HRM ; Telepathien ; [442-51-3] ; UV 0175000 ; ACon0_001194 ; ACon1_000061 ; BPBio1_000602 ; BSPBio_000546 ; MEGxp0_001875 ; NCGC00094869-01 ; NCGC00094869-02 ; NCGC00094869-03 ; NCGC00094869-05 ; Oprea1_596686 ; Prestwick2_000613 ; Prestwick3_000613 ; SPECTRUM1500867 ; Spectrum5_001914 ; ST069315 ; UNII-4FHH5G48T7 ; Banisterine ; Telepathine ; Harman ; UNII:4FHH5G48T7 ; HARMINE˜ ; HARMINE-D3 ; 4FHH5G48T7 ; Not available ; IN00286 ; UV0175000 ; Harmine|1-Methyl-7-methoxy-b-carboline ; Harmine|Banisterine ; Telepathine ; Harman ; Harmine|6-Methoxyharmane ; "
78,254.0,"76958-67-3 ; (1aR,8S,10Z,13S,14S,15aR)-5,13,14-Trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione ; 6H-Oxireno[k][2]benzoxacyclotetradecin-6,12(1aH)-dione ; 8,9,13,14,15,15a-hexahydro-5,13,14-trihydroxy-3-methoxy-8-methyl- ; (1aR,8S,10Z,13S,14S,15aR)- ; (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione ; (2R,4R,6S,7S,12S)-6,7,16-trihydroxy-18-methoxy-12-methyl-3,13-dioxatricyclo[13.4.0.02,4]nonadeca-1(19),9,15,17-tetraene-8,14-dione ; (2R,4R,6S,7S,9Z,12S)-6,7,16-trihydroxy-18-methoxy-12-methyl-3,13-dioxatricyclo[13.4.0.0²,⁴]nonadeca-1(19),9,15,17-tetraene-8,14-dione ; (1AR,3S,4S,9S,15bR)-3,4,12-trihydroxy-14-methoxy-9-methyl-3,4,8,9-tetrahydro-1aH-benzo[c]oxireno[2,3-e][1]oxacyclotetradecine-5,11(2H,15bH)-dione ; (1aR,3S,4S,9S,15bR,Z)-3,4,12-trihydroxy-14-methoxy-9-methyl-1a,3,4,8,9,15b-hexahydro-5H-benzo[c]oxireno[2,3-e][1]oxacyclotetradecine-5,11(2H)-dione ; MFCD08457932 ; 3H-Oxireno[k][2]benzoxacyclotetradecin-5,11(2H,4H)-dione,1a,8,9,15b-tetrahydro-3,4,12-trihydroxy-14-methoxy-9-methyl-,(1aR,3S,4S,6Z,9S,15bR)- ; "
79,62.0,"SU5607 ; 1,3-Dihydro-3-[(2,4,6-trimethoxyphenyl)methylene]-2H-indol-2-one ; 3-[(2,4,6-TRIMETHOXY-PHENYL)-METHYLENE]-INDOLIN-2-ONE ; 3-(2,4,6-trimethoxybenzylidene)indolin-2-one ; (3Z)-3-(2,4,6-Trimethoxybenzylidene)-1,3-dihydro-2H-indol-2-one ; 2H-Indol-2-one ; 1,3-dihydro-3-[(2,4,6-trimethoxyphenyl)methylene]- ; 3-[(2,4,6-Trimethoxyphenyl)methylidenyl]-indolin-2-one ; 186611-52-9 ; 3-[(2,4,6-trimethoxyphenyl)methylidene]-2,3-dihydro-1H-indol-2-one ; IC-261 ; MFCD00118156 ; 3-[(2,4,6-trimethoxyphenyl)methylidene]-1H-indol-2-one ; "
80,172.0,IKK 16 ; (4-{[4-(1-benzothiophen-2-yl)pyrimidin-2-yl]amino}phenyl)[4-(pyrrolidin-1-yl)piperidin-1-yl]methanone ; (4-(4-(benzo[b]thiophen-2-yl)pyrimidin-2-ylamino)phenyl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone ; Methanone ; [4-[(4-benzo[b]thien-2-yl-2-pyrimidinyl)amino]phenyl][4-(1-pyrrolidinyl)-1-piperidinyl]- ; IKK Inhibitor VII ; [4-[[4-(1-benzothiophen-2-yl)pyrimidin-2-yl]amino]phenyl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone ; IKK-16 ; 873225-46-8 ; (4-{[4-(1-Benzothiophen-2-yl)-2-pyrimidinyl]amino}phenyl)[4-(1-pyrrolidinyl)-1-piperidinyl]methanone ; CHEMBL200027 ; [873225-46-8] ; MFCD23704180 ; IKK16 ; IKK16;IKK-16 ; (4-((4-(Benzo[b]thiophen-2-yl)pyrimidin-2-yl)amino)phenyl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone ; IKK-16 (IKK Inhibitor VII) ; [4-[[4-(1-benzothiophen-2-yl)-2-pyrimidinyl]amino]phenyl]-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone ; [4-[(4-benzo[b]thien-2-yl-2-pyrimidinyl)amino]phenyl][4-(1-pyrrolidinyl)-1-piperidinyl]-methanone ; ikk-16(free base) ; 4-(1-BENZOTHIOPHEN-2-YL)-N-{4-[4-(PYRROLIDIN-1-YL)PIPERIDINE-1-CARBONYL]PHENYL}PYRIMIDIN-2-AMINE ; IKK 16 free ; IKK-16 (free base) ; 
81,63.0,2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide ; TPCA-1 ; 2-[(Aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide ; 507475-17-4 ; 2-(Carbamoylamino)-5-(4-fluorophenyl)thiophene-3-carboxamide ; 3-Thiophenecarboxamide ; 2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)- ; [5-(p-fluorophenyl)-2-ureido]thiophene-3-carboxamide ; [507475-17-4] ; 5-(4-Fluorophenyl)-2-ureidothiophene-3-carboxylic acid amide ; 5-(4-fluorophenyl)-2-ureidothiophene-3-carboxamide ; HA 1077 | ; IKK-2 Inhibitor IV ; MFCD09037541 ; 2-(Carbamoylamino)-5-(4-fluorophenyl)-3-thiophenecarboxamide ; IKK2 Inhibitor IV ; CHEMBL257167 ; TPCA1 ; TPCA-1|TPCA1 ; TPCA 1 ; 5-(4-Fluoro-phenyl)-2-ureido-thiophene-3-carboxylic acid amide ; IN1461 ; IN1464 ; NM7 ; 9M632G86CC ; 
82,173.0,"3-pyridinecarbonitrile ; 2-amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-(4-piperidinyl)- ; acetic acid ; ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy) ; 2-amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-(piperidin-4-yl)pyridine-3-carbonitrile ; 2-Amino-6-(2-cyclopropylmethoxy-6-hydroxy-phenyl)-1'',2'',3'',4'',5'',6''-hexahydro-[4,4'']bipyridinyl-3-carbonitrile ; 2-Amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-(4-piperidinyl)nicotinonitrile ; 2-amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-piperidin-4-yl-nicotinonitrile ; 406208-42-2 ; CHEMBL368427 ; [406208-42-2] ; 2-AMINO-6-(2-(CYCLOPROPYLMETHOXY)-6-HYDROXYPHENYL)-4-(4-PIPERIDINYL)-3-PYRIDINECARBONITRILE ; Not available ; 2-amino-6-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-4-(4-piperidinyl)-3-pyridine-carbonitrile ; "
83,64.0,"N-(3,5-Bis-trifluoromethylphenyl)-5-chloro-2-hydroxybenzamide ; N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide ; IMD 0354 ; N-[3,5-Bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide ; 978-62-1 ; TCMDC-125465 ; Benzamide ; N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxy- ; [978-62-1] ; Kinome_1864 ; IKK-2 Inhibitor V ; IMD0354 ; N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxy-benzamide ; NCGC00165811-01 ; UNII-76145IS906 ; MFCD00218820 ; N-(3,5-Bis-trifluoromethyl-phenyl)-5-chloro-2-hydroxy-benzamide ; CHEMBL536151 ; IN1463 ; UNII:76145IS906 ; 76145IS906 ; "
84,167.0,"1,1'-Dithiodi-2-naphthol ; acetic acid ; ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy) ; 1,1'-disulfanediyldinaphthalen-2-ol ; 2-Naphthalenol ; 1,1'-dithiobis- ; 1-[(2-hydroxy-1-naphthyl)dithio]-2-naphthol ; 1,1'-Disulfanediyldi(2-naphthol) ; IPA 3 ; [42521-82-4] ; 1-[(2-hydroxynaphthyl)disulfanyl]naphthalen-2-ol ; 42521-82-4 ; 1,1'-Dithiodi-2-naphthtol ; Eflornithine | ; IPA-3 ; 1,1'-dithiobis-2-naphthalenol ; 1,1'-disulfanediylbis(naphthalen-2-ol) ; 1-[(2-hydroxynaphthalen-1-yl)disulfanyl]naphthalen-2-ol ; 1-(2-hydroxynaphthalen-1-yl)disulfanylnaphthalen-2-ol ; 1-[(2-hydroxy-1-naphthyl)disulfanyl]-2-naphthalenol ; 1-[(2-hydroxy-1-naphthyl)disulfanyl]-2-naphthol ; 1-[(2-hydroxy-1-naphthyl)disulfanyl]naphthalen-2-ol ; UNII-3XFG6MQ9G2 ; MFCD00388917 ; IPA3 ; AC1LAV4U ; F0400-0044 ; UNII:3XFG6MQ9G2 ; IPA 3;IPA3 ; bis-(2-hydroxy-1-naphthyl)disulphide ; 1-[(2-hydroxy-1-naphthalenyl)disulfanyl]-2-naphthalenol ; 1,1'-disulfanediyldi(naphthalen-2-ol) ; Bis(2-hydroxy-1-naphthyl) disulfide ; Not available ; 3XFG6MQ9G2 ; dihydroxydinaphthyldisulphide ; IPA-3|1,1'-dithiobis-2-naphthalenol ; "
85,133.0,"N-(1-(2-morpholinoethyl)-1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide ; Benzamide ; N-[1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitro- ; Ciclosporin A | ; 509093-47-4 ; N-(2-Morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole ; N-{1-[2-(4-Morpholinyl)ethyl]-1H-benzimidazol-2-yl}-3-nitrobenzamide ; N-{1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazol-2-yl}-3-nitrobenzamide ; N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]-3-nitrobenzamide ; CHEMBL379787 ; N-[1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitro-benzamide ; [509093-47-4] ; MFCD09752602 ; IRAK-1-4 Inhibitor I ; Not available ; 1-(2-(4-Morpholinyl)ethyl)-2-(3-nitrobenzoylamino)benzimidazole ; "
86,145.0,"200-664-3 ; 97161-97-2 ; Antibiotic K 252a ; Antibiotic SF 2370 ; K252a ; 99533-80-9 ; KSA ; 6-carboxylate ; K-252a ; Nocardiopsis sp. ; 6,9-Epoxy-15H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-7-carboxylic acid ; 6,7,8,9,16,17-hexahydro-7-hydroxy-6-methyl-15-oxo- ; methyl ester ; (6S,7R,9R)- ; K 252a ; (9S,10R,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester ; SF 2370 | ; 2,3,9S,10R,11,12R-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid ; methyl ester ; methyl (5S,6R,8R)-6-hydroxy-5-methyl-13-oxo-5,6,7,8,14,15-hexahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacene-6-carboxylate ; KC6500000 ; methyl (15S,16R,18R)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1(26),2(6),7(27),8,10,12,20,22,24-nonaene-16-carboxylate ; UNII-IV7H45AM5B ; [99533-80-9] ; methyl (15S,16R,18R)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1,6,8(13),9,11,20,22,24,26-nonaene-1 ; MFCD00161522 ; UNII:IV7H45AM5B ; (9S,10R,12R)-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG-3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-10-CARBOXYLIC ACID METHYL ESTER ; MFCD09878276 ; IV7H45AM5B ; (+)-Antibiotic K 252a ; (+)-Antibiotic SF 2370 ; Protein kinase inhibitor K252a ; SF 2370 ; Lithium Phenyl(2,4,6-trimethylbenzoyl)phosphinate | Lithium PTMB phosphinate | ; NZ0550000 ; K252a|SF 2370 ; "
87,292.0,"Bromo Paullone ; Paullone Analog 5 ; STO175 ; K00061 ; 9-Bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one ; 142273-20-9 ; 9-Bromo-7,12-dihydroindolo(3,2-d)(1)benzazepin-6(5H)-one ; 9-Bromo-7,12-dihydro-indolo  [3,2-d]  [1]benzazepin-6(5H)-one ; Indolo[3,2-d][1]benzazepin-6 (5H)-one ; 9-bromo-7,12-dihydro-, ; 14383-51-8 ; 9-Bromo-7,12-dihydro-indolo- [3,2-d]- [1]benzazepin-6(5H)-one ; 9-Bromo-7,12-dihydro-indolo[3,2-d][1]benzazepin-6(5H)-one ; 9-bromo-5,12-dihydro-7H-benzo[2,3]azepino[4,5-b]indol-6-one ; 9-bromo-7,12-dihydr9-Bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one ; Indolo[3,2-d][1]benzazepin-6(5H)-one ; 9-bromo-7,12-dihydro- ; [142273-20-9] ; Kinome_3565 ; MFCD02683595 ; 9-Bromopaullone ; 9-Bromo-7,12-dihydro-indolo[3,2-d][1]-benzazepin-6(5H)-one ; Indolo[3,2-d][1]benzazepin-6(5H)-one ; 9-bromo-7,12-dihydro-, ; 9-bromo-7,12-dihydrobenzo[2,3]azepino[4,5-b]indol-6(5H)-one ; 14-bromo-8,18-diazatetracyclo[9.7.0.02,7.012,17]octadeca-1(11),2,4,6,12,14,16-heptaen-9-one ; 9-bromo-7,12-dihydro-5H-indolo[3,2-d][1]benzazepin-6-one ; Indolo[3,2-d][1]benzazepin-6(5H)-one,9-bromo-7,12-dihydro- ; Kenpaullone|9-Bromopaullone ; "
88,67.0,"1-(N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl)-4-phenylpiperazine ; 127191-97-3 ; 1-[N,O-bis(5-Isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine ; 5-Isoquinolinesulfonic acid ; 4-[(2S)-2-[(5-isoquinolinylsulfonyl)methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl]phenyl ester ; (S)-5-Isoquinolinesulfonic acid 4-[2-[(5-isoquinolinylsulfonyl)methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl]phenyl ester ; 4-[(2S)-2-[(Isoquinolin-5-ylsulfonyl)(methyl)amino]-3-oxo-3-(4-phenylpiperazin-1-yl)propyl]phenyl isoquinoline-5-sulfonate ; Isoquinoline-5-sulfonic acid 4-[(S)-2-[(isoquinoline-5-sulfonyl)-methyl-amino]-3-oxo-3-(4-phenyl-piperazin-1-yl)-propyl]-phenyl ester ; 1-(N,O-bis(1,5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl)-4-phenylpiperazine ; [127191-97-3] ; 4-[(2S)-2-[(5-isoquinolinylsulfonyl)methylamino]-3-oxo- 3-(4-phenyl-1-piperazinyl)propyl]phenylisoquinolinesulfonicacid ester KN-62 ; 4-[(2S)-2-[(5-isoquinolinylsulfonyl)methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl] phenyl isoquinolinesulfonic acid ester ; 5-isoquinolinesulfonic acid [4-[(2S)-2-[5-isoquinolinylsulfonyl(methyl)amino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl]phenyl] ester ; [4-[(2S)-2-[isoquinolin-5-ylsulfonyl(methyl)amino]-3-oxidanylidene-3-(4-phenylpiperazin-1-yl)propyl]phenyl] isoquinoline-5-sulfonate ; (S)-4-(2-(N-methylisoquinoline-5-sulfonamido)-3-oxo-3-(4-phenylpiperazin-1-yl)propyl)phenyl isoquinoline-5-sulfonate ; 4-[(2S)-2-[(5-isoquinolinylsulfonyl)methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl]phenyl ester ; 5-isoquinolinesulfonic acid ; 4-[(2S)-2-[(5-Isoquinolinylsulfonyl)(methyl)amino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl]phenyl 5-isoquinolinesulfonate ; [4-[(2S)-2-[isoquinolin-5-ylsulfonyl(methyl)amino]-3-oxo-3-(4-phenylpiperazin-1-yl)propyl]phenyl] isoquinoline-5-sulfonate ; [4-[(2S)-2-[5-isoquinolylsulfonyl(methyl)amino]-3-oxo-3-(4-phenylpiperazin-1-yl)propyl]phenyl] isoquinoline-5-sulfonate ; MFCD00083180 ; (S)-4-(2-(N-methylisoquinoline-5-sulfonamido)-3-oxo-3-(4-phenylpiperazin-1-yl)propyl)phenylisoquinoline-5-sulfonate ; (S)-4-(2-(N-methylisoquinoline-5-sulfonamido)-3-oxo-3-(4-phenylpiperazin-1-yl)propyl)phenyl isoquinoline-5-sulfonat ; NX4899725 ; 5-Isoquinolinesulfonic acid 4-[(2S)-2-[(5-isoquinolinylsulfonyl)methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl]phenyl ester ; 5-Isoquinolinesulfonicacid,4-[(2S)-2-[(5-isoquinolinylsulfonyl)methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl]phenylester ; CHEMBL28324 ; 4-[(2S)-2-(N-methylisoquinoline-5-sulfonamido)-3-oxo-3-(4-phenylpiperazin-1-yl)propyl]phenyl isoquinoline-5-sulfonate ; KN62 (S isomer) ; KN 62|KN-62|KN62 (S isomer) ; 1-[N,O-BIS-(5-ISOQUINOLINESULFONYL)-N-METHYL-L-TYROSYL]-4-PHENYLPIPERAZINE ; [4-[2-[isoquinolin-5-ylsulfonyl(methyl)amino]-3-oxo-3-(4-phenylpiperazin-1-yl)propyl]phenyl] isoquinoline-5-sulfonate ; KN 62 ; KN62 ; "
89,69.0,KN93 ; N-(2-{[(4-Chlorocinnamyl)(methyl)amino]methyl}phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide ; N-[2-[[[(E)-3-(4-chlorophenyl)prop-2-enyl]-methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide ; Benzenesulfonamide ; N-[2-[[[3-(4-chlorophenyl)-2-propen-1-yl]methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4-methoxy- ; N-[2-[[3-(4-chlorophenyl)prop-2-enyl-methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide ; 
90,70.0,"108068-98-0 ; 9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid ; 2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo- ; hexyl ester ; (9R,10R,12S)-rel- ; KT-5720 ; 6,9-Epoxy-15H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-7-carboxylic acid ; 6,7,8,9,16,17-hexahydro-7-hydroxy-6-methyl-15-oxo- ; hexyl ester ; (6R,7S,9S)- ; UNII-58HV29I28S ; (9R,10S,12S)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid hexyl ester ; antibiotic KT 5720 ; hexyl (5R,6S,8S)-6-hydroxy-5-methyl-13-oxo-5,6,7,8,14,15-hexahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacene-6-carboxylate ; (9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3â€²,2â€²,1â€²-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid hexyl ester ; MFCD00132118 ; UNII:58HV29I28S ; MFCD11867896 ; "
91,71.0,"Benzenemethanol ; 5-[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy- ; Benzenemethanol ; 5-[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy- ; rel- ; 938440-64-3 ; (5-{2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-(morpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl}-2-methoxyphenyl)methanol ; KU 0063794 ; [938440-64-3] ; KU-0063794 ; AZD-2014 ; 5-[2-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol ; rel-5-[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol ; (5-(2-((2R,6S)-2,6-Dimethylmorpholino)-4-morpholinopyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol ; KU0063794(KU63794) ; (5-(2-((2R,6S)-2,6-dimethyl morpholino)-4-morpholinopyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol ; rel-5-[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-benzenemethanol ; KU 63794 ; {5-[2-((2S,6R)-2,6-Dimethyl-morpholin-4-yl)-4-morpholin-4-yl-pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-phenyl}-methanol ; (5-{2-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl}-2-methoxyphenyl)methanol ; (5-(2-((2R,6S)-2,6-dimethylmorpholino)-4-morpholinopyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol, ; [5-[2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-morpholino-pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-phenyl]methanol ; MFCD11977741 ; KU0063794 ; Rel-5-[2-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-(4-morp holinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol ; [5-[2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-morpholin-4-ylpyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol ; [5-[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-(4-morpholinyl)-7-pyrido[2,3-d]pyrimidinyl]-2-methoxyphenyl]methanol ; [5-[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-morpholino-7-pyrido[5,6-e]pyrimidinyl]-2-methoxyphenyl]methanol ; [5-[2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-morpholin-4-yl-pyrido[5,6-e]pyrimidin-7-yl]-2-methoxy-phenyl]methanol ; [5-[2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-morpholin-4-ylpyrido[5,6-e]pyrimidin-7-yl]-2-methoxyphenyl]methanol ; [5-[2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-morpholino-pyrido[5,6-e]pyrimidin-7-yl]-2-methoxy-phenyl]methanol ; KU-63794 ; (5-(2-((2S,6R)-2,6-dimethylmorpholino)-4-morpholinopyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol ; MFCD22666594 ; (5-(2-((2R,6S)-2,6-dimethylmorpho ; 5-2-(2R,6S)-2,6-dimethyl-4-morpholinyl-4-(4-morpholinyl)pyrido2,3-dpyrimidin-7-yl-2-methoxybenzenemethanol ; Rel-5-2-(2R,6S)-2,6-dime thyl-4-morpholinyl-4-(4-morpholinyl)pyrido2,3-dpyrimidin-7-yl-2-methoxy-benzenemethanol ; KU 0063794 ; KU0063794 ; ku-0063794(ku 0063794) ; mTOR Inhibitor ; Ku-0063794 ; "
92,150.0,Argatroban ; 4H-Pyran-4-one ; 2-(4-morpholinyl)-6-(1-thianthrenyl)- ; 2-Morpholin-4-yl-6-thianthren-1-ylpyran-4-one ; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one ; 587871-26-9 ; 2-(Morpholin-4-yl)-6-(thianthren-1-yl)-4H-pyran-4-one ; 2-Morpholino-6-(thianthren-1-yl)-4H-pyran-4-one ; KU 55933 ; [587871-26-9] ; KU55933 ; 2-(4-Morpholinyl)-6-(1-thianthrenyl)-4H-pyran-4-one ; 2-(morpholin-4-yl)-6-(thianthren-1-yl)pyran-4-one ; ATM Kinase Inhibitor ; MFCD08276985 ; CHEMBL222102 ; 2-(4-morpholinyl)-6-(1-thianthrenyl)-4-pyranone ; 2-morpholino-6-(1-thianthrenyl)-4-pyranone ; 2-morpholino-6-thianthren-1-yl-pyran-4-one ; EC-000.1920 ; UNII-O549494L5D ; KU-55933|KU55933 ; UNII:O549494L5D ; KU 55933;KU55933 ; KU - 55933 ; O549494L5D ; ku-55933 (atm kinase inhibitor) ; 2-â€‹(4-â€‹morpholinyl)â€‹-â€‹6-â€‹(1-â€‹thianthrenyl)â€‹-4H-â€‹pyran-â€‹4-â€‹one ; 2-​(4-​morpholinyl)​-​6-​(1-​thianthrenyl)​-4H-​pyran-​4-​one ; ATM Kinase Inhibitor ; KU-55933 ; 
93,159.0,"LDN193189 ; 1062368-24-4 ; 4-[6-[4-(1-piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]Quinoline ; 4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline ; LDN193189(DM3189) ; 4-[6-[4-(1-piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline ; DM 3189 ; LDN 193189 ; 4-{6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl}quinoline ; Quinoline ; 4-[6-[4-(1-piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]- ; 4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline ; LDN-193189 ; 4-[6-[4-(1-piperazinyl)phenyl]-3-pyrazolo[1,5-a]pyrimidinyl]quinoline ; MFCD17392570 ; [1062368-24-4] ; MFCD17169988 ; DM-3189 ; LDN 193189 ; LDN-193189 ; DM-3189 ; DM 3189 ; LDN 193189;LDN193189 ; ldn193189 free base ; "
94,318.0,"Leflunomide ; Arava ; lefunamide ; Arava (TN) ; Leflunomide [USAN:INN] ; SU 101 (pharmaceutical) ; 75706-12-6 ; CAS-75706-12-6 ; 5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide ; 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide ; 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide ; alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide ; 4-Isoxazolecarboxamide ; 5-methyl-N-(4-(trifluoromethyl)phenyl ; N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide ; 4-Isoxazolecarboxamide ; 5-methyl-N-(4-(trifluoromethyl)phenyl)- ; 5-Methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide ; Isoxazole-4-carboxamide ; 5-methyl-N-[4-(trifluoromethyl)phenyl]- ; 210165-51-8 ; 17194-82-0 ; 5-Methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide ; a,a,a-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide ; 5-Methylisoxazole-4-carboxylic Acid Trifluoromethylanilide ; Lefunomide ; 5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide ; 4-Isoxazolecarboxamide ; 5-methyl-N-[4-(trifluoromethyl)phenyl]- ; Leflunomid ; 5-Methyl-N-[4-(trifluormethyl)phenyl]isoxazol-4-carboxamid ; 5-méthyl-N-[4-(trifluorométhyl)phényl]isoxazole-4-carboxamide ; Leflunomida [INN-Spanish] ; N-(4-trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide ; SU101 ; TL8005179 ; Aventis Behring Brand of Leflunomide ; Aventis Brand of Leflunomide ; Aventis Pharma Brand of Leflunomide ; C045463 ; Hoechst Brand of Leflunomide ; 4323174 ; 5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide) ; [75706-12-6] ; (5-methylisoxazol-4-yl)-N-[4-(trifluoromethyl)phenyl]carboxamide ; Toxic Solid ; Organic ; N.O.S. (Leflunomide) ; MFCD00867593 ; 5-Methyl-N-[4-(trifluoromethyl)-phenyl]isoxazole-4-carboxamide ; leflunomida ; leflunomide ; leflunomidum ; 4-isoxazolecarboxamide ; 5-methyl-N-[4-(trifluoromethyl)phenyl] ; Leflunomidum [INN-Latin] ; Lefunomide [INN-Spanish] ; NY2354200 ; Leflunomidum ; leflunomida ; 5-methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide ; HWA486 ; Leflunomidum ; Lefunomide ; 5-methyl-n-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamid ; LEFLUNOMIDE-D4 ; 5-methylisoxazole-4-carboxylic acid (4-trifluorome ; G162GK9U4W ; 5079 ; Leflunomide for peak identification ; 5-Methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4- carboxamide ; DB01097 ; "
95,180.0,"Benzoic acid ; 4-(aminomethyl)- (9CI) ; Lenalidomide ; Revlimid ; Revimid ; IMiD3 ; 3-(4-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione ; 2,6-Piperidinedione ; 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)- ; 191732-72-6 ; 346670-73-3 ; 443912-14-9 ; 3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione ; 3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidin-2,6-dion ; 2,6-Piperidinedione ; 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)- ; C467567 ; CC5013 ; Celgene brand of lenalidomide ; IMiD3 cpd ; 3-(4-Amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione ; Revimid;Revlimid ; 3-(7-amino-3-oxo-1h-isoindol-2-yl)piperidine-2,6-dione ; CC-5013 ; Revlimid ; 3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2,6-piperidinedione ; (3S)-3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione ; Lelidomide ; lenalidomide [INN_en] ; 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline ; RAC LENALIDOMIDE-13C5 ; MFCD07772307 ; 2,6-piperidinedione ; 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)- ; MFCD22207056 ; 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione ; CC 5013 ; Revimid ; Revlimid ; Lenalidomide ; CC-5013 ; (3R)-3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2,6-piperidinedione ; 2,6-Piperidinedione ; 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)- ; 2,6-piperidinedione ; 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl) ; BR-47482 ; [191732-72-6] ; OR-2352 ; 3-(4-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione ; IMid-1 ; Ladevina ; Lenangio ; 4-amino-2-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-2,3-dihydro-1H-isoindol-1-one ; Ladevina (Trade name) ; 191732-72-6 ; 443912-14-9 ; Revlimid (lenalidomide) ; CC-5013 ; IMid-1 ; Ladevina ; Lenangio ; Lenalidomide (CC-5013) ; 3-(7-methyl-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione ; Revlimid;CC-5013;CC5013;CC 5013 ; LENALIDOMIDE-D5 ; 879126-98-4 ; Revlimid,IMiD3,CC 5013,CDC-501,CDC 501 ; '191732-72-6 ; TM7342160 ; 8505 ; 10g ; 3-(4-amino-1-oxo-2-isoindolinyl)piperidine-2,6-dione ; 1-Oxo-4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole ; E3 Ligase ligand ; DB00480 ; "
96,298.0,"62004-35-7 ; Butanenitrile ; 2-[[(2,5-dibromophenyl)amino]hydroxymethylene]-3-oxo- ; (2E)-2-{[(2,5-Dibromophenyl)amino](hydroxy)methylene}-3-oxobutanenitrile ; "
97,284.0,"Luthium chloride ; LiCl ; Lithium chloride ; Lithium chloride (LiCl) ; 231-212-3 ; 404596-80-1 ; 7447-41-8 ; 16712-20-2 ; lithium chloride anhydrous ; hydrochloric acid lithium salt ; Lithium chloride solution ; Lithium atomic spectroscopy standard concentrate 1.00 g Li ; 85144-11-2 ; Chlorku litu [Polish] ; Chlorure de lithium [French] ; EINECS 231-212-3 ; 7789-01-7 ; Chloride ; Lithium ; D018021 ; Lithiumchlorid ; LITHIUM MONOCHLORIDE ; chlorolithium ; lithiumchloride ; chlorure de lithium ; Lithium chloride,anhydrous ; MFCD00011078 ; 7447-41-5 ; LithiumChlorideGr(Anhydrous) ; Lithium chloride,crystal ; lithium;chloride ; CHEMBL69710 ; Lopac0_000604 ; MolMap_000071 ; UNII-G4962QA067 ; WLN: LI G ; cloruro de litio ; lithii chloridum ; [7447-41-8] ; MFCD00149764 ; UNII:G4962QA067 ; LITHIUM-7LI CHLORIDE ; G4962QA067 ; Electrolyte solution ; Lithium standard solution ; Lithium chloride 1 M solution ; MFCD00190539 ; Lithium chloride ; anhydrous ; Lithium chloride battery grade ; Lithium chloride ; ACS grade ; LiCl231-212-3MFCD00011078 ; "
98,203.0,"2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one ; LY-294,002 ; 8-Phenyl-2-(morpholin-4-yl)-chromen-4-one ; K00235 ; 4H-1-Benzopyran-4-one ; 2-(4-morpholinyl)-8-phenyl- ; 154447-36-6 ; 2-MORPHOLIN-4-YL-7-PHENYL-4H-CHROMEN-4-ONE ; 4H-1-Benzopyran-4-one ; 2-(4-morpholinyl)-8-phenyl ; 4H-1-Benzopyran-4-one ; 2-(4-morpholinyl)-8-phenyl- (9CI) ; H-1-Benzopyran-4-one ; 2-(4-morpholinyl)-8-phenyl- (9CI) ; LY2 ; 2-(4-Morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride ; C085911 ; 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one hydrochloride ; 2-(Morpholin-4-yl)-8-phenyl-4H-chromen-4-one ; [154447-36-6] ; 2-morpholino-8-phenyl-4H-chromen-4-one ; Kinome_3543 ; 2-(4-Morpholinyl)-8-phenyl-4H-chromen-4-one ; 2-(morpholin-4-yl)-8-phenylchromen-4-one ; 2-(4-Morpholino)-8-phenyl-4H-1-benzopyran-4-one ; 4H-1-Benzopyran-4-one,2-(4-morpholinyl)-8-phenyl- ; 2-Morpholin-4-yl-8-phenyl-chromen-4-one ; 2-morpholino-8-phenyl-chromen-4-one ; MFCD00270881 ; 15447-36-6 ; 2-morpholin-4-yl-8-phenyl-4h-chromen-4-one ; 2-morpholin-4-yl-8-phenylchromen-4-one ; 2-(4-morpholinyl)-8-phenyl-1-benzopyran-4-one ; 2-morpholino-8-phenyl-4-chromenone ; 2-morpholino-8-phenyl-chromone ; MFCD01530034 ; "
99,72.0,"169939-94-0 ; 18-dimethylaminomethyl-(18S)-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8(13),9,11,22(27),23,25-nonaene-3,5-dione ; methane sulphonic acid salt ; 13-((Dimethylamino)methyl)-10,11,14,15-tetrahydro-4,9:16,21 -dimetheno-1H,13H-dibenzo(e,k)pyrrolo(3,4-h)(1,4,13) oxadiazacyclohexadecene-1,3(2H)-dione methanesulfonate ; LY 333531 mesylate ; 9H,18H-5,21:12,17-Dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione ; 9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro- ; methanesulfonate ; 192050-59-2 ; 9H,18H-5,21:12,17-Dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione ; 9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro- ; methanesulfonate (1:1) ; MFCD09970504 ; "
100,73.0,4-(3-Pyridin-2-yl-1H-pyrazol-4-yl)quinoline ; PY1 ; 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]-quinoline ; HTS 466284 ; LY-364947 ; Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor ; 4-(3-Pyridin-2-yl)-1H-pyrazol-4-ylquinoline ; LY 364947 ; 396129-53-6 ; 4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline ; Quinoline ; 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]- ; [3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole ; [396129-53-6] ; 4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)quinoline ; HTS-466284 ; LY364947 ; 2-[4-(Quinolin-4-yl)-1H-pyrazol-3-yl]pyridine ; 3-(Pyridin-2-yl)-4-(quinolin-4-yl)-1H-pyrazole ; 4-[(3-Pyridin-2-yl)-1H-pyrazol-4-yl)]quinoline ; HTS 466284 | ; 2-[4-(Quinolin-4-yl)-1H-pyrazol-3-yl]pyridine ; 3-(Pyridin-2-yl)-4-(quinolin-4-yl)-1H-pyrazole ; TbetaR-I Inhibitor and ALK5 Inhibitor I ; ALK Inhibitor 5 ; 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline ; 4-[5-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline ; Quinoline ; 4-[5-(2-pyridinyl)-1H-pyrazol-4-yl]- ; 2-[4-(Quinolin-4-yl)-1H-pyrazol-3-yl]pyridine ; 3-(Pyridin-2-yl)-4-(quinolin-4-yl)-1H-pyrazole ; 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]Í­quinoline ; 4-(5-pyridin-2-yl-1H-pyrazol-4-yl)quinoline ; 4-[5-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline ; TbetaR-I inhibitor ; TGF-beta RI kinase inhibitor ; LY 364947|LY-364947|TbetaR-I inhibitor ; HTS466284 ; Transforming Growth Factor-Î² Type I Receptor Kinase Inhibitor ; HTS466284;LY364947 ; 4-[3-(PYRIDIN-2-YL)-2H-PYRAZOL-4-YL]QUINOLINE ; Not available ; 
101,74.0,"Chloride ; Hydrochloride ; 200-659-6 ; hydron ; Metformin ; Diabefagos ; Diabetosan ; Meguan ; Metformin hydrochloride ; N1,N1-Dimethylbiguanide ; Metformin monohydrochloride ; Dimethylbiguanide hydrochloride ; N,N-Dimethylbiguanide hydrochloride ; N1,N1-Dimethylbiguanide hydrochloride ; Biguanide ; 1,1-dimethyl- ; monohydrochloride ; 657-24-9 ; Imidodicarbonimidic diamide ; N,N-dimethyl- ; monohydrochloride ; 1115-70-4 ; 91-52-1 ; Glucophage ; Glyciphage ; Siamformet ; Riomet ; Glucophage (TN) ; Metiguanide monohydrochloride ; 1,1-Dimethylbiguanide hydrochloride ; 214-230-6 ; 15537-72-1 ; Metformin HCl ; Imidodicarbonimidic diamide ; N,N-dimethyl- ; hydrochloride (1:1) ; N,N-Dimethylimidodicarbonimidic diamide hydrochloride ; 1,1-Dimethylbiguanide monohydrochloride ; N,N-Dimethylimidodicarbonimidic diamide hydrochloride (1:1) ; 1115-70-4 (15537-72-1) ; 1-carbamimidamido-N,N-dimethylmethanimidamide hydrochloride ; 3-carbamimidoyl-1,1-dimethyl-guanidine ; metforminhydrochloride ; NG 60 | ; CSC | ; Metformin hydrochloride (Glucophage) ; Metformin (hydrochloride) ; N,N-dimethyl-imidodicarbonimidic diamide ; monohydrochloride ; 3-carbamimidoyl-1,1-dimethyl-guanidine hydrochloride ; MFCD00012582 ; [1115-70-4] ; 1,1-Dimethylbiguanidehydrochloride ; 1185166-01-1 ; 3-(diaminomethylidene)-1,1-dimethylguanidine;hydrochloride ; 3-(diaminomethylidene)-1,1-dimethylguanidine ; [amino-(diaminomethylideneamino)methylidene]-dimethylazanium and chloride ; 3-carbamimidoyl-1,1-dimethylguanidine ; METFORMIN-D6-HYDROCHLORIDE ; HYDROGEN METFORMIN HCL CHLORIDE ; 3-carbamimidoyl-1,1-dimethylguanidine;hydrochloride ; c4h12cln5 ; metformin hcl(glucophage) ; metformin ; hcl ; 786Z46389E ; N-[amino(dimethylamino)methylidene]guanidine hydrochloride ; (E)-2-carbamimidoyl-1,1-dimethylguanidine hydrochloride ; Metformin hydrochloride solution ; Metformin HCl|Diabetosan ; 1 1-DIMETHYLBIGUANIDE HYDROCHLORIDE ; Metformin hydrochloride ; EP grade ; "
102,184.0,"MK-2206 ; 1032350-13-2 ; 8-[4-(1-Aminocyclobutyl)phenyl]-9-phenyl-1,2,4-triazolo[3,4-f][1,6]naphthyridin-3(2H)-one dihydrochloride ; 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-2H,3H-[1,2,4]triazolo[3,4-f]1,6-naphthyridin-3-one hydrochloride ; 1032349-77-1 ; 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one dihydrochloride ; 1032349-93-1 ; 8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3(2H)-one ; MK-2206 dihydrochloride ; Mk2206 ; 8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3(2H)-one dihydrochloride ; MK 2206 ; 1,2,4-Triazolo[3,4-f][1,6]naphthyridin-3(2H)-one ; 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl- ; hydrochloride (1:2) ; 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one;dihydrochloride ; 8-[4-(1-Aminocyclobutyl)phenyl]-9-phenyl[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3(2H)-one dihydrochloride ; MFCD12912151 ; MK 2206 (hydrochloride) ; 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-1,2,4-triazolo[3,4-f][1,6]naphthyridin-3(2H)-one ; dihydrochloride ; 4-{[(2S,4R)-1-(4-Biphenylyl)-5-ethoxy-4-methyl-5-oxo-2-pentanyl]amino}-4-oxobutanoic acid ; MFCD14584463 ; 8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthy ridin-3(2H)-one ; MK-2206 (hydrochloride) ; [1032350-13-2] ; MK-2206 2HCl ; [1032349-93-1] ; MFCD18633239 ; MK-2206 HCl salt ; 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one and dihydrochloride ; MK-2206 dihydrochloride;MK-2206;MK2206 ; MK-2206 DIHYDROCHLORIDE SALT ; 8-[4-(1-AMINOCYCLOBUTYL)PHENYL]-9-PHENYL-2H-[1,2,4]TRIAZOLO[3,4-F]1,6-NAPHTHYRIDIN-3-ONE DIHYDROCHLORIDE ; MK-2206,MK2206,MK 2206 ; (2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester ; MK 2206 2HCl ; 8-[4-(1-AMINOCYCLOBUTYL)PHENYL]-9-PHENYL-2H,3H-[1,2,4]TRIAZOLO[3,4-F]1,6-NAPHTHYRIDIN-3-ONE DIHYDROCHLORIDE ; (2R,4S)-4-[(3-Carboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic acid ethyl ester ; 4-[[(2S,4R)-5-Ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoic acid calcium salt ; AHU377 calcium salt ; mk 2206 (dihydrochloride) ; mk22062hcl ; "
103,322.0,"ML-7 ; 1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride ; 109376-83-2 ; 110448-33-4 ; 105637-50-1 ; 1-(5-Chloronaphthalenesulfonyl)homopiperazine hydrochloride ; 1-[(5-Iodo-1-naphthyl)sulfonyl]-1,4-diazepane hydrochloride (1:1) ; 1H-1,4-Diazepine ; hexahydro-1-[(5-iodo-1-naphthalenyl)sulfonyl]- ; hydrochloride (1:1) ; ML 7 hydrochloride ; Hexahydro-1-[(5-iodo-1-naphthalenyl)sulfonyl]-1H-1,4-diazepine hydrochloride ; ML-7 HYDROCHLORIDE ; 1-[(5-iodo-1-naphthalenyl)sulfonyl]-1,4-diazepane hydrochloride ; 1-(5-iodanylnaphthalen-1-yl)sulfonyl-1,4-diazepane hydrochloride ; ML-7HYDROCHLORIDE ; 1-((5-Iodonaphthalen-1-yl)sulfonyl)-1,4-diazepane hydrochloride ; ML-7 HYDROCHLORIDE HCL ; Hydrochloride ; 1-(5-Iodonaphthalene-1-sulfonyl)homopiperazine ; HCl ; MFCD00065524 ; (6-Bromo-3-methoxy-2-methylphenyl)methanol ; MFCD21333200 ; 110451-91-7 ; ML-7 (hydrochloride) ; hexahydro-1-[(5-iodo-1-naphthalenyl)sulfonyl]-1H-1,4-diazepine ; monohydrochloride ; 1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepinehydrochloride ; Hexahydro-1-[(5-iodo-1-naphthalenyl)sulfonyl]-1H-1,4-diazepine monohydrochloride ; 1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4 -diazepine ; hydrochloride ; 1-((5-Iodonaphthalen-1-yl)sulfonyl)-1,4-diazepanehydrochloride ; 1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-Diazepine hydrochloride£»ML-7 HYDROCHLORIDE ; ML-7-hydrochloride ; 1-(5-iodonaphthalen-1-yl)sulfonyl-1,4-diazepane;hydrochloride ; 109376-83-2 ; 110448-33-4 ; [110448-33-4] ; [110451-91-7] ; ML-7 HCl ; 1-(5-iodonaphthalen-1-ylsulfonyl)-1,4-diazepane hydrochloride ; hydron and 1-(5-iodonaphthalen-1-yl)sulfonyl-1,4-diazepane and chloride ; HYDROGEN 1-(5-IODONAPHTHALEN-1-YLSULFONYL)-1,4-DIAZEPANE CHLORIDE ; 1-(5-Iodonaphthalene-1-Sulfonyl)-1H-Hexahydro-1,4-Diazepine HCl (en) ; "
104,170.0,"ML-9 ; ML 9 ; K00008 ; 1-(5-Chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine HCl ; 1-(5-Chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride ; 1H-1,4-Diazepine ; 1-((5-chloro-1-naphthalenyl)sulfonyl)hexahydro- ; monohydrochloride ; 105637-50-1 ; 1-(5-Chloronaphthalenesulphonyl)-1H-hexahydro-1,4-diazepine hydrochloride [ML-9] ; ML 9 hydrochloride ; 1-(5-Chloronaphthalenesulfonyl)homopiperazine hydrochloride ; 1-[(5-Chloro-1-naphthyl)sulfonyl]-1,4-diazepane hydrochloride (1:1) ; 1H-1,4-Diazepine ; 1-[(5-chloro-1-naphthalenyl)sulfonyl]hexahydro- ; hydrochloride (1:1) ; [105637-50-1] ; ML-9HYDROCHLORIDE ; z-Pseudosubstrate inhibitory peptide (scrambled) | ; Hydrochloride ; 1-(5-Chloronaphthalene-1-sulfonyl)homopiperazine ; HCl ; 1-[(5-chloro-1-naphthalenyl)sulfonyl]hexahydro-1H-1,4-diazepine ; monohydrochloride ; 1-(5-Chloronaphthalenesulfonyl)-1H-hexahydro-1,4-diazepine ; hydrochloride ; 1-((5-Chloronaphthalen-1-yl)sulfonyl)-1,4-diazepane hydrochloride ; 1-(5-Chloronaphthalenesulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride ; ML-9 HYDROCHLORIDE ; MFCD00065525 ; 1-(5-chloronaphthalen-1-yl)sulfonyl-1,4-diazepane;hydrochloride ; UNII-BZ2L6JK93I ; 1-[(5-chloro-1-naphthalenyl)sulfonyl]-1,4-diazepan-4-ium ; 1-(5-chloronaphthalen-1-yl)sulfonyl-1,4-diazepane and hydron and chloride ; 1H-1,4-Diazepine,1-[(5-chloro-1-naphthalenyl)sulfonyl]hexahydro- ; hydrochloride (1:1) ; UNII:BZ2L6JK93I ; ML 9 HYDROCHLORIDE;1-(5-CHLORONAPHTHALENESULFONYL)HOMOPIPERAZINEHYDROCHLORIDE ; Not available ; BZ2L6JK93I ; 1-(5-Chloronaphthalenesulphonyl)-1H-hexahydro-1,4-diazepine hydrochloride ; "
105,77.0,"MLN4924 ; 1160295-21-5 ; [(1S,2S,4R)-4-{4-[(1S)-2,3-Dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl]methyl sulfamate ; Sulfamic acid ; [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl ester ; 905579-51-3 ; Pevonedistat ; [(1S,2S,4R)-4-(4-{[(1S)-2,3-dihydro-1H-inden-1-yl]amino}-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl]methyl sulfamate ; ((1S,2S,4R)-4-(4-((S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate ; MLN 4924 ; Sulfamic acid [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl ester ; MLN-4924 ; MFCD17215201 ; [(1S,2S,4R)-2-hydroxy-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclopentyl]methyl sulfamate ; [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl sulfamate ; [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxy-cyclopentyl]methyl sulfamate ; sulfamic acid [(1S,2S,4R)-2-hydroxy-4-[4-[[(1S)-1-indanyl]amino]-7-pyrrolo[2,3-d]pyrimidinyl]cyclopentyl]methyl ester ; sulfamic acid [(1S,2S,4R)-2-hydroxy-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclopentyl]methyl ester ; UNII-S3AZD8D215 ; ((1S,2S,4R)-4-(4-(((S)-2,3-dihydro-1H-inden-1-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate ; [905579-51-3] ; UNII:S3AZD8D215 ; Pevonedistat;MLN-4924;MLN 4924 ; sulfamic acid [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-7-pyrrolo[2,3-d]pyrimidinyl]-2-hydroxycyclopentyl]methyl ester ; B39 ; 9605 ; S3AZD8D215 ; [(1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl]methyl sulfamate ; pevonedistat (mln4924) ; "
106,78.0,"1201902-80-8 ; ixazomib ; Ixazomib citrate ; 1239908-20-3 ; MLN9708,MLN-9708,MLN 9708 ; 1,3,2-Dioxaborinane-4-acetic acid ; 4-carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo- ; 4-(Carboxymethyl)-2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid ; 4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid ; MLN-9708 ; 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid ; 4-(carboxymethyl)-2-[(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid ; [1201902-80-8] ; MFCD18251437 ; MLN 9708 ; 133876-92-3 ; Nattokinase ; 4-carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid ; IXAZOMIB CITRATE 1,3,2-DIOXABORINANE ; 4-(carboxymethyl)-2-[(1r)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylicacid ; ixazomib citrate (mln9708) ; "
107,171.0,N-{3-[(5-Cyclopropyl-2-{[3-(4-morpholinylmethyl)phenyl]amino}-4-pyrimidinyl)amino]propyl}cyclobutanecarboxamide ; 1190378-57-4 ; n-(3-((5-cyclopropyl-2-((3-(4-morpholinylmethyl)phenyl)amino)-4-pyrimidinyl)amino)propyl)cyclobutanecarboxamide ; MRT 67307;MRT-67307 ; N-[3-[[5-cyclopropyl-2-[3-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]amino]propyl]cyclobutanecarboxamide ; MRT67307 ; MRT-67307 ; [1190378-57-4] ; MFCD19443643 ; N-[3-[[5-Cyclopropyl-2-[[3-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]propyl]-cyclobutanecarboxamide hydrochloride ; MRT 67307 ; N-{3-[(5-Cyclopropyl-2-{3-[(morpholin-4-yl)methyl]anilino}pyrimidin-4-yl)amino]propyl}cyclobutanecarboxamide ; N-[3-[[5-cyclopropyl-2-[[3-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]propyl]-Cyclobutanecarboxamide ; N-[3-[[5-cyclopropyl-2-[3-(4-morpholinylmethyl)anilino]-4-pyrimidinyl]amino]propyl]cyclobutanecarboxamide ; 1FV ; N-{3-[(5-Cyclopropyl-2-{[3-(Morpholin-4-Ylmethyl)phenyl]amino}pyrimidin-4-Yl)amino]propyl}cyclobutanecarboxamide ; mrt67307 hcl ; n-[3-[[5-cyclopropyl-2-[[3-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]propyl]cyclobutanecarboxamide ; N-(3-((5-cyclopropyl-2-((3-(morpholinomethyl)phenyl)amino)pyrimidin-4-yl)amino)propyl)cyclobutanecarboxamide ; N-(3-{[5-CYCLOPROPYL-2-({3-[(MORPHOLIN-4-YL)METHYL]PHENYL}AMINO)PYRIMIDIN-4-YL]AMINO}PROPYL)CYCLOBUTANECARBOXAMIDE ; 
108,178.0,"Necrostatin-1 ; MTH-DL-Tryptophan ; MTH-trp ; Nec-1 ; methyl-thiohydantoin-tryptophan ; methylthiohydantoin-DL-tryptophan ; Hydantoin ; 5-(indol-3-ylmethyl)-3-methyl-2-thio- (7CI,8CI) ; 4-Imidazolidinone ; 5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo- ; 4-Imidazolidinone ; 5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo- (9CI) ; 4311-88-0 ; 5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxo-4-imidazolidinone ; 5-(indol-3-ylmethyl)-3-methyl-2-thio-Hydantoin ; 5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxoimidazolidin-4-one ; 5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxo-imidazolidin-4-one ; Nec-1; ; 5-((1H-indol-3-yl)methyl)-3-methyl-2-thioxoimidazolidin-4-one ; Nec-1;MTH-trp;MTH-DL-Tryptophan ; [4311-88-0] ; 64419-92-7 ; Nec-1 and Necrostatin-1 ; 5-(Indol-3-ylmethyl)-(2-thio-3-methyl)hydantoin ; 5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanylideneimidazolidin-4-one ; 5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxo-4-imidazolidinone ; 5-(Indol-3-ylmethyl)-3-methyl-2-thio-hydantoin ; MTH-DL-Tryptophan ; MFCD00056916 ; 5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone ; 5-(1H-Indol-3-ylmethyl)-2-mercapto-3-methyl-3,5-dihydro-imidazol-4-one ; 5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxo-4-imidazolidinone ; 5-(Indol-3-ylmethyl)-3-methyl-2-thio-hydantoin ; MTH-DL-Tryptophan ; 5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanylidene-4-imidazolidinone ; 4-Imidazolidinone,5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo- ; Necrostatin 1 ; IN1207 ; Necroptotic Inhibitor ; MTH-DL-Tryptophan,Nec-1 ; 5-[(1H-INDOL-3-YL)METHYL]-3-METHYL-2-SULFANYLIDENEIMIDAZOLIDIN-4-ONE ; "
109,80.0,"N-{4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl}-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)benzamide ; NG25 ; 1315355-93-1 ; NG 25;NG-25 ; N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)benzamide ; NG-25 ; NG 25 trihydrochloride ; [1315355-93-1] ; MFCD19443255 ; NG 25 ; 3-((1H-Pyrrolo[2,3-b]pyridin-4-yl)oxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide ; N-{4-[(4-Ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-4-methyl-3-[(1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]benzamide ; Not available ; N-{4-[(4-Ethylpiperazin-1-Yl)methyl]-3-(Trifluoromethyl)phenyl}-4-Methyl-3-(1h-Pyrrolo[2,3-B]pyridin-4-Yloxy)benzamide ; NG2 ; N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)-benzamide trihydrochloride ; "
110,81.0,"569344-28-1 ; BEZ-235 ; 2-Methyl-2-{4-[3-methyl-2-oxo-8-(3-quinolinyl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl]phenyl}propanenitrile ; Benzeneacetonitrile ; 4-[2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-alpha,alpha-dimethyl- ; BEZ235 ; 915019-65-7 ; NVP-BEZ 235 ; 2-(4-(2,3-dihydro-3-methyl-2-oxo-8-(quinolin-3-yl)imidazo[4,5-c]quinolin-1-yl)phenyl)-2-methylpropanenitrile ; NVP-BEZ235 ; BEZ235(NVP-BEZ235) ; 2-methyl-2-[4-(3-methyl-2-oxo-8-(3-quinolyl)(4-imidazolino[4,5-c]quinolinyl))phenyl]propanenitrile ; Kinome_2911 ; 2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile ; BEZ235 (NVP-BEZ235) ; 2-Methyl-2-[4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl]phenyl]propionitrile ; BEZ 235 ; 4-[2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-alpha,alpha-dimethyl-Benzeneacetonitrile ; 2-methyl-2-[4-(3-methyl-2-oxo-8-(3-quinolyl)(4-imidazolino[4,5-c]quinolinyl))p henyl]propanenitrile ; 2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile ; Benzeneacetonitrile,4-[2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-a,a-dimethyl- ; NVP BEZ235 ; NVPBEZ235 ; 2-methyl-2-{4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl]phenyl}propanenitrile ; Dactolisib ; MFCD10565944 ; 2-Methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile ; Benzeneacetonitrile ; 4-[2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-a,a-dimethyl- ; 4-[2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-a,a-dimethyl-benzeneacetonitrile ; NVP-BEZ235-NX ; S1009 ; 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile ; mTOR Inhibitor ; BEZ235 ; 2-[4-[2-keto-3-methyl-8-(3-quinolyl)imidazo[4,5-c]quinolin-1-yl]phenyl]-2-methyl-propionitrile ; 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-imidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile ; 2-methyl-2-[4-[3-methyl-2-oxo-8-(3-quinolyl)-1-imidazo[4,5-c]quinolinyl]phenyl]propanenitrile ; 2-methyl-2-[4-[3-methyl-2-oxo-8-(3-quinolyl)imidazo[4,5-c]quinolin-1-yl]phenyl]propanenitrile ; NVP-BEZ-235 ; UNII-RUJ6Z9Y0DT ; BEZ235|NVP-BEZ235 ; [915019-65-7] ; 2-methyl-2-[3-methyl-2-oxo-8-(3-quinolinyl)-1-imidazo[4,5-c]quinolinyl]propanenitrile ; BEZ235 (NVP-BEZ235 ; Dactolisib) ; UNII:RUJ6Z9Y0DT ; NVP-BEZ 235;BEZ-235;BEZ 235;NVP-BEZ235 ; 2-METHYL-2-{4-[3-METHYL-2-OXO-8-(QUINOLIN-3-YL)-1H,2H,3H-IMIDAZO[4,5-C]QUINOLIN-1-YL]PHENYL}PROPANENITRILE ; 2-METHYL-2-{4-[3-METHYL-2-OXO-8-(QUINOLIN-3-YL)IMIDAZO[4,5-C]QUINOLIN-1-YL]PHENYL}PROPANENITRILE ; RUJ6Z9Y0DT ; 4-[2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-Î±,Î±-dimethyl-benzeneacetonitrile ; dactolisib (bez235 ; nvp-bez235) ; nvp-bez235 ; free base ; 4-[2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-α,α-dimethyl-benzeneacetonitrile ; NVP BEZ 235 ; "
111,277.0,OSU03012 ; 742112-33-0 ; OSU-03012 ; 2-amino-N-(4-(5-(phenanthren-2-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)acetamide ; 2-amino-N-{4-[5-(phenanthren-2-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}acetamide ; 2-amino-N-{4-[5-(phenanthren-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl}acetamide ; OSU-03012 (AR-12) ; 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide ; Acetamide ; 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]- ; N-{4-[5-(2-Phenanthryl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}glycinamide ; 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]acetamide ; MFCD12912272 ; 2-amino-N-[4-[5-phenanthren-2-yl-3-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide ; 2-amino-N-[4-[5-(2-phenanthryl)-3-(trifluoromethyl)-1-pyrazolyl]phenyl]acetamide ; 2-amino-N-[4-[5-(2-phenanthryl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide ; 2-amino-N-[4-[5-phenanthren-2-yl-3-(trifluoromethyl)pyrazol-1-yl]phenyl]ethanamide ; AR-12|OSU03012 ; [742112-33-0] ; OSU 03012 ; AR-12 ; OSU03012 ; OSU 03012 ; AR 12 ; N-{4-[5-(phenanthren-2-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}glycinamide ; PDK1 inhibitor AR-12 ; 3-[(tert-butyldimethylsilyl)oxy]cyclopentan-1-ol ; Not available ; osu-03012(ar-12) ; 2-Amino-N-{4-[5-(2-phenanthryl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}acetamide ; AR-12 (OSU-03012) ; 
112,82.0,"Parthenolide ; 20554-84-1 ; 2513-77-1 ; 4xi-Germacra-1(10),11(13)-dien-12-oic acid ; 4,5-epoxy-6.alpha.-hydroxy- ; gamma-lactone ; 29552-41-8 ; Oxireno(9,10)cyclodeca(1,2-b)furan-9(1aH)-one ; 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene- ; (-)-Parthenolide ; MFCD00134592 ; Oxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one ; 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene- ; (4Z)-1a,5-Dimethyl-8-methylene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one ; AKOS015840066 ; Ambotz20554-84-1 ; CHEMBL3186408 ; "
113,267.0,"PCI-32765 ; 936563-96-1 ; 1-{(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl}-2-propen-1-one ; 2-Propen-1-one ; 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]- ; (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one ; PCI-32765 (Ibrutinib) ; Ibrutinib ; PCI 32765 ; 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one ; CRA-032765 ; Imbruvica ; PCI32765 ; ibrutinib ; ibrutinibum ; 1-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one ; 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-2-propen-1-one ; PCI-32765-00 ; (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo-[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one ; 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinyl]-2-propen-1-one ; 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one ; MFCD20261150 ; UNII-1X70OSD4VX ; ibrutinibum ; [936563-96-1] ; Ibrutinib (PCI-32765) ; Ibrutinib(PCI-32765) ; 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one ; PCI-32765 (Ibrutinib () ; UNII:1X70OSD4VX ; Ibrutinib;PCI32765;PCI 32765 ; 1X70OSD4VX ; 9566 ; PCI-32765 ; ibrutinib ; Ibrutinib|PCI-32765 ; "
114,288.0,"391210-10-9 ; Benzamide ; N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- ; PD-325901 ; N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide ; benzamide ; N-[[(2R)-2,3-dihydroxypropyl]oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- ; (R)-(-)-N-(2,3-dihydroxy-propoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide ; N-[((R)-2,3-dihydroxypropyl)oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide ; (R)-N-(2,3-Dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)benzamide ; 301210-10-9 ; N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2[(2-fluoro-4-iodophenyl)amino]-benzamide ; PD0325901 ; N-[(2R)-2,3-dihydroxyproposy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide ; N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide ; N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- benzamide ; N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide ; PD-0325901 ; (R)-N-(2,3-Dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide ; PD325901 ; PD325901 | ; MFCD08435926 ; Benzamide,N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- ; 391209-97-5 ; N-((R)-2,3-Dihydroxy[propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide ; N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide ; N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-anilino)benzamide ; PD-0235901 ; [391210-10-9] ; BR-78415 ; N-((R)-2,3-dihydroxypropoxy)-2-(2-fluoro-4-iodophenylamino)-3,4-difluorobenzamide ; US8575391 ; 340 ; 3,4-difluoro-2-[(2-fluoro-4-iodo-phenyl)amino]-N-glyceryloxy-benzamide ; N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodo-phenyl)amino]benzamide ; PD-0325901|PD0325901 ; (S)-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide ; N-(2R)-2,3-dihydroxyproposy-3,4-difluoro-2-(2-fluoro-4-iodophenyl)amino-benzamide ; N-(2R)-2,3-dihydroxypropoxy-3,4-diflu oro-2-(2-fluoro-4-iodophenyl)amino-benzamide ; PD 0325901 ; PD325901 ; PD-0325901 ; 870474-62-7 ; PD-03259011 ; PD 325901 ; (R)-N-(2,3-Dihydroxypropoxy)-3,4-difluoro-2-((2-fl ; Not available ; 4BM ; c16h14f3in2o4 ; pd0325901 (pd325901) ; N-((r)-2,3-dihydroxy-propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide ; "
115,211.0,"mevastatin ; PD0332991 ; 571189-11-2 ; 827022-32-2 ; Palbociclib ; 827022-33-3 ; PD 0332991 HCl ; PD 0332991 (Palbociclib) HCl ; PD 0332991 hydrochloride ; Palbociclib HCl ; 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one ; Palbociclib hydrochloride ; 1279034-84-2 ; Pyrido[2,3-d]pyrimidin-7(8H)-one ; 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]- ; hydrochloride (1:1) ; 6-Acetyl-8-cyclopentyl-5-methyl-2-{[5-(1-piperazinyl)-2-pyridinyl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride (1:1) ; 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride ; PD 0332991 (hydrochloride) ; 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride ; MFCD22420809 ; PD-0332991 HCl ; [827022-32-2] ; Palbociclib (hydrochloride) ; PD0332991 hydrochloride ; PD-0332991 hydrochloride ; PD0332991 HCl ; Palbociclib (PD-0332991) HCl ; Palbociclib(PD0332991) ; 827022-32-2 ; 571190-30-2 (free base) ; 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one and hydrochloride ; 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride (20:37) ; PD0332991;PD-0332991;PD 0332991 ; PD-0332991 hydrochloride;PD0332991 hydrochloride;PD 0332991 hydrochloride ; 6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-{[5-(PIPERAZIN-1-YL)PYRIDIN-2-YL]AMINO}PYRIDO[2,3-D]PYRIMIDIN-7-ONE HYDROCHLORIDE ; 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one hydrochloride ; 2-Pyrrolidinone ; 5-(4-piperidinyl)- ; hydrochloride ; 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8h)-one hydrochloride(wx135243s1) ; palbociclib (pd0332991 hcl) ; palbociclib (pd-0332991) hydrochloride ; pd0332991.hcl ; pyrido[2,3-d]pyrimidin-7(8h)-one,6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-,monohydrochloride ; pd0332991hcl ; 6-ACetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride(20:37) ; 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridyl]amino]pyrido[2,3-d]pyrimidin-7(8h)-one hydrochloride ; "
116,206.0,"2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide ; C120227 ; CI 1040 ; PD 184352 ; PD184352 ; Benzamide ; 2-[(2-chloro-4-iodophenyl)amino]-N-(cyclopropylmethoxy)-3,4-difluoro- ; 212631-79-3 ; 2-[(2-Chloro-4-iodophenyl)amino]-N-(cyclopropylmethoxy)-3,4-difluorobenzamide ; 2-(2-Chloro-4-iodo-phenylamino)-N-cyclopropylmethoxy-3,4-difluoro-benzamide ; 2-(2-chloro-4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide ; CI-1040 (PD184352) ; 2-[(2-Chloro-4-iodophenyl)amino]-N-cyclopropylmethoxy)-3,4-difluorobenzamide ; PD-18435 ; CI-1040 | ; PD 184,352 ; PD 184352 ; Free Base ; CI1040 ; 2-[(2-chloro-4-iodophenyl)amino]-N-(cyclopropylmethoxy)-3,4-difluoro-benzamide ; MFCD02683961 ; 4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide ; 3,4-Difluoro-2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxybenzamide ; C.I. 1040 ; 2-((2-Chloro-4-iodophenyl)amino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide ; PD184352 (CI-1040) ; PD184,352 ; [212631-79-3] ; 2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide ; CHEMBL105442 ; 2-[(2-chloro-4-iodo-phenyl)amino]-N-(cyclopropylmethoxy)-3,4-difluoro-benzamide ; CI 1040|CI1040|PD-184352|PD184352 ; CI1040;CI 1040;PD184352;PD-184352;PD 184352 ; Not available ; pd 184352ci-1040 ; pd-184352(ci-1040) ; "
117,213.0,"Btp2 | ; PF 3644022 ; (10R)-10-Methyl-3-(6-methyl-3-pyridinyl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one ; 8H-[1,4]Diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one ; 9,10,11,12-tetrahydro-10-methyl-3-(6-methyl-3-pyridinyl)- ; (10R)- ; 1276121-88-0 ; [1276121-88-0] ; (10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one ; (15R)-15-methyl-5-(6-methylpyridin-3-yl)-11-thia-6,14,17-triazatetracyclo[8.8.0.02,7.012,18]octadeca-1(10),2,4,6,8,12(18)-hexaen-13-one ; PF3644022 ; PF-3644022 ; PF 3644022|PF3644022 ; (15R)-15-methyl-5-(6-methylpyridin-3-yl)-11-thia-6,14,17-triazatetracyclo[8.8.0.0²,⁷.0¹²,¹⁸]octadeca-1(10),2(7),3,5,8,12(18)-hexaen-13-one ; Not available ; "
118,214.0,PF 4708671 ; 2-[[4-(5-Ethylpyrimidin-4-yl)piperazin-1-yl]methyl]-5-(trifluoromethyl)-1H-benzo[d]imidazole ; PF-04708671 ; PF-4708671 ; 1255517-76-0 ; 2-[[4-(5-ethyl-4-pyrimidinyl)-1-piperazinyl]methyl]-6-(trifluoromethyl)-1H-benzimidazole ; PF 04708671 ; 2-((4-(5-ethylpyrimidin-4-yl)piperazin-1-yl)methyl)-5-(trifluoromethyl)-1H-benzo[d]imidazole ; 1H-Benzimidazole ; 2-[[4-(5-ethyl-4-pyrimidinyl)-1-piperazinyl]methyl]-6-(trifluoromethyl)- ; 1H-Benzimidazole ; 2-[[4-(5-ethyl-4-pyrimidinyl)-1-piperazinyl]methyl]-5-(trifluoromethyl)- ; 2-{[4-(5-Ethyl-4-pyrimidinyl)-1-piperazinyl]methyl}-5-(trifluoromethyl)-1H-benzimidazole ; PF4708671 ; [1255517-76-0] ; 2-[[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl]-6-(trifluoromethyl)-1H-benzimidazole ; MFCD18086922 ; 2-[4-(5-Ethyl-pyrimidin-4-yl)-piperazin-1-ylmethyl]-5-trifluoromethyl-1H-benzoimidazole ; 2-((4-(5-Ethylpyrimidin-4-yl)piperazin-1-yl)methyl)-6-(trifluoromethyl)-1H-benzo[d]imidazole ; 2-{[4-(5-Ethylpyrimidin-4-Yl)piperazin-1-Yl]methyl}-5-(Trifluoromethyl)-1h-Benzimidazole ; 5FI ; AGN-PC-0940P1 ; CHEMBL2134202 ; GTPL8036 ; MLS006011193 ; PF 4708671;PF4708671 ; 2-{[4-(5-Ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-6-(trifluoromethyl)-1H-benzimidazole ; 
119,83.0,"371935-74-9 ; PI 103 hydrochloride ; [371935-74-9] ; 3-(4-(4-Morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol ; Kinome_3597 ; 3-[6-(morpholin-4-yl)-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(13),2,4,6,9,11-hexaen-4-yl]phenol ; PI103 ; 3-[4-(4-Morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol ; Phenol ; 3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]- ; 3-[4-Morpholin-4-ylpyrido[3',2':4,5]furo[3,2-d]pyriMidin-2-yl]phenol ; 3-(4-morpholinopyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol ; 3-[4-(4-morpholinyl)pyrido[3’,2’:4,5]furo[3,2-d]pyrimidin-2-yl]-phenol ; 3-[4-(4-morpholinyl)pyrido[3Õ,2Õ:4,5]furo[3,2-d]pyrimidin-2-yl]-phenol ; cid_9884685 ; pyridofuropyrimidine derivative ; 2 ; MFCD11983145 ; 3-(4-morpholin-4-ylpyrido[2,3]furo[2,4-b]pyrimidin-2-yl)phenol ; PI 103 ; PIK 103 ; :4,5]furo[3,2-d]pyrimidin-2-yl)phenol ; UNII-YQX02F616F ; PI 103|PIK 103 ; UNII:YQX02F616F ; PI 103;PI103 ; PI - 103 ; compound 2 [PMID: 17601739] ; 3-[4-(morpholin-4-yl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol ; PIK-103 ; 3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl] ; 3-(4-Morpholin-4-Ylpyrido[3',2':4,5]furo[3,2-D]pyrimidin-2-Yl)phenol ; X6K ; YQX02F616F ; 3-[4-(4-morpholinyl)pyrido[3â€™,2â€™:4,5]furo[3,2-d]pyrimidin-2-yl]-phenol ; "
120,160.0,"10083-24-6 ; Astringinine ; E-Piceatannol ; 3-hydroxyresveratol ; 3,3',4'5-Tetrahydroxystilbene ; 3,3',4,5'-Stilbenetetrol ; 3,5,3',4'-tetrahydroxystilbene ; 3,3',4,5'-tetrahydroxystilbene ; trans-3,3',4,5'-tetrahydroxystilbene ; K00089 ; 4-(2-(3,5-Dihydroxyphenyl)vinyl)-1,2-benzenediol ; (E)-4-[2-(3,5Dihydroxyphenyl)ethenyl]1,2-benzenediol ; 1,2-Benzenediol ; 4-(2-(3,5-dihydroxyphenyl)ethenyl)- ; 3,3′,4,5′-Tetrahydroxy-trans-stilbene ; 4-[(E)-2-(3,5-Dihydroxyphenyl)vinyl]benzene-1,2-diol ; 4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol ; 1,2-Benzenediol ; 4-(2-(3,5-dihydroxyphenyl)ethenyl)- ; 21100-92-5 ; 4339-71-3 ; 3,3',4',5-tetrahydroxystilbene ; 4-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,2-benzenediol ; PIT ; 4-[(E)-2-(3,5-Dihydroxyphenyl)vinyl]-1,2-benzenediol ; 1,2-Benzenediol ; 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]- ; 1879860 ; 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol ; (E)-4-(3,5-dihydroxystyryl)benzene-1,2-diol ; 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,2-diol(Piceatannol) ; 4-[2-(3,5-dihydroxyphenyl)-(E)-1-ethenyl]-1,2-benzenediol ; 4-[2-(3,5-dihydroxyphenyl)-(E)-1-ethenyl]-1,2-benzenediol(Piceatannol) ; (E)-4-[2-(3,5-Dihydroxyphenyl)ethenyl]1,2-benzenediol ; [10083-24-6] ; trans-Piceatannol ; 3,4,3',5'-Tetrahydroxy-trans-stilbene ; 5-[(E)-2-(3,4-Dihydroxyphenyl)vinyl]benzene-1,3-diol ; NSC-365798 ; 4-[(E)-2-[3,5-bis(oxidanyl)phenyl]ethenyl]benzene-1,2-diol ; 106325-86-4 ; CIS-PICEATANNOL ; CZ8937690 ; MFCD00221715 ; 1,2-Benzenediol ; 4-[2-(3,5-dihydroxyphenyl)ethenyl]- ; 5-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]benzene-1,3-diol ; R 483 | BM 131258 | ; 3,3â€²,4,5â€²-Tetrahydroxy-trans-stilbene ; UNII:6KS3LS0D4F ; 4-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol ; 6KS3LS0D4F ; 5-[2-(3,4-dihydroxyphenyl)ethenyl]benzene-1,3-diol ; E'piceatannol' ; 4-[(1e)-2-(3,5-dihydroxyphenyl)-ethenyl]-1,2-benzenediol ; 4-(3,5-Dihydroxystyryl)benzene-1,2-diol ; 3,3',4,5'-Tetrahydroxy-trans-stilbene ; Astringenin ; "
121,84.0,"Deskar ; Pirfenidone ; Pirfenidone [USAN:INN] ; 5-Methyl-1-phenyl-2(1H)-pyridone ; 5-methyl-1-phenyl-2-(1h)-pyridone ; 2(1H)-Pyridone ; 5-methyl-1-phenyl- ; 2(1H)-Pyridinone ; 5-methyl-1-phenyl- ; 5-21-07-00197 (Beilstein Handbook Reference) ; 53179-13-8 ; 5-21-07-00197 ; 39856-57-0 ; 53178-13-8 ; Pirfenidona [INN-Spanish] ; C093844 ; 5-Methyl-1-phenyl-2(1H)-pyridinone ; 5-Methyl-1-phenylpyridin-2(1H)-one ; 5-Methyl-1-phenyl-1H-pyridin-2-one ; [53179-13-8] ; Compound C | BML-275 | ; 1020719-62-3 ; 5-METHYL-N-PHENYL-2-1H-PYRIDONE-D5 ; MFCD00866047 ; 5-Methyl-N-phenyl-2-1H-pyridone [pirfenidone] ; 5-Methyl-1-phenyl-2(1H)pyridinone ; BR-72929 ; Uv1148200 ; Esbriet ; Pirespa ; Etuary ; OR-2236 ; 5-methyl-1-phenyl-1,2-dihydropyridin-2-one ; 5-Methyl-1-phenyl-2-pyridinone ; 5-Methyl-N-phenyl-2-1H-pyridone-d5 ( Pirfenidone-d5 ) ; 5-methyl-1-phenylpyridin-2-one ; 5-methyl-1-phenyl-2-pyridone ; 5-methyl-1-phenyl-pyridin-2-one ; Lopac0_000907 ; Pirfenidonum [INN-Latin] ; UNII-D7NLD2JX7U ; pirfenidona ; pirfenidonum ; AMR69 ; pirfenidona ; pirfenidone ; pirfenidonum ; 5-Methyl-N-phenyl-2-1H-pyridone ; UNII:D7NLD2JX7U ; Esbriet;AMR69;Deskar;Pirespa ; 1526549 ; D7NLD2JX7U ; Pirfenidone-d5 ; 3825 ; Pirfenidone D5 ; pirfenidone(amr69) ; pirfenidone(rs20011449) ; 吡非尼酮api ; 5-Methyl-N-phenyl-2-1H-pyridone|5-Methyl-1-phenyl-2(1H)pyridinone|Pirfenidone ; Pirfenidone|5-Methyl-1-phenyl-2(1H)pyridinone|Pirfenidone ; Pirfenidone|5-methyl-1-phenyl-2(1H)-pyridinone ; Pirfenidone ; EP grade ; "
122,262.0,"(8Z)-8-(1H-imidazol-4-ylmethylidene)-6,8-dihydro-7H-[1,3]thiazolo[5,4-e]indol-7-one ; 8-[1-(1H-imidazol-4-yl)-meth-(Z)-ylidene]-6,8-dihydro-thiazolo[5,4-e]indol-7-one ; 7H-Thiazolo[5,4-e]indol-7-one ; 6,8-dihydro-8-(1H-imidazol-4-ylmethylene)- ; C16 (PKR inhibitor) ; 8- -6,8-DIHYDRO-THIAZOLO[5,4-E]INDOL-7-ONE ; 608512-97-6 ; (8Z)-8-(1H-Imidazol-4-ylmethylene)-6,8-dihydro-7H-[1,3]thiazolo[5,4-e]indol-7-one ; PKR Inhibitor ; (Z)-8-((1H-Imidazol-4-yl)methylene)-6H-thiazolo[5,4-e]indol-7(8H)-one ; 7H-Thiazolo[5,4-e]indol-7-one ; 6,8-dihydro-8-(1H-imidazol-5-ylmethylene)- ; (8Z)-8-(1H-Imidazol-5-ylmethylene)-6,8-dihydro-7H-[1,3]thiazolo[5,4-e]indol-7-one ; (8E)-8-(1H-imidazol-5-ylmethylidene)-6H-pyrrolo[2,3-g][1,3]benzothiazol-7-one ; C16 ; (8Z)-8-(1H-imidazol-5-ylmethylidene)-6H,7H,8H-[1,3]thiazolo[5,4-e]indol-7-one ; AC1O5VPR ; AC1O5VPR|ASN 11124542 ; (Z)-8-((1H-imidazol-5-yl)methylene)-6,8-dihydro-7H-thiazolo[5,4-e]indol-7-one ; [608512-97-6] ; (8Z)-8-(1H-imidazol-5-ylmethylidene)-6H-pyrrolo[2,3-g][1,3]benzothiazol-7-one ; IMIDAZOLO-OXINDOLE PKR INHIBITOR C16 ; (8Z)-6,8-Dihydro-8-(1H-imidazol-5-ylmethylene)-7H-pyrrolo[2,3-g]benzo[d]thiazol-7-one ; 1159885-47-8 ; 6,8-dihydro-8-(1H-imidazol-5-ylmethylene)-7H-pyrrolo[2,3-g]benzothiazol-7-one ; 8-[(1H-IMIDAZOL-5-YL)METHYLIDENE]-6H,7H,8H-[1,3]THIAZOLO[5,4-E]INDOL-7-ONE ; Not available ; MFCD06735404 ; "
123,264.0,"Isoliensinine ; Isoliensinin ; 6817-41-0 ; 7-Isoquinolinol ; 1,2,3,4-tetrahydro-1-[[4-hydroxy-3-[[(1R)-1,2,3,4-tetrahydro-6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-7-isoquinolinyl]oxy]phenyl]methyl]-6-methoxy-2-methyl- ; (1R)-1-(4-Hydroxy-3-{[(1R)-6-methoxy-1-(4-methoxybenzyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy}benzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol ; 1029872-54-5 ; Vemurafenib ; N-[3-[[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-Propanesulfonamide ; PLX 4032 ; (1R)-1-(4-Hydroxy-3-{[(1R)-6-methoxy-1-(4-methoxybenzyl)-2-methyl-1,2,3,4-tetrahydro-7-isoquinolinyl]oxy}benzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-7-isoquinolinol ; [6817-41-0] ; MFCD11042260 ; (1R)-1-(4-hydroxy-3-{[(1R)-6-methoxy-1-(4-methoxybenzyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy}benzyl)-6-methoxy-2-methyl- ; (1R)-1-[(4-HYDROXY-3-{[(1R)-6-METHOXY-1-[(4-METHOXYPHENYL)METHYL]-2-METHYL-3,4-DIHYDRO-1H-ISOQUINOLIN-7-YL]OXY}PHENYL)METHYL]-6-METHOXY-2-METHYL-3,4-DIHYDRO-1H-ISOQUINOLIN-7-OL ; (1R)-1-[[4-hydroxy-3-[[(1R)-6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenyl]methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol ; 14028-85-4 ; (R)-1-(4-hydroxy-3-(((R)-6-methoxy-1-(4-methoxybenzyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)oxy)benzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol ; PLX 4032|Vemurafenib ; (+)-Isoliensinine ; "
124,85.0,"918505-84-7 ; N-[3-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide ; PLX-4720 ; N-[3-({5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl}carbonyl)-2,4-difluorophenyl]propane-1-sulfonamide ; N-(3-{5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide ; PLX 4720 ; PLX4720 ; N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide ; Propane-1-sulfonic acid[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]-amide ; Propane-1-sulfonic acid [3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]-amide ; 1-Propanesulfonamide ; N-[3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]- ; N-{3-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}-1-propanesulfonamide ; N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide ; MFCD14635203 ; Propane-1-sulfonic acid[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl]-amide ; N-(3-(5-Chloro-1h-pyrrolo[2,3-b]ipyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide ; [918505-84-7] ; N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2 ; 4-difluorophenyl]propane-1-sulfonamide ; N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide ; N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl]propane-1-sulfonamide ; N-[3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-oxomethyl]-2,4-difluorophenyl]-1-propanesulfonamide ; N-[3-(5-chloro1H-pyrrolo[5,4-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide ; N-[3-(5-chloro1H-pyrrolo[5,4-b]pyridine-3-carbonyl)-2,4-difluorophenyl]propane-1-sulfonamide ; N-[3-[(5-chloro-1H-pyrrolo[5,4-b]pyridin-3-yl)carbonyl]-2,4-difluoro-phenyl]propane-1-sulfonamide ; N-[3-[(5-chloro-1H-pyrrolo[5,4-b]pyridin-3-yl)-oxomethyl]-2,4-difluorophenyl]propane-1-sulfonamide ; UNII-EQY31RO8HA ; Raf Kinase Inhibitor V ; UNII:EQY31RO8HA ; PLX4720 ; PLX 4720 ; PLX4720 ; PLX-4720 ; PLX 4720 ; EQY31RO8HA ; 324 ; n-[3-[(5-chloro-1h-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-1-propanesulfonamideplx-4720 ; Chemistry 11737 ; "
125,86.0,"1-ter-butyl-3-p-tolyl-1h-pyrazolo[3,4-d]pyrimidin-4-ylamine ; 1-(tert-butyl)-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; PP1 ; PP 1 ; 1-(tert-butyl)-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine ; 1-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 172889-26-8 ; 1-tert-butyl-3-(4-methylphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine ; 1H-Pyrazolo[3,4-d]pyrimidin-4-amine ; 1-(1,1-dimethylethyl)-3-(4-methylphenyl)- ; 1-tert-butyl-3-p-tolyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; [172889-26-8] ; Kinome_2004 ; 3-(4-Methylphenyl)-1-(2-methyl-2-propanyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; PYRAZOLOPYRIMIDINE 1 ; 1-(tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE,1-(1,1-DIMETHYLETHYL)-3-(4-METHYLPHENYL)- ; PP1 (Src Inhibitor) ; 1-(1,1-dimethylethyl)-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; MFCD01076570 ; 4-Amino-1-tert-butyl-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidine ; Free Base ; 1-tert-butyl-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine ; PP1 Free Base ; EI 275 ; PP-1 ; 1-tert-Butyl-3-p-tolyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine ; 4-Amino-5-(methylphenyl)-7-(t-butyl)pyrazolo-(3,4-d)pyrimidine ; 1-tert-butyl-3-(4-methylphenyl)pyrazolo[4,5-e]pyrimidin-4-amine ; "
126,87.0,"PP 2 (enzyme inhibitor) ; PP 2 ; PP2-AG1879 ; AG1879 ; K00048 ; 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine ; 1-(tert-butyl)-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 1H-Pyrazolo[3,4-d]pyrimidin-4-amine ; 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)- ; 1H-Pyrazolo[3,4-d]pyrimidin-4-amine ; 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)- (9CI) ; 172889-27-9 ; 9-(4-chlorophenyl)-7-tert-butyl-3,5,8-triaza-7-azoniabicyclo[4.3.0]nona-2,4,6,9-tetraen-2-amine ; PP2 ; 1-tert-Butyl-3-(4-chloro-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine ; 1-(tert-butyl)-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine ; 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo(3,4-d)pyrimidine ; C412373 ; PP2 cpd ; Src family kinase inhibitor PP2 ; 3-(4-chlorophenyl) 1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 1-(tert-butyl)-3-(4-chlorophenyl)-4-aminopyrazolo[3,4-d]pyrimidine ; 1-tert-butyl-3-(4-chlorophenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine ; 4-amino-5-(4-chlorophenyl)-7-(tert-butyl)pyrazolo[3,4-d]pyrimidine ; [172889-27-9] ; Kinome_2000 ; 3-(4-Chlorophenyl)-1-(2-methyl-2-propanyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE,3-(4-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)- ; PP2 and AG 1879 ; 1-tert-butyl-3-(4-chlorophenyl)pyrazolo[4,5-e]pyrimidin-4-amine ; MFCD01568210 ; 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 3-(4-chlorophenyl)1-(1,1-dimethylethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine ; 1-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine ; CHEMBL406845 ; 1-tert-butyl-3-(4-chlorophenyl)-4-pyrazolo[3,4-d]pyrimidinamine ; PP-2 ; AGL 1879;PP 2;PP-2 ; PP2 (KINASE INHIBITOR) ; PP 2 (AG 1879) ; 4-amino-3-(4-chlorophenyl)-1-(t-butyl)-1h-pyrazolo[3,4-d]pyrimidine ; "
127,294.0,"PP242 ; 2-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol ; 1H-Indol-5-ol ; 2-[4-amino-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]- ; PP 242 ; 1092351-67-1 ; 2-[4-Amino-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-1H-indol-5-ol ; 2-{4-amino-1-isopropylpyrazolo[3,4-d]pyrimidin-3-yl}-1H-indol-5-ol ; 2-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)1H-indol-5-ol ; TORKinib ; MFCD12196869 ; 2-[4-amino-1-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-1H-indol-5-ol ; PP-242 ; Fluoxetine glucuronide ; 2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol ; T56-LIMKi | ; PP242|TORKinib ; [1092351-67-1] ; Torkinib (PP242) ; PP-242 ; 2-(4-Amino-1-isopropyl-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-1H-indol-5-ol ; P2X ; 2-(4-amino-1-isopropyl-1h-pyrazolo[3,4-d]pyrimidin-3-yl)-1h-indol-5-ol, ; 2-[4-amino-1-(1-methylethyl)-1h-pyrazolo-[3,4-d]pyrimidin-3-yl]-1h-indol-5-ol ; "
128,223.0,"5-Amino-1-Phenylpyrazole-4-Carboxamide ; 50427-77-5 ; 4-Amino-1-phenylpyrazolo(3,4-e)pyrimidine ; 1-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine ; 5334-30-5 ; pp3 ; 1-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine ; 4-AMINO-1-PHENYLPYRAZOLO[3,4-D]PYRIMIDINE ; 1H-Pyrazolo[3,4-d]pyrimidin-4-amine ; 1-phenyl- ; PP 3 ; 1-phenylpyrazolo[5,4-d]pyrimidine-4-ylamine ; 198460 ; 4-Amino-7-phenylpyrazol[3,4-d]pyrimidine ; NSC 50566 ; NSC 11602 ; NSC 1401 ; 4-Amino-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine ; SBB028425 ; [5334-30-5] ; 1-phenylpyrazolo[3,4-d]pyrimidin-4-amine ; CHEMBL65063 ; IN1145 ; KKDPIZPUTYIBFX-UHFFFAOYSA-N ; 1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine ; '5334-30-5 ; c11h9n5 ; pp-3 ; 5-Amino-1-phenylpyrazole-4-carboxamide|NSC 11602|NSC 50566 ; "
129,88.0,"2-{[(1R,2S)-2-Aminocyclohexyl]amino}-4-{[3-(2H-1,2,3-triazol-2-yl)phenyl]amino}-5-pyrimidinecarboxamide ; 5-Pyrimidinecarboxamide ; 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]- ; 4-(3-(2H-1,2,3-triazol-2-yl)phenylamino)-2-((1R,2S)-2-aminocyclohexylamino)pyrimidine-5-carboxamide ; P 505-15 ; 1370261-96-3 ; P505-15 ; 4-(3-(2H-1,2,3-Triazo-2-yl)phenylamino)-2-((1R,2S)-2-aminocyclohexylamino) pyrimidine-5-carboxamide acetate ; 1370261-97-4 ; 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-5-pyrimidinecarboxamide ; BIIB-057 ; 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[3-(triazol-2-yl)anilino]pyrimidine-5-carboxamide ; BIIB057 ; PRT 062607 ; PRT062607 ; PRT-062607 ; PRT-2607 ; 4-((3-(2H-1,2,3-Triazol-2-yl)phenyl)amino)-2-(((1R,2S)-2-aminocyclohexyl)amino)pyrimidine-5-carboxamide ; PRT-062607;P505-15;PRT-2607;BIIB-057 ; MFCD22580425 ; 2-{[(1r,2s)-2-Aminocyclohexyl]amino}-4-{[3-(2h-1,2,3-Triazol-2-Yl)phenyl]amino}pyrimidine-5-Carboxamide ; 3YT ; 1194954-52-3 ; K9C42672RH ; "
130,89.0,"N-(6-Chloro-9H-beta-carbolin-8-yl)-nicotinamide ; 3-Pyridinecarboxamide ; N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)- ; PS-1145 ; 431898-65-6 ; N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)nicotinamide ; PS 1145 ; N-(6-Chloro-9H-beta-carbolin-8-yl)nicotinamide ; MFCD18089825 ; N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)pyridine-3-carboxamide ; CHEMBL79004 ; PS1145 ; PS1145;PS 1145 ; N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)-3-pyridinecarboxamide ; "
131,90.0,Purv ; 2-(1R-Isopropyl-2-hydroxyethylamino)-6-(3-chloroanilino)-9-isopropylpurine ; 212844-53-6 ; 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine ; P01 ; 2-({6-[(3-CHLOROPHENYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)-3-METHYLBUTAN-1-OL ; Purvalanol- A ; (2R)-2-[[6-[(3-Chlorophenyl)amino]-9-(1-methylethyl)-9H-purin-2-yl]amino]-3-methyl-1-butanol ; 8645511 ; (2R)-2-({6-[(3-chlorophenyl)amino]-9-(propan-2-yl)-9H-purin-2-yl}amino)-3-methylbutan-1-ol ; (2R)-2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methylbutan-1-ol ; 1-Butanol ; 2-[[6-[(3-chlorophenyl)amino]-9-(1-methylethyl)-9H-purin-2-yl]amino]-3-methyl- ; [212844-53-6] ; PURVALANOLA ; NG 60 | ; (2R)-2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol ; NG 60 ; (R)-2-((6-((3-Chlorophenyl)amino)-9-isopropyl-9H-purin-2-yl)amino)-3-methylbutan-1-ol ; SG-60 ; allo-I1e-isoindoline | ; MFCD02179211 ; (2R)-2-[[6-(3-chloroanilino)-9-isopropyl-purin-2-yl]amino]-3-methyl-butan-1-ol ; (2R)-2-[[6-(3-chloroanilino)-9-propan-2-ylpurin-2-yl]amino]-3-methylbutan-1-ol ; CHEBI:47600 ; PURVALANOL A;(2R)-2-[[6-[(3-CHLOROPHENYL)AMINO]-9-(1-METHYLETHYL)-9H-PURIN-2-YL]AMINO]-3-METHYL-1-BUTANOL ; purvalanol a(ng 60) ; Purvalanol A|SG-60 ; 
132,149.0,Purvalanol B ; PURVALANOL ; (2R)-2-[[6-[(3-Chloro-4-carboxyphenyl)amino]-9-(1-methylethyl)-9H-purin-2-yl]amino]-3-methyl-1-butanol ; 212844-54-7 ; 8653450 ; 2-chloro-4-{[2-{[(1R)-1-(hydroxymethyl)-2-methylpropyl]amino}-9-isopropyl-9H-purin-6-yl]amino}benzoic acid ; 2-chloro-4-{[2-{[(2R)-1-hydroxy-3-methylbutan-2-yl]amino}-9-(propan-2-yl)-9H-purin-6-yl]amino}benzoic acid ; 2-Chloro-4-[(2-{[(2R)-1-hydroxy-3-methylbutan-2-yl]amino}-9-isopropyl-9H-purin-6-yl)amino]benzoic acid ; [212844-54-7] ; Benzoic acid ; 2-chloro-4-[[2-[[(1R)-1-(hydroxymethyl)-2-methylpropyl]amino]-9-(1-methylethyl)-9H-purin-6-yl]amino]- ; AY 25712 | ; NG 95 | ; 2-Chloro-4-[(2-{[(2R)-1-hydroxy-3-methyl-2-butanyl]amino}-9-isopropyl-9H-purin-6-yl)amino]benzoic acid ; NG 95 ; MFCD04118312 ; 220792-00-7 ; 2-chloro-4-[[2-[[(2R)-1-hydroxy-3-methylbutan-2-yl]amino]-9-propan-2-ylpurin-6-yl]amino]benzoic acid ; DG5056865 ; 2-chloro-4-[(2-{[(2R)-1-hydroxy-3-methylbutan-2-yl]amino}-9-(propan-2-yl)-9H-purin-6-yl)amino]benzoic acid ; Purvalanol B(NG 95) ; NG95 ; NG-95|NG95 ; (R)-2-chloro-4-((2-((1-hydroxy-3-methylbutan-2-yl)amino)-9-isopropyl-9H-purin-6-yl)amino)benzoic acid ; (R)-2-chloro-4-((2-((1-hydroxy-3- methylbutan-2-yl)amino)-9-isopropyl-9h-purin-6-yl)amino)benzoic acid ; (R)-2-chloro-4-(2-(1-hydroxy-3-methylbutan-2-ylamino)-9-isopropyl-9H-purin-6-ylamino)benzoic acid ; 4-(2-((R)-1-hydroxy-3-methylbutan-2-ylamino)-9-isopropyl-9h-purin-6-ylamino)-2-chlorobenzoic acid ; NG 95;NG95;NG-95 ; Purvalanol B ; (2R)-2-[[6-[(3-Chloro-4-carboxyphenyl)amino]-9-(1-methyl ethyl)-9H-purin-2-yl]amino]-3-methylbutanol ; 2-chloro-4-[[2-[[(1R)-1-(hydroxymethyl)-2-methylpropyl]amino]-9-(1-methylethyl)-9H-purin-6-yl]amino]-benzoic acid ; Purvalanol B(NG-95) ; 63148-65-2 ; Untitled Document ; 
133,157.0,"4,6-Quinazolinediamine ; N4-[2-(4-phenoxyphenyl)ethyl]- ; QNZ ; 545380-34-5 ; 6-Amino-4-(4-phenoxyphenylethylamino)quinazoline ; NF-kappaB Activation Inhibitor ; N-[2-[4-(phenoxy)phenyl]ethyl]quinazoline-4,6-diamine ; QNZ (EVP4593) ; N4-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine ; N4-(4-phenoxyphenethyl)quinazoline-4,6-diamine ; EVP 4593 ; MFCD06411436 ; 4-N-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine ; N4-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine ; AG-F-89549 ; EVP4593 ; NF-kB activation inhibitor ; AG-F-89549|EVP4593 ; [545380-34-5] ; EVP-4593 ; EVP4593;EVP 4593;EVP-4593 ; 6-Amino-4-(4-phenoxyphenylethylamino)quinazoline;N4-[2-(4-Phenoxyphenyl)ethyl]-4,6-quinazolinediamine;Qnz ; QNZ(EVP4593) ; 6-amino-4-(4-phenoxyphenylethylamino) quinazoline ; "
134,319.0,"6-Hydroxyquercetin ; 3,3'4,5,6,7-hexOH-Flavone ; 201-973-6 ; 3,3',4',5,6,7-HEXAHYDROXYFLAVONE ; 3,3',4' ; 5,6,7-Hexahydroxyflavone ; Flavone ; 3,3',4',5,6,7-hexahydroxy- ; Flavone ; 3,3',4',5,6,7-hexahydroxy- (8CI) ; 90-18-6 ; 2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy-4-benzopyrone ; 3,5,6,7-Tetrahydroxy-2-(3,4-dihydroxyphenyl)-4H-1-benzopyran-4-one ; 4H-1-Benzopyran-4-one ; 4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy- ; 4H-1-Benzopyran-4-one ; 2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy- ; 4H-1-Benzopyran-4-one ; 2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy- (9CI) ; MYU ; 2-(3,4-Dihydroxyphenyl)-3,5,6,7-tetrahydroxy-4H-1-benzopyran-4-one ; 6-Hydroxycyanidenolon 1555 ; 2-(3,4-Dihydroxyphenyl)-3,5,6,7-tetrahydroxy-4H-chromen-4-one ; 2-(3,4-Dihydroxyphényl)-3,5,6,7-tétrahydroxy-4H-chromén-4-one ; 2-(3,4-Dihydroxyphenyl)-3,5,6,7-tetrahydroxy-4H-chromen-4-on ; 4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy- ; Quercetagenin ; ,5,6,7-Hexahydroxyflavone ; 2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy-4-chromenone ; 2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy-chromen-4-one ; 2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxychromen-4-one ; 2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy-chromone ; EINECS 201-973-6 ; ST5331681 ; UNII-SV68G507VO ; 2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy-1-benzopyran-4-one ; UNII:SV68G507VO ; (3,5,6,7,3',4'-Hexahydroxyflavone) ; Quercetagetin  [90-18-6] ; 3,5,6,7-Tetrahydroxy-2-(3,4-Dihydroxyphenyl)-4h-Chromen-4-One ; SV68G507VO ; Quercetagetin|3,3',4',5,6,7-Hexahydroxyflavone ; MFCD00017428 ; "
135,92.0,"R-406 ; 6-({5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one ; 2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one ; 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl- ; 6-({5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one ; 6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one ; 841290-80-0 ; Kinome_1211 ; R406 ; R406(free base) ; 841290-81-1 ; 6-[[5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-2Hpyrido[3,2-b]-1,4-oxazin-3(4H)-one ; 6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one ; R 406 ; 6-[[5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one ; 6-[5-Fluoro-2-(3,4,5-trimethoxy-phenylamino)-pyrimidin-4-ylamino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one ; MFCD09970820 ; 6-[5-Fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one ; 6-5-Fluoro-2-(3,4,5-trimethoxyphenylamino)-pyrimidin-4-ylamino-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one ; 6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one benzenesulfonate ; 6-5-Fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one ; R406 (free base) ; 6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one ; 6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one ; CHEMBL475251 ; 6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one ; 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl]amino]-2,2-dimethyl-4H-pyrido[2,3-e][1,4]oxazin-3-one ; tamatinib ; R406 free base ; R 406|R-406|R406 free base ; 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one ; [841290-80-0] ; [841290-81-1] ; MFCD18385012 ; 6-{[5-Fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino}-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one ; UNII:RC3A285J2G ; 585 ; RC3A285J2G ; r406(freebase) ; r406(游离的） ; SYK Inhibitor ; "
136,93.0,"200-664-3 ; 200-835-2 ; (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate ; RAPAMYCIN ; Sirolimus ; Rapamune ; Rapamycin Immunosuppressant Drug ; 53123-88-9 ; RAP ; Antibiotic AY 22989 ; (-)-Rapamycin ; RapA ; SILA 9268A ; 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine ; RPM ; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl]-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone ; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,2 ; 1,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone ; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34 aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hex adecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydro xy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy- 6,8,12,14,20,26-hexamethyl-23,2 ; (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetra ; 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine ; Rapamycin from Streptomyces hygroscopicus ; (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa ; (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-méthoxycyclohexyl]-1-méthyléthyl}-19,30-diméthoxy-15,17,21,23,29,35-hexaméthyl-11,36-dioxa ; 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone ; 9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl- ; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)- ; AY 22989 ; Sirolimus ; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone ; Rapamycin (Sirolimus) ;  Rapamycin ; 33554-73-3 ; Rapamycin ; Streptomyces hygroscopicus ; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34 aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hex adecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydro xy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy- 6,8,12,14,20,26-hexamethyl-23,27-ep ; (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone ; [53123-88-9] ; (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone ; Rapamycin(Sirolimus) ; Sirolimus ; Rapamune ; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-ep ; Sirolimus,Rapamune ; Sirolimus(Rapamycin) ; (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentoneAntibiotic AY 22989 ; sirolimus ; sirolimusum ; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,2 ; 2,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone ; MFCD00867594 ; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl]-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,1 ; 2,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone ; Rapamycin C-7 ; analog 4 ; VE6250000 ; AY 22989 ; Sirolimus ; UNII-W36ZG6FT64 ; sirolimusum ; UNII:W36ZG6FT64 ; (9S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2R)-1-[(3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone ; (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0,4,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone ; Sirolimus solution ; Rapamycin|(-)-Rapamycin|Sirolimus ; Rapamycin|(-)-Rapamycin ; "
137,181.0,"Resveratrol ; 501-36-0 ; Benzoic acid ; 4-(aminomethyl)- (9CI) ; STL ; trans-resveratrol ; (E)-resveratrol ; 3,4',5-stilbenetriol ; 3,4',5-trihydroxystilbene ; 3,5,4'-trihydroxystilbene ; 3,4',5-trihydroxy-stilbene ; 3,5-dihydroxy-4'-methoxystilbene ; 3,5,4'-Trihydroxy-trans-stilbene ; 3,4′,5-Trihydroxy-trans-stilbene ; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol ; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol ; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol ; 1,3-Benzenediol ; 5-(2-(4-hydroxyphenyl)ethenyl)- ; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]benzene-1,3-diol ; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol ; 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol ; cis-Resveratrol ; (E)-5-[2-(4-HYDROXYPHENYL)ETHENYL]-1,3-BENZENEDIOL ; (E)-5-(p-Hydroxystyryl)resorcinol ; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol ; trans-3,4',5 - trihydroxystilbene ; 1,3-Benzenediol ; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]- ; 270262-96-9 ; 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol ; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol ; Boc-Arg(Tos)-OH ; 5-[2-(4-Hydroxy-phenyl)-vinyl]-benzene-1,3-diol ; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol ; TL8003323 ; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol ; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol ; 1912434 ; 61434-67-1 ; Resveratrol ; E- ; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol ; (E)-5-(4-hydroxystyryl)benzene-1,3-diol ; [501-36-0] ; 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol ; 31100-06-8 ; trans-Resveratrol ; 3,4',5-Trihydroxy-trans-stilbene ; trans-Stilbene-3,4',5-triol ; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzene-1,3-diol ; 501-36-0  ; 36469-58-6  ; 204076-78-8 ; E)-5-(p-Hydroxystyryl)resorcinol ; Resvida ; (Z)-3,5,4'-trihydroxystilbene ; trans-Resveratrol ; 3,4',5-Trihydroxy-trans-stilbene ; trans-Stilbene-3,4',5-triol ; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzene-1,3-diol ; trans-3,4',5-Trihydroxystilbene ; MFCD00133799 ; 3,5,4â€²-trihydroxystilbene ; RV ; 610-504-8 ; 3,4',5-Trihydroxy-trans-stilbene ; trans-Stilbene-3,4',5-triol ; trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene ; 3,4,5-Trihydroxy-trans-stilbene ; BR-39118 ; cis Resveratrol ; '501-36-0 ; CZ8987000 ; OR-1053 ; trans-stilbene resveratrol ; ,5-Trihydroxystilbene ; ,5-Trihydroxy-trans-stilbene ; 31100-06-8 (DELETED) ; 5-[(E)-2-(4-hydroxyphenyl)vinyl]resorcinol ; 5-[2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol ; 5-[2-(4-hydroxyphenyl)vinyl]resorcinol ; BPBio1_000479 ; BSPBio_000435 ; BSPBio_001114 ; BSPBio_003461 ; IDI1_002152 ; Lopac0_001111 ; NCGC00024003-00 ; NCGC00024003-06 ; NCGC00024003-07 ; NCGC00024003-08 ; Oprea1_727238 ; Prestwick2_000508 ; Prestwick3_000508 ; SGCUT00007 ; SMP1_000257 ; SPECTRUM1502223 ; Spectrum5_000552 ; SRT-501 ; ST057251 ; to_000079 ; UNII-Q369O8926L ; MFCD09841240 ; 3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol ; 63556-13-0 ; RESVERATROL-(4-HYDROXYPHENYL-13C6) ; 3,4â€²,5-Trihydroxy-trans-stilbene ; Resveratrol ; natural ; Resveratrol ; synthetic ; UNII:Q369O8926L ; 1,3-Benzenediol ; 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]- ; 1,3-Benzenediol ; 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]- ; trans-Resveratrol ; 3,4',5-Trihydroxy-trans-stilbene ; trans-Stilbene-3,4',5-triol ; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzene-1,3-diol ; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]benzene-1,3-diol ; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol ; (E)-resveratrol ; 3,4',5-trihydroxy-trans-stilbene ; 3,4',5-trihydroxystilbene ; 3,5,4'-trihydroxystilbene ; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol ; trans-resveratrol ; Q369O8926L ; 3,4,5-stilbenetriol ; 5-[2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol (resveratrol) ; nanoactive res;bioactive resveratrol ; nanoactive resveratrol ; resveratrol (synthetic) ; resveratrol standard ; trans-resveratrol(rs20015683) ; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol ; (resveratrol) ; 白藜芦醇 ; Resveratrol|3,4,5-Trihydroxy-trans-stilbene ; "
138,342.0,"Ro 31-8220 ; Ro 31 8220 ; 125314-64-9 ; Carbamimidothioic acid ; 3-(3-(2,5-dihydro-4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-1H-pyrrol-3-yl)-1H-indol-1-yl)propyl ester ; 138489-18-6 ; 5366323 ; 3-{3-[4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl]-1H-indol-1-yl}propyl imidothiocarbamate ; 3-{3-[4-(1-Methyl-1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl]-1H-indol-1-yl}propyl carbamimidothioate ; Ro 31-8220 mesylate ; Ro 31-8220 mesylate (Bisindolylmaleimide IX) ; Ro-31-8220 ; Carbamimidothioic acid ; 3-[3-[2,5-dihydro-4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-1H-pyrrol-3-yl]-1H-indol-1-yl]propyl ester ; Bisindolylmaleimide IX ; BIM-9 ; Ro 31-8220 ; RO 31-8220 METHANESULFONATE ; 3-[3-[4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propylsulfanylmethanimidamide ; bisindolymaleimide IX ; Ro 318220 ; Ro-318220 ; Ro31-8220 ; [3-[3-[2,5-diketo-4-(1-methylindol-3-yl)-3-pyrrolin-3-yl]indol-1-yl]propylthio]formamidine ; [3-[3-[4-(1-methyl-3-indolyl)-2,5-dioxo-3-pyrrolyl]-1-indolyl]propylthio]formamidine ; 3-[3-[4-(1-methylindol-3-yl)-2,5-dioxo-pyrrol-3-yl]indol-1-yl]propylsulfanylformamidine ; 3-[3-[4-(1-methylindol-3-yl)-2,5-dioxo-pyrrol-3-yl]indol-1-yl]propylsulfanylmethanimidamide ; BiomolKI_000033 ; BiomolKI2_000041 ; BSPBio_001077 ; CHEBI:38912 ; DRN ; IDI1_002124 ; NCGC00092293-02 ; NCGC00092293-03 ; bisindolymaleimide IX|Ro 318220|Ro-318220 ; 3-[3-[4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propyl carbamimidothioate ; Carbamimidothioic acid,3-[3-[2,5-dihydro-4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-1H-pyrrol-3-yl]-1H-indol-1-yl]propylester ; MFCD00236436 ; "
139,156.0,"(Z)-5-(quinolin-6-ylmethylene)-2-(thiophen-2-ylmethylamino)thiazol-4(5H)-one ; 4(5H)-Thiazolone ; 5-(6-quinolinylmethylene)-2-[(2-thienylmethyl)amino]- ; Ro 3306 ; 872573-93-8 ; 5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone ; Ro-3306 ; Casodex | ICI 176,334 | ; 2-[[Thiophen-2-yl)methyl]amino]-5-[1-(quinolin-6-yl)meth-(Z)-ylidene]thiazol-4-one ; (5Z)-5-(6-quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone ; (5Z)-5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-1,3-thiazol-4(5H)-one ; 5Z-(6-quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone ; MFCD17392573 ; CHEMBL393929 ; THZ1 ; [872573-93-8] ; (5Z)-5-(quinolin-6-ylmethylidene)-2-(thiophen-2-ylmethylamino)-1,3-thiazol-4-one ; 5-(6-QUINOLINYLMETHYLENE)-2-[(2-THIENYLMETHYL)AMINO]-4-(5H)-THIAZOLONE ; (Z)-5-(Quinolin-6-ylmethylene)-2-((thiophen-2-ylmethyl)amino)thiazol-4(5H)-one ; (5Z)-5-Quinolin-6-ylmethylene-2-[(thiophen-2-ylmethyl)-amino]-thiazol-4-one ; "
140,175.0,"Roscovitine ; 2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol ; (R)-Roscovitine ; R-roscovitine ; Seliciclib ; Rosco ; CYC202 ; K00020 ; 2-(R)-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine ; 186692-46-6 ; RRC ; 1-Butanol ; 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2- yl)amino)- ; 2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino] -(R)-1-butanol ; 1-Butanol ; 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-   yl)amino)- ; CYC-202Roscovitine ; (2R)-2-{[6-(Benzylamino)-9-isopropyl-9H-purin-2-yl]amino}-1-butanol ; 1-Butanol ; 2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]- ; 2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol ; 186692-44-4 ; (2R)-2-{[6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl]amino}butan-1-ol ; Roscovitine (R) ; (2R)-2-{[6-(Benzylamino)-9-isopropyl-9H-purin-2-yl]amino}butan-1-ol ; Roscovitine(CYC202) ; 6-Benzylamino-2[(R)-(1'-ethyl-2'-hydroxyethylamino)]-9-isopropylpurine         Roscovitine ; 6-Benzylamino-2[(R)-(1'-ethyl-2'-hydroxyethylamino)]-9-isopropylpurine Roscovitine ; CYC202 ; Seliciclib ; R-roscovitine ; (R)-2-(6-(benzylAmino)-9-isopropyl-9H-purin-2-ylAmino)butan-1-ol ; 6-(Benzylamino) -2(R)-[[1-(hydroxymethyl)propyl]amino]-9-isopropylpurine ; (2R)-2-[[6-(phenylmethylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol ; Roscovitine ; (S)-Isomer ; 2-(S)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine ; Roscovitine (Seliciclib ; CYC202) ; MFCD02266401 ; (R)-2-((6-(Benzylamino)-9-isopropyl-9H-purin-2-yl)amino)butan-1-ol ; cid_160355 ; Roscovitine (Seliciclib,CYC202) ; 2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]- 9H-purin-2-yl]amino]-(R)-1-butanol ; (2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol ; (2R)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]-1-butanol ; R-roscovitineoscovitine ; (+)-Seliciclib ; (2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]amino]butan-1-ol ; (2R)-2-[[6-(phenylmethylamino)-9-propan-2-yl-purin-2-yl]amino]butan-1-ol ; (2R)-2-[[9-isopropyl-6-(phenylmethylamino)-2-purinyl]amino]butan-1-ol ; (2R)-2-[[9-isopropyl-6-(phenylmethylamino)purin-2-yl]amino]butan-1-ol ; BCBcMAP01_000013 ; BiomolKI_000048 ; BiomolKI2_000054 ; BSPBio_001078 ; HSCI1_000092 ; IDI1_002134 ; Lopac0_001102 ; methyl)propyl]amino]-9-isopropylpurine ; NCGC00094374-02 ; NCGC00094374-03 ; SMP1_000266 ; (2S)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]amino]butan-1-ol ; (2S)-2-[[6-(phenylmethylamino)-9-propan-2-yl-purin-2-yl]amino]butan-1-ol ; (2S)-2-[[6-(phenylmethylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol ; (2S)-2-[[9-isopropyl-6-(phenylmethylamino)-2-purinyl]amino]butan-1-ol ; (2S)-2-[[9-isopropyl-6-(phenylmethylamino)purin-2-yl]amino]butan-1-ol ; HSCI1_000094 ; UNII-AIR55KO85E ; (2R)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-1-butanol ; (2R)-2-{[6-(benzylamino)-9-(1-methylethyl)-9H-purin-2-yl]amino}butan-1-ol ; (R)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-1-butanol ; (R)-roscovitine|CYC-202|CYC202|R-roscovitineoscovitine ; [186692-46-6] ; 6-(Benzylamino)-2(R)-[[1-(hydroxymethyl)propyl]amino]-9-isopropylpurine ; Roscovitine (CYC202,Seliciclib) ; CYC202 ; R-roscovitine ; Seliciclib ; EL5610000 ; 8546 ; "
141,95.0,"200-659-6 ; Water-18O ; 14314-42-2 ; 125602-71-3 ; Fenofibrate ; 49562-28-9 ; fluorometholone ; Indomethacin ; 53-86-1 ; Mirtazapine ; Remeron ; Remeron SolTab ; Azamianserin ; Mirtazepine ; Remergil ; Remergon ; Zispin ; 6-AZAMIANSERIN ; Mirtazapine [USAN:BAN:INN] ; Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine ; 1,2,3,4,10,14b-hexahydro-2-methyl- ; 61337-67-5 ; 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine ; Pyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine ; 1,2,3,4,10,14b-hexahydro-2-methyl- ; 85650-52-8 ; 2226-96-2 ; 90-16-4 ; 96-47-9 ; 98-59-9 ; (S)-(+)-Epichlorohydrin ; 426-13-1 ; 4-Fluorobromobenzene ; 460-00-4 ; 540-63-6 ; 17392-83-5 ; Glycopyrrolate bromide ; (S)-(-)-2-Chloropropionic acid ; Hydrocortisone hemisuccinate ; Clobetasol 17-propionate ; 25122-46-7 ; Halobetasol Propionate ; 66852-54-8 ; 10147-36-1 ; 1-Benzosuberone ; 826-73-3 ; Dapoxetine hydrochloride ; 129938-20-1 ; 2446-83-5 ; 2987-16-8 ; 14649-03-7 ; 19172-47-5 ; Fosthiazate ; 98886-44-3 ; 15186-48-8 ; 459-47-2 ; 67843-74-7 ; 83784-20-7 ; 14691-89-5 ; 262-714-0 ; 61337-87-9 ; 262-735-5 ; 61364-37-2 ; TETRACHLORVINPHOS ; 22248-79-9 ; Sunitinib ; 557795-19-4 ; butafosfan ; 17316-67-5 ; mepirzepine ; 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine ; 2-Methyl-1,2,3,4,10,14b-hexahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepine ; Methyl (R)-(+)-Lactate ; 32644-15-8 ; 119707-74-3 ; Mirtazapina [INN-Spanish] ; 2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine ; 64665-57-2 ; Pinacolborane ; 25015-63-8 ; (R)-(+)-2,2-Dimethyl-1,3-dioxolane-4-carboxaldehyde ; Sodium stannate trihydrate ; 2-méthyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazépine ; 2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepin ; 12209-98-2 ; Mepirzapin ; Mirtazipine ; Promyrtil ; Rexer ; 85272-31-7 ; 391210-10-9 ; (14bR)-2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine ; (+)-(S)-4-[4-[1-(4-chlorophenyl)-1-(2-pyridyl)methoxy]piperidin-1-yl]butyric acid ; 29617-66-1 ; Tolytriazole Sodium Salt ; 549345 ; (S)-(-)-1-Phenylethyl isocyanate ; Diisopropylazodicarboxylate ;  61337-67-5  ; (S)-(-)-3,3'-DIBROMO-1,1'-BI-2-NAPHTHOL ; 288-060-6 ; Mirtazanine ; 877399-52-5 ; 868395-53-3 ; 4-Hydroxy-2,2,6,6-tetramethyl piperidinyloxy ; [85650-52-8] ; 5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8(13),9,11,16,18-hexaene ; MAEM ; 4-Hydroxy-2-Adamantone ; 26278-43-3 ; 155306-71-1 ; Ruxolitinib ; 941678-49-5 ; Crizotinib ; 5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8(13),9,11,15,17-hexaene ; 84994-24-1 ; S-2-Bromopropionic acid ; 21667-63-0 ; MFCD00865427 ; 956906-93-7 ; Esmirtazapine ; 152121-53-4 ; 919103-31-4 ; (rs)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino-(2,1-a)pyrido(2,3-c)(2)benzazepine ; 4-Acetylamino-2,2,6,6-tetramethylpiperidin-1-oxyl ; BOC-HIS(BOC)-PRO-OH ; 158211-50-8 ; 178455-03-3 ; p-Toluene sulphonyl chloride ; 6-Methyl-b-oxo-2-Pyridinepropanenitrile ; Boc-Trp(Boc)-Pro-OH ; 51186-83-5 ; Remeron;Avanza ; Mirtazapine (Remeron ; Avanza) ; 3-(2-Cyanoacetyl)benzonirile ; 3021-02-1 ; Org 3770 | 6-Azamianserin | ; mirtazapina ; mirtazapine ; mirtazapinum ; 1216678-68-0 ; MIRTAZAPINE-D3 ; 71875-81-5 ; Avanza ; Trans-4-(Maleimidomethyl)Cyclohexanecarboxylic Acid-Nhs ; Mianserin, 6-Aza- ; ORG 3770 ; 2-Methyl-1,2,3,4,9,13b-hexahydro-2,4a,5-triaza-tribenzo[a,c,e]cycloheptene ; H-Trp-Pro-OH ; 38136-75-3 ; 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c](2)benzazepine ; Norset ; Ethane-1.2-dithiol ; Ethyl-4-fluorobenzene ; 1-Propane Sulfonyl Chloride ; (R)-BoroPhe-(+)-Pinanediol-hydrochloride ; (R)-BoroAla(+)-Pinanediol-hydrochloride ; 61337675 ; Axit ; Mepirzapine ; Mirtabene ; Mirtaz ; Mirtazapin ; Mirtazapina ; Mirtazapinum ; Mirtazon ; Avanza (Trade name) ; Axit (Trade name) ; Mirtabene (Trade name) ; Mirtaz (Trade name) ; Mirtazon (Trade name) ; Norset (Trade name) ; Promyrtil (Trade name) ; Remergil (Trade name) ; Remergon (Trade name) ; Remeron SolTab (Trade name) ; Rexer (Trade name) ; 102961-72-8 ; Mirtazapinum [INN-Latin] ; SolTab ; 5-methyl-2,5,19-triazatetracyclo[13.4.0.0²,⁷.0⁸,¹³]nonadeca-1(15),8,10,12,16,18-hexaene ; 6-Azamianserin ; Mepirzapine ; Mirtazapin ; Mirtazapina ; Mirtazapine ; Mirtazapinum ; Avanza ; Mirtabene ; Mirtaz ; Mirtazon ; Norset ; Promyrtil ; Remergil ; Remergon ; Remeron SolTab ; Zispin ; MIRTAZAPINE ; MIRTAZAPINE-D4 ; 365549-33-3 ; Mianserin ; 6-Aza- ; 1,2,3,4,10,14b-hexahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine ; 3,3Dimethylbutyaldehyde ; 2-Methyletrahydrofuran ; Lawesson' reagent ; 1,2,3-Benzotriazin-4-(3H)one ; Bis(trifluoromethanesulfonic acid)di-tert-butylsilanediyl ester ; 3,3',5,5'-Azobenzene tetracarboxylic acid ; Mirtazapine solution ; Mirtazapine for system suitability ; Mirtazapine|Mepirzepine ; DB00370 ; "
142,96.0,"N-(5-Chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine ; N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)-4-quinazolinamine ; 4-Quinazolinamine ; N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]- ; Saracatinib ; N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine ; 379231-04-6 ; N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine ; AZD0530(Saracatinib) ; {5-(2H-3,4,5,6-tetrahydropyran-4-yloxy)-7-[2-(4-methylpiperazinyl)ethoxy]quinazolin-4-yl}(5-chloro(2H-benzo[d]1,3-dioxolan-4-yl))amine ; N-(5-chloro-2H-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine ; Saracatinib ; AZD 0530 ; 4-(6-Chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline ; N-(5-chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)quinazolin-4-amine ; Intedanib ; 656247-17-5 ; Saracatinib ; Free Base ; Saracatinib (AZD0530) ; MFCD09832698 ; 7-[2-[4-Methylpiperazin-1-yl]ethoxy]-5-[[tetrahydropyran-4-yl]oxy]-4-[[6-chloro-2,3-methylenedioxyphenyl]amino]quinazoline ; [379231-04-6] ; N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine ; N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-(4-oxanyloxy)-4-quinazolinamine ; (5-chloro-1,3-benzodioxol-4-yl)-[7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxy-quinazolin-4-yl]amine ; N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-(4-tetrahydropyranyloxy)-4-quinazolinamine ; N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxy-quinazolin-4-amine ; UNII-9KD24QGH76 ; AZD-0530|AZD0530 ; AZD 0530 ; N-(5-chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine ; AZD0530 ; Saracatinib ; UNII:9KD24QGH76 ; AZD0530 ; AZD-0530;AZD 0530 ; 9017 ; 9KD24QGH76 ; "
143,339.0,SB202190 ; FHPI ; 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole ; 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole ; 152121-30-7 ; Phenol ; 4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]- ; acetic acid ; ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy) ; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole ; 4-[4-(4-Fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol ; 4-[4-(4-Fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl]phenol ; 4-[5-(4-fluorophenyl)-4-pyridin-4-yl-1H-imidazol-2-yl]phenol ; 4-(4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)phenol ; 4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]-phenol ; 4-[4-(4-Fluorphenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol ; 4-[5-(4-Fluorophenyl)-4-(pyridin-4-yl)-1H-imidazol-2-yl]phenol ; Phenol ; 4-[5-(4-fluorophenyl)-4-(4-pyridinyl)-1H-imidazol-2-yl]- ; [152121-30-7] ; 4-(4-(4-fluorophenyl)-5-(pyridin-4-yl)-2H-imidazol-2-yl)phenol ; Kinome_3708 ; 4-[4-(4-Fluorophenyl)-5-(pyridin-4-yl)-2H-imidazol-2-yl]phenol ; 4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-phenol ; 4-[5-(4-Fluorophenyl)-4-(4-pyridinyl)-1H-imidazol-2-yl]phenol ; MFCD00941964 ; biotinylated SB202190 ; SB202190 (FHPI) ; CHEBI:79090 ; SB 202190 ; Immobilized ; SB202190 ; SB-202190 ; 52121-30-7 ; Not available ; 2RE ; 4-[4-(4-FLUOROPHENYL)-5-(PYRIDIN-4-YL)-3H-IMIDAZOL-2-YL]PHENOL ; sb202190(fhpi) ; 
144,97.0,"SB202190 ; SB203580 ; K00038 ; 152121-47-6 ; 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole ; 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole ; 4-[5-(4-FLUORO-PHENYL)-2-[4-METHANESULFINYL-PHENYL]-3H-IMIDAZOL-4-YL]-PYRIDINE ; pyridine ; 4-(5-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-4-yl)- ; Pyridine ; 4-[5-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-yl]- ; 4-[5-(4-Fluoro-phenyl)-2-(4-methanesulfinyl-phenyl)-3H-imidazol-4-yl]-pyridine ; 4-[5-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-3H-imidazol-4-yl]pyridine ; C093642 ; 4-(4'-Fluorophenyl)-2-(4'-methylsulphinylphenyl)-5-(4'-pyridyl)imidazole ; 4-{4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl}pyridine ; Pyridine ; 4-[4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl]- ; 4-[5-(4-Fluorophenyl)-2-[4-(methylsulfonyl)phenyl]-1H-imidazol-4-yl]pyridine ; 4-(4-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-5-yl)pyridine ; 4-(5-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-4-yl)pyridine ; 4-[5-(4-Fluoro-phenyl)-2-(4-methanesulfinyl-phenyl)-1H-imidazol-4-yl]-pyridine ; 4-[5-(4-Fluoro-phenyl)-2-(4-methanesulfinyl-phenyl)-3H-imidazol-4-yl]-pyridine(SB 203580) ; 4-[5-(4-Fluoro-phenyl)-2-(4-methylsulfoxide-phenyl)-3H-imidazol-4-yl]-pyridine ; 70288-65-2 ; SB-203580 in ; [152121-47-6] ; 4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-5-(4-pyridyl)-1H-imidazole ; Kinome_2521 ; RWJ 64809 ; PB 203580 ; 4-[5-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-3H-imidazol-4-yl]pyridine ; RWJ 64809,PB 203580 ; RWJ 64809 ; 4-(4-(4-Fluorophenyl)-2-(4-(methylsulfinyl)-phenyl)-1H-imidazol-5-yl)pyridine ; MFCD00922198 ; 4-[4-(4-fluorophenyl)-2-[4-methylsulfinyl)phenyl]-1H-imidazol-5-yl]-pyridine ; {4-[4-(4-Fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenyl}(methyl)sulfoniumolate ; Sulfonium ; [4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenyl]hydroxymethyl- ; inner salt ; MFCD09054716 ; PB 203580 ; 4-[5-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-4-yl]pyridine ; xioSB-203580 ; 4-[4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl]pyridine ; 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazol ; cid_176155 ; UT3967600 ; 4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine ; 4-[4-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1H-imidazol-5-yl]pyridine ; 652162-77-1 ; SB-203580 ; 896734-47-7 ; SB-203580 ; PB 203580|RWJ 64809|SB-203580 ; CHEMBL10 ; UNII:OU13V1EYWQ ; RWJ 64809;SB203580;SB-203580 ; 4-{4-(4-fluorophenyl)-2-[4-(methanesulfinyl)phenyl]-1H-imidazol-5-yl}pyridine ; OU13V1EYWQ ; "
145,98.0,"3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione ; 1H-Pyrrole-2,5-dione ; 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)- ; 280744-09-4 ; C417521 ; 3-(2,4-Dichloro-phenyl)-4-(1-methyl-1H-indol-3-yl)-pyrrole-2,5-dione ; [280744-09-4] ; SB216763 ; MFCD09753369 ; 3-(2,4-Dichloro-phenyl)-4-(1-methyl ; -1H-indol-3-yl)-pyrrole-2,5-dione ; 3-(2,4-Dichlorophenyl)-4-(1-methyl- 1H-indol-3-yl)-1H-pyrrole-2,5-dione ; 3-(2,4-Dichloro-phenyl)-4-(1-methyl ; -1H-indol-3-yl)-pyrrole-2,5-dione ; 3-(2,4-Dichlorophenyl)-4-(1-methylindol-3-yl)-1H-pyrrole-2,5-dione ; UX9565000 ; 3-(2,4-dichlorophenyl)-4-(1-methylindol-3-yl)pyrrole-2,5-dione ; 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione ; 3-(2,4-dichlorophenyl)-4-(1-methyl-3-indolyl)pyrrole-2,5-dione ; SB-216763|SB216763 ; SB-216763;SB216763 ; '280744-09-4 ; 280744-09-4. ; Chemistry 4435 ; "
146,189.0,"3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione ; 1H-Pyrrol-2,5-dione ; 3-((3-chloro-4-hydroxyphenyl)amino)-4-(2-nitrophenyl)- ; 3-[(3-Chloro-4-hydroxyphenyl)  amino]-4-(2-nitrophenyl)-1H-pyrrol-2,5-dione ; 264218-23-7 ; 3-[(3-Chloro-4-hydroxyphenyl)- amino]-4-(2-nitrophenyl)-1H-pyrrol-2,5-dione ; C417520 ; 3-[(3-Chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione ; 1H-Pyrrole-2,5-dione ; 3-[(3-chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)- ; 3-(3-Chloro-4-hydroxy-phenylamino)-4-(2-nitro-phenyl)-pyrrole-2,5-dione ; 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione ; 3-[(3-Chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)-1H-pyrrol-2,5-dione ; [264218-23-7] ; SB415286 ; UX9000000 ; 3-(3-chloro-4-hydroxyanilino)-4-(2-nitrophenyl)pyrrole-2,5-dione ; CHEMBL322970 ; 3-[(3-chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)pyrrole-2,5-dione ; SB 415286|SB415286 ; 3-((3-chloro-4-hydroxyphenyl)amino)-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione ; MFCD04039789 ; SB-415286 ; SB415286 ; 3-(3-chloro-4-hydroxyanilino)-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione ; "
147,278.0,"Compound 14 ; 4-(5-Benzol[1,3]dioxol-5-yl-4-pyrldin-2-yl-1H-imidazol-2-yl)-benzamide hydrate ; 4-[4-(1,3-Benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]-benzamide hydrate ; 4-[4-(3,4-Methylenedioxyphenyl)-5-(2-pyridyl)-1H-imidazol-2-yl]-benzamide hydrate ; SB 431542 hydrate ; SB-431542 ; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide ; C459179 ; SB 431542 ; SB431542 ; 4-[4-(1,3-Benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide ; 301836-41-9 ; 4-[4-(1,3-Benzodioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl]benzamide ; 4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide ; 4-(4-Benzo[1,3]dioxol-5-yl-5-pyridin-2-yl-1H-imidazol-2-yl)-benzamide ; Benzamide ; 4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]- ; [301836-41-9] ; Kinome_3428 ; 4-[4-(2H-1,3-benzodioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl]benzamide ; 4-[4-(3,4-Methylenedioxyphenyl)-5-(2-pyridyl)-1H-imidazol-2-yl]benzamide ; MFCD05865244 ; 4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]-benzamide ; 4-[5-(1,3-Benzodioxol-5-yl)-4-(2-pyridinyl)-1H-imidazol-2-yl]benzamide ; Benzamide ; 4-[5-(1,3-benzodioxol-5-yl)-4-(2-pyridinyl)-1H-imidazol-2-yl]- ; 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide ; CHEMBL440084 ; compound 14|SB431542 ; MFCD11045982 ; 4-(4-Benzo[1,3]dioxol-5-yl-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide ; UNII:E1557V1V0N ; SB 431542 ; SB431542 ; 4-(4-(1,3-Benzodioxole-5-yl)-5-(2-pyridyl)-1H-imidazole-2-yl)benzamide ; Not available ; 085 ; 4-[5-(1,3-Benzodioxol-5-Yl)-4-(Pyridin-2-Yl)-1h-Imidazol-2-Yl]benzamide ; E1557V1V0N ; culturesure® sb431542 ; "
148,99.0,"2-[4-(1,3-benzodioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl]-6-methylpyridine ; 2-(4-(benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine ; Pyridine ; 2-[4-(1,3-benzodioxol-5-yl)-2-(1,1-dimethylethyl)-1H-imidazol-5-yl]-6-methyl- ; SB 505124 ; 694433-59-5 ; 2-[4-(1,3-Benzodioxol-5-yl)-2-(1,1-dimethylethyl)-1H-imidazol-5-yl]-6-methyl-pyridine ; SB505124 ; 2-[5-(1,3-Benzodioxol-5-yl)-2-(1,1-dimethylethyl)-1H-imidazol-4-yl]-6-methylpyridine ; TGF-beta RI Inhibitor III ; 2-[4-(1,3-Benzodioxol-5-yl)-2-(2-methyl-2-propanyl)-1H-imidazol-5-yl]-6-methylpyridine ; MFCD20926329 ; 2-[4-(1,3-Benzodioxol-5-yl)-2-(tert-butyl)-1H-imidazol-5-yl]-6-methylpyridine ; 2-[4-(2H-1,3-benzodioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl]-6-methylpyridine ; SB-505124|SB505124 ; 2-(4-(benzo[d][1,3]dioxol-5-yl)-2-(tert-butyl)-1H-imidazol-5-yl)-6-methylpyridine ; 2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine ; [694433-59-5] ; MFCD11045901 ; SB 505124;SB505124 ; 2-[4-(1,3-BENZODIOXOL-5-YL)-2-(1,1-DIMETHYLETHYL)-1H-IMIDAZOL-5-YL]-6-METHYLPYRIDINE ; 2-[4-(1,3-benzodioxol-5-yl)-2-(1,1-dimethylethyl)-1H-imidazol-5-yl]-6-methyl-pyridin ; MFCD23160357 ; "
149,100.0,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydroinden-1-one oxime ; 1H-Inden-1-one ; 5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-(4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro- ; oxime ; [2-(4-{4-[(1Z)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-5-(pyridin-4-yl)-1H-imidazol-2-yl}phenoxy)ethyl]dimethylamine ; 5-[2-[4-[2-(Dimethylamino)ethoxy]phenyl]-5-(4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro-1H-inden-1-one oxime ; 405554-55-4 ; 2-(4-{4-[(1Z)-1-(Hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-5-(4-pyridinyl)-1H-imidazol-2-yl}phenoxy)-N,N-dimethylethanamine ; SB 590885 ; SB-590885 ; SB590885 ; GSK2118436 ; MFCD16038645 ; [405554-55-4] ; CHEMBL200622 ; SB590885 ; SB 590885 ; (1Z)-5-(2-{4-[2-(dimethylamino)ethoxy]phenyl}-5-pyridin-4-yl-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime ; (1Z)-5-(2-{4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}-5-PYRIDIN-4-YL-1H-IMIDAZOL-4-YL)INDAN-1-ONE OXIME ; (1Z)-N-{5-[2-{4-[2-(dimethylamino)ethoxy]phenyl}-4-(pyridin-4-yl)-1H-imidazol-5-yl]-2,3-dihydro-1H-inden-1-ylidene}hydroxylamine ; (Z)-SB-590885 ; (Z)-5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime ; 5-(2-(4-(2-Dimethylaminoethoxy)phenyl)-5-(4-pyridinyl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime ; "
150,101.0,"3-amino-5-(thiophen-3-yl)thiophene-2-carboxamide ; 4-Amino-[2,3']bithiophenyl-5-carboxylic acid amide ; SC-514 ; [2,3'-Bithiophene]-5-carboxamide ; 4-amino- ; 354812-17-2 ; SC 514 ; [354812-17-2] ; 4-Amino-[2',3'-bithiophene]-5-carboxamide ; 4-amino-[2,3'-bithiophene]-5-carboxamide ; 5-(Thien-3-yl)-3-aminothiophene-2-carboxamide ; 354812-15-0 ; 3-amino-5-thiophen-3-ylthiophene-2-carboxamide ; [354812-15-0] ; MFCD00206459 ; GK 01140 ; GK01140 ; GK-01140 ; SC514 ; GK 01140;SC 514;SC514;GK-01140;GK01140 ; 3-amino-5-(3-thiophenyl)-2-thiophenecarboxamide ; 4-amino-[2,3]bithiophenyl-5-carboxylic acid amide ; 4-amino-[2,3-bithiophene]-5-carboxamide ; sc-514 (gk 01140) ; "
151,102.0,SL 327 ; a-[Amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl)benzeneacetonitrile ; 305350-87-2 ; (2Z)-3-amino-3-[(4-aminophenyl)sulfanyl]-2-[2-(trifluoromethyl)phenyl]prop-2-enenitrile ; Benzeneacetonitrile ; alpha-[amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl)- ; (alphaZ)- ; a-(amino-((4-aminophenyl)thio)methylene)-2-(trifluoromethyl)benzeneacetonitrile ; (2Z)-3-Amino-3-[(4-aminophenyl)sulfanyl]-2-[2-(trifluoromethyl)phenyl]acrylonitrile ; [305350-87-2] ; SL327 ; (Z)-3-amino-3-(4-aminophenylthio)-2-(2-(trifluoromethyl)phenyl)acrylonitrile ; SL-327 ; Arundic acid | ; Benzeneacetonitrile ; a-[amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl)- ; MFCD06411432 ; (Z)-3-amino-3-(4-aminophenyl)sulfanyl-2-[2-(trifluoromethyl)phenyl]prop-2-enenitrile ; SL-327|SL327 ; Î±-[Amino-(4-aminophenylthio)methylene)-2-(trifluoromethyl)phenylacetonitrile ; SL 327 ; SL-327 ; 3-AMINO-3-[(4-AMINOPHENYL)SULFANYL]-2-[2-(TRIFLUOROMETHYL)PHENYL]PROP-2-ENENITRILE ; 297744-39-9 ; Î±-[amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl)-benzeneacetonitrile ; (Z)-3-amino-3-((4-aminophenyl)thio)-2-(2-(trifluoromethyl)phenyl)acrylonitrile ; alpha-[Amino-(4-aminophenylthio)methylene)-2-(trifluoromethyl)phenylacetonitrile ; 
152,161.0,"5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl 3,4-di-O-acetyl-6-deoxy-alpha-L-mannopyranoside ; kaempferol 3-O-(3'',4''-di-O-acetyl-alpha-L-rhamnopyranoside ; 4H-1-Benzopyran-4-one ; 3-[(3,4-di-O-acetyl-6-deoxy-alpha-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)- ; SL 0101-1 ; 77307-50-7 ; SL-0101 ; SL 0101 ; SL0101 ; [(2S,3S,4S,5R,6S)-4-acetyloxy-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-5-hydroxy-2-methyloxan-3-yl] acetate ; SL0 ; 3-[(3,4-di-O-acetyl-6-deoxy-Î±-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one ; "
153,188.0,Enterosalil ; Entrosalyl ; Glutosalyl ; Kerasalicyl ; Diuretin ; Magsalyl ; Salsonin ; Alysine ; Kerosal ; Nadisal ; Salisod ; Aroall ; CLIN ; Parbocyl-rev ; Neo-salicyl ; Sodium salicylate ; Salicylate ; Sodium ; Monosodium salicylate ; Sodium o-hydroxybenzoate ; sodium 2-hydroxybenzoate ; Salicylic acid ; sodium salt ; Salicylic acid ; monosodium salt ; Benzoic acid ; 2-hydroxy- ; monosodium salt ; 54-21-7 ; Corilin ; Sodium ; 2-hydroxybenzoate ; Enterosalicyl ; Pabalate ; Idocyl novum ; Natium salicylicum ; Salsonin (TN) ; Salicylic acid Na+ ; Monosodium 2-hydroxybenzoate ; 200-198-0 ; o-Hydroxybenzoic acid monosodium salt ; 2-Hydroxybenzoic acid monosodium salt ; 2-Hydroxybenzoic acid ; monosodium salt ; 18495-69-7 ; 94413-51-1 ; 219-308-3 ; 2408-36-8 ; 236-693-3 ; 13465-10-6 ; Ardall ; salicylic acid sodium salt ; salicylic acid monosodium salt ; 2-hydroxybenzoic acid sodium salt ; camporisin ; EINECS 200-198-0 ; Natrium salicylat [German] ; Benzoic acid ; 2-hydroxy- ; sodium salt (1:1) ; D012980 ; SODIUM ORTHO-HYDROXYBENZOATE ; Sodium Salicylate2-Hydroxybenzoic acid monosodium saltSodium o-hydroxybenzoate ; 3732792 ; sodiumsalicylate ; Sodium 2-carboxyphenolate ; Salicylate-sodium ; Nasal ; Salicylic acid ; na ; MFCD00002440 ; sodium;2-hydroxybenzoate ; NCGC00094780-01 ; NCGC00094780-02 ; SPECTRUM1500533 ; Spectrum5_001120 ; ST5406592 ; UNII-WIQ1H85SYP ; [54-21-7] ; 2-hydroxybenzoic acid ; sodium ; 2-hydroxybenzoic acid;sodium ; 2-oxidanylbenzoic acid ; sodium ; A830040 ; AGN-PC-04FEW9 ; MolPort-035-395-710 ; SCHEMBL290962 ; sodium and 2-hydroxybenzoate ; UNII:WIQ1H85SYP ; Salicylic acid sodium salt;2-Hydroxybenzoic acid sodium salt ; 2-Hydroxy Benzoic acid ; sodium salt ; Salicylsaeure-Na-salz ; 90218-97-6 ; Benzoic acid ; 2-hydroxy- ; monosodium salt ; coupled with 4-amino-1-naphthalenesulfonic acid and diazotized 2-(4-aminophenyl)-1H-benzimidazol-5-amine ; sodium salt ; WIQ1H85SYP ; Salicylic acid sodium ; SALICYLATE-SODIUM|SODIUM 2-HYDROXYBENZOATE ; Natrii salicylas ; VO5075000 ; Sodium salicylate ; Ph. Eur. grade ; 
154,265.0,"Sodium ; Valproic acid ; Depakine ; Convulex ; Depakene ; Ergenyl ; 2-Propylpentanoic acid ; valproate ; Depakin ; Depakene (TN) ; 99-66-1 ; VPA ; 4-Methylmorpholine ; sodium valproate ; Valproate Sodium ; Epilim ; Eurekene ; Labazene ; Selenica ; Orfiril ; Valerin ; Natrium valproat ; Selenica (TN) ; Sodium 2-propylpentanoate ; Dipropylacetate sodium ; Sodium dipropylacetate ; Sodium bispropylacetate ; Valproic acid sodium salt ; Valproinsaeure ; natrium ; Sodium 2-propylvalerate ; Sodium n-dipropylacetate ; Valproate sodium (USAN) ; Sodium valproate (JP15) ; Sodium 2-n-propyl-pentanoate ; 2-Propylvaleric acid sodium salt ; 2-Propylpentanoic acid sodium salt ; Valproic acid sodium salt (1:1) ; KW 6066N ; 213-961-8 ; Valeric acid ; 2-propyl- ; sodium salt ; Pentanoic acid ; 2-propyl- ; sodium salt ; 2-PROPYLPENTANOIC ACID ; SODIUM SALT ; 1069-66-5 ; Depakote ; Depakote ER ; Divalproex sodium ; Pentanoic acid ; 2-propyl- ; sodium salt (2:1) ; DEPAKOTE CP ; 1069-66-5 ; 99-66-1 ; 2-propylpentanoate de sodium ; Natrium-2-propylpentanoat ; DEPACON ; Valdisoval ; EINECS 213-961-8 ; MFCD00002672 ; Pentanoic acid ; 2-propyl- ; sodium salt (1:1) ; Sodium Valeproate  ; Valproic acid sodium ; 2-Propylpentanoic acid sodium ; Valproic acid ; sodium salt ; 2-Propylpentanoate ; sodium2-propylpentanoate ; MFCD00078604 ; Valproic acid sodium salt (Sodium valproate) ; sodium;2-propylpentanoate ; VPA | Sodium Valproate | ; YV7876000 [RTECS] ; QA-1100 ; 2-Propylpentanoic Acid ; Na ; NCGC00094208-02 ; NCGC00094208-03 ; SPECTRUM1500606 ; UNII-5VOM6GYJ0D ; [1069-66-5] ; Sodium valproate (2-Propylpentanoic acid ; sodium salt) ; sodium and 2-propylpentanoate ; UNII:5VOM6GYJ0D ; 2-(PROPYL-2,3-13C2)PENTANOIC-4,5-13C2 ACID SODIUM SALT ; 4212221 ; YV7876000 ; 5VOM6GYJ0D ; Sodium valproate|Valproic acid ; "
155,103.0,"Pyrazolanthrone ; Pyrazoleanthrone ; anthrapyrazolone ; 1,9-Pyrazoloanthrone ; 1 ; 9-Pyrazoloanthrone ; 2H-Dibenzo[cd,g]indazol-6-one ; anthra[1,9-cd]pyrazol-6(2H)-one ; 204-955-6 ; Anthra[1,9-cd]pyrazol-6 (2H)-one ; SP600125 ; anthra(1,9-cd)pyrazol-6(2H)-one ; K00068 ; 129-56-6 ; 229975-97-7 ; 1,6-dihydrodibenzo[cd,g]indazol-6-one ; Anthra-1,9-pyrazol-6-none ; Dibenz[cd,g]indazol-6(2H)-one ; Dibenzo[cd,g]indazol-6(2H)-on ; Dibenzo[cd,g]indazol-6(2H)-one ; 1,9,PYRAZOLEANTHRONE ; TL8000704 ; C432165 ; Anthra[1-9-cd]pyrazol-6(2H)-one ; 14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one ;  129-56-6 ; Pyrazolanthrone; ; Pyrazolanthrone;Anthrapyrazolone;Anthra[1,9-cd]pyrazol-6(2H)-one;SP600125 ; [129-56-6] ; Kinome_3844 ; SP-600125 ; 129-56-6 ; 67072-00-8 (potassium salt) ; CB458560 ; WLN: T C6665 1A P IV OMNJ ; 14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one ; JNK Inhibitor II ; 1,9-pyrazoloanthrone|JNK Inhibitor II ; SP 600125;SP-600125 ; UNII:1TW30Y2766 ; 1TW30Y2766 ; c14h8n2o ; 1,9-pyrazoleanthrone ; CRAMP-18 (mouse) ; anthra[1,9-cd]pyrazol-6-one ; CB4585000 ; SP 600125|anthra[1,9-cd]pyrazol-6(2H)-one ; dibenzo[cd,g]indazol-6(2H)-one|dibenz[cd,g]indazol-6(2H)-one ; SP600125|dibenzo[cd,g]indazol-6(2H)-one ; "
156,112.0,"1177741-83-1 ; Phenol ; 4-[[4-(4-chlorophenyl)-2-thiazolyl]amino]- ; hydrochloride (1:1) ; 4-{[4-(4-Chlorophenyl)-1,3-thiazol-2-yl]amino}phenol hydrochloride (1:1) ; 4-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]amino]phenol hydrochloride ; "
157,111.0,"N-(6,7-dimethoxy-4-quinazolinyl)-N-(4-phenoxyphenyl)amine ; 4-Quinazolinamine ; 6,7-dimethoxy-N-(4-phenoxyphenyl)- ; 6,7-Dimethoxy-N-(4-phenoxyphenyl)quinazolin-4-amine ; (6,7-Dimethoxy-quinazolin-4-yl)-(4-phenoxy-phenyl)-amine ; Src I1 ; [179248-59-0] ; 179248-59-0 ; Src Kinase Inhibitor I ; 4-(4'-Phenoxyanilino)-6,7-dimethoxyquinazoline ; Src  Kinase Inhikitor ; MFCD01815300 ; 6,7-Dimethoxy-N-(4-phenoxyphenyl)- ; (4'-oxyphenyl-phenylamino)-6,7-dimethoxyquinazoline ; SKI-1 ; Src-l1 ; Src Inhibitor-1 ; KIN001-030 ; CHEMBL97771 ; Src Kinase Inhikitor ; CHEBI:78332 ; IN1082 ; SRC I1;6,7-DIMETHOXY-N-(4-PHENOXYPHENYL)-4-QUINAZOLINAMINE ; Src Inhibitor 1 ; src i 1 ; "
158,185.0,"2-Quinoxalinecarboxamide ; N-[2-[3-(1-piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]- ; N-{2-[3-(1-Piperazinylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}-2-quinoxalinecarboxamide ; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide ; N-(2-(3-(piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide ; SRT1720 ; 1001645-58-4 ; 925434-55-5 ; SRT-1720 ; n-(2-(3-(1-piperazinylmethyl)imidazo(2,1-b)thiazol-6-yl)phenyl)-2-quinoxalinecarboxamide ; MFCD14584468 ; N-(2-(3-(piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide hydrochloride ; N-[2-[3-(1-piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-Quinoxalinecarboxamide ; SRT 1720 ; CHEMBL257991 ; N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]quinoxaline-2-carboxamide ; [1001645-58-4] ; MFCD18074509 ; [925434-55-5] ; SRT-1720 ; SRT1720 ; STR-1720 ; N-(2-{3-[(Piperazin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)quinoxaline-2-carboxamide ; '925434-55-5 ; "
159,113.0,"Staurosporine ; Staurosporin ; Antibiotic 230 ; (+)-Staurosporine ; antibiotic am 2282 ; AM-2282 ; Alkaloid AM-2282 from Streptomyces ; 62996-74-1 ; 8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one ; 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)- ; (8alpha,9beta,10beta,12alpha)-(+)- ; STU ; 109189-95-9 ; 9,13-Epoxy-1H,9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)-benzodiazonin-1-one ; 2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)- ; (9S-(9alpha,10beta,11beta,13alpha)- ; 9,13-Epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one ; 2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)- ; (9S,10R,11R,13R)- (9CI) ; 9,13-Epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one ; 2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)- ; [9S-(9alpha,10beta,11beta,13alpha)]- ; STO ; 943-45-3 ; STP ; (R)-RETRO-THIORPHAN ; STS ; Antibiotic AM-2282 ; 6,10-Epoxy-6H,16H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-16-one ; 7,8,9,10,17,18-hexahydro-7-methoxy-6-methyl-8-(methylamino)- ; (6S,7R,8R,10R)- ; Staurosporine ; from Streptomyces sp. ; (5S,6R,7R,9R)-6-methoxy-5-methyl-7-methylamino-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-14-one ; 220038-19-7 ; 622996-74-1 ; [62996-74-1] ; AM-2282 ; [9S-(9a,10b,11b,13a)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one ; (-)-Staurosporine ; Staurosporine,AM-2282,STS ; 2,3,10,11,12,13-hexahydro-10R-methoxy-9S-methyl-11R-methylamino-9S,13R-epoxy-1H,9H-diindolo[1,2,3-gh;3’,2’,1’-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one ; MFCD00077402 ; 1,2,3,4-Tetrahydro staurosporine ; KD5084000 ; (5S,6R,7R,9R)-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-14(5H)-one ; (2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14(28),15(19),20(27),21,23,25-nonaen-16-one ; BSPBio_001146 ; MEGxm0_000307 ; NCGC00162400-01 ; NCGC00162400-02 ; QTL1_000078 ; (+)-staurosporine|antibiotic 230|antibiotic AM-2282 ; (5R,7R,8R,9S)-8-methoxy-9-methyl-7-(methylamino)-6,7,8,9,14,15-hexahydro-5H,16H-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-16-one ; MFCD18252446 ; Antibiotic AM-2282;STS;AM-2282 ; Staurosporine (CGP 41251) ; 613-127-7 ; STP|AM-2282 ; E'staurosporine' ; 2,3,10,11,12,13-hexahydro-10R-methoxy-9S-methyl-11R-methylamino-9S,13R-epoxy-1H,9H-diindolo[1,2,3-gh;3â€™,2â€™,1â€™-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one ; Staurosporine from Streptomyces sp. ; j62837 ; staurosporine from streptomyces sp ; "
160,114.0,"STO-609 ; STO609 ; 52029-86-4 ; 7H-Benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid ; 7-oxo- ; 7-Oxo-7H-benzimidazo[2,1-a]benzo[de]isoquinoline-3-carboxylic acid ; 11-oxo-3,10-diazapentacyclo[10.7.1.02,10.04,9.016,20]icosa-1(19),2,4,6,8,12,14,16(20),17-nonaene-17-carboxylic acid ; STO 609|STO-609 ; MFCD06411456 ; LSM-3164 ; 609 ; 7-Oxo-7h-Benzimidazo[2,1-A]benz[de]isoquinoline-3-Carboxylic Acid ; 7-oxo-7h-benzo[de]benzo[4,5]imidazo[2,1-a]isoquinoline-3-carboxylic acid ; acetate salt ; 7h-benzimidazo[2,1-a]benz[de]isoquinoline-7-one-3-carboxylic acid ; 7-oxo-7H-benzo[de]benzo[4,5]imidazo[2,1-a]isoquinoline-3-carboxylic acid ; "
161,179.0,"1421-68-7 ; 71009-17-1 ; semaxanib ; Semaxinib ; SU5416 ; 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one ; 194413-58-6 ; 204005-46-9 ; 3-(3,5-Dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one ; 2H-Indol-2-one ; 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro- ; (3E)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one ; (3E)-3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-2H-indol-2-one ; (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]indolin-2-one ; (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one ; MFCD01940922 ; Semaxinib(SU 5416) ; 2H-INDOL-2-ONE ; 3-[(3,5-DIMETHYL-1H-PYRROL-2-YL)METHYLENE]-1,3-DIHYDRO-,(3E)- ; (E)-3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one ; 194413-57-5 ; (3E)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one ; "
162,115.0,"2,3-Dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-indole-5-sulfonamide ; 330161-87-0 ; 2-oxo-3-(4,5,6,7-tetrahydro--1H-indol-2-ylmethylene)-2,3-dihydro-1H-indole-5-sulfonic acid dimethylamide ; C416927 ; SU-6656 ; (3Z)-N,N-Dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)indoline-5-sulfonamide ; 1H-Indole-5-sulfonamide ; 2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]- ; (3Z)-N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-1H-indole-5-sulfonamide ; 2-Oxo-3-[1-(4,5,6,7-tetrahydro-1H-indol-2-yl)-meth-(Z)-ylidene]-2,3-dihydro-1H-indole-5-sulfonic acid dimethylamide ; 1H-Indole-5-sulfonamide ; 2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]- ; (3Z)-N,N-Dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)-5-indolinesulfonamide ; MFCD10565928 ; (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE ; [330161-87-0] ; 1240328-42-0 ; su5566 ; (Z)-N,N-dimethyl-2-oxo-3-((4,5,6,7-tetrahydro-1H-indol-2-yl)methylene)indoline-5-sulfonamide ; "
163,116.0,"SU6668 ; 1H-Pyrrole-3-propanoic acid ; 5-((Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl- ; 210644-62-5 ; 5-((Z)-1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid ; 3-(4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl)-2-indolinone ; 3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid ; 1H-Pyrrole-3-propanoic acid ; 5-((1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl- ; 252916-29-3 ; 3-(2,4-Dimethyl-5-((2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propionic acid ; 5-((1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid ; (Z)-3-(2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl)-propionic acid ; (Z)-3-(2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid ; C412603 ; SU 6668 ; SU006668 ; 3-{2,4-Dimethyl-5-[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid ; 3-{2,4-Dimethyl-5-[2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-1H-pyrrol-3-yl}-propionic acid ; (Z)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid ; 3-[2,4-Dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl]-propionic acid ; 1H-Pyrrole-3-propanoic acid ; 5-[(Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl- ; [252916-29-3] ; 3-(2,4-dimethyl-5-{[(3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid ; 170151-24-3 ; 2,4-Dimethyl-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-pyrrole-3-propanoic acid ; 1H-Pyrrole-3-propanoic acid ; 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl- ; 5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid ; 3-{2,4-Dimethyl-5-[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid ; SU-6668(TSU-68) ; PDGFR Tyrosine Kinase Inhibitor VI ; SU6668 ; TSU-68 (SU6668) ; 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid ; TSU 68 ; Orantinib ; 3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid ; MFCD09743433 ; Orantinib ; PDGFRTyrosineKinaseInhibitorVI,SU6668 ; UX9641810 ; 3-(2,4-dimethyl-5-((Z)-(2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid ; 3-[2,4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid ; 245036-27-5 ; 210644-62-5 ; 252916-29-3 ; 3-[2,4-dimethyl-5-[(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid ; 3-[2,4-dimethyl-5-[(2-oxo-3-indolinylidene)methyl]-1H-pyrrol-3-yl]propanoic acid ; 3-[2,4-dimethyl-5-[(2-oxoindolin-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid ; 3-[2,4-dimethyl-5-[(Z)-(2-oxo-3-indolinylidene)methyl]-1H-pyrrol-3-yl]propanoic acid ; 3-[2,4-dimethyl-5-[(Z)-(2-oxoindolin-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid ; 3-[5-[(2-ketoindolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrol-3-yl]propionic acid ; 3-[5-[(Z)-(2-ketoindolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrol-3-yl]propionic acid ; UNII-9RL37ZZ665 ; SU-6668|TSU-68 ; (E)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid ; TSU68 ; 2,4-Dimethyl-5-(1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl-pyrrole-3-propanoic acid ; Tsu-68 (su6668 ; orantinib) ; UNII:9RL37ZZ665 ; SU 6668;TSU68;TSU 68;SU6668 ; 3-(2,4-DIMETHYL-5-{[(3Z)-2-OXO-1H-INDOL-3-YLIDENE]METHYL}-1H-PYRROL-3-YL)PROPANOIC ACID ; TSU-68 (SU6668,Orantinib) ; 1044712-39-1 ; TSU68 | Orantinib | ; 1H-Pyrrole-3-propanoicacid ; 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl- ; Pdgfr tyrosine kinase inhibitor vi,su6668 ; 9267 ; 9RL37ZZ665 ; MFCD03426212 ; TSU-68 (Random Configuration) ; (Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid ; 3-[2,4-dimethyl-5-[(z)-(2-oxo-1h-indol-3-ylidene)methyl]-1h-pyrrol-3-yl]propanoicacid ; 5-[(z)-(1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-propanoic acid ; orantinib (tsu-68) ; orantinib (tsu-68 ; su6668) ; tsu68(su6668,orantinib) ; "
164,208.0,"RORASUL ; 207-175-4 ; 446-86-6 ; sulfasalazine ; sulphasalazine ; Azulfidine ; Salazopyrin ; sulcolon ; accucol ; Salazosulfapyridine ; Salazopyridin ; Benzosulfa ; azopyrin ; Reupirin ; Salisulf ; Colo-Pleon ; Salicylazosulfapyridine ; SASP ; 209-974-3 ; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene ; 599-79-1 ; Benzoic acid ; 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)- ; benzoic acid ; 2-hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]- ; 5-22-08-00433 ; 2-Hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid ; benzoic acid ; 2-hydroxy-5-[2-[4-[(2-pyridinylamino)sulfonyl]phenyl]diazenyl]- ; 5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid ; sulfasalazine delayed-release ; 2-Hydroxy-5-{[4-(2-pyridinylsulfamoyl)phenyl]diazenyl}benzoic acid ; TL8003811 ; (3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid ; 2-hydroxy-5-({4-[(2-pyridylamino)sulfonyl]phenyl}diazenyl)benzoic acid ; 2-hydroxy-5-(2-{4-[(pyridin-2-yl)sulfamoyl]phenyl}diazen-1-yl)benzoic acid ; "
165,117.0,"(-)-Malic acid ; (2S)-2-hydroxybutanedioic acid ; Suxamethonium chloride ; 71-27-2 ; 200-747-4 ; Sunitinib ; Sutent ; 557795-19-4 ; Sunitinib malate ; SU-11248 L-malate salt ; SU-011248 L-malate salt ; PHA-290940AD ; PNU-290940AD ; 1H-Pyrrole-3-carboxamide ; N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl- ;     (2S)-hydroxybutanedioate (1:1) ; 341031-54-7 ; Butanedioic acid ; hydroxy- ; compd. with N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1) ; Butanedioic acid ; 2-hydroxy- ; compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1) ; (2S)-2-hydroxybutanedioic acid - N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1) ; SU010398 ; SU011248 L-malate salt ; (2S)-2-Hydroxysuccinic acid - N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1) ; TL8002546 ; Sunitinib Maleate ; (2S)-2-Hydroxysuccinic acid ; SunitinibMalate ; [341031-54-7] ; n-(2-(diethylamino)ethyl)-5-((z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3-carboxamide (2s)-hydroxybutanedioate ; N-[2-(diethylamino)ethyl]{5-[(5-fluoro-2-oxo(1H-benzo[d]azolin-3-ylidene))methyl]-2,4-dimethylpyrrol-3-yl}carboxamide ; (2S)-2-hydroxybutanedioic acid ; Sutent ; SU-11248 ; N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidine)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-2-hydroxybutanedioate salt ; 2,2'-[(1,4-Dioxo-1,4-butanediyl)bis(oxy)]bis(N,N,N-trimethylethanaminium) dichloride ; (Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (S)-2-hydroxysuccinate ; N-(2- -5-( - -2,4-dimethyl-1H-pyrrole-3-carboxamide -hydroxybutanedioate ; SU 11248 | ; Sunitinib Malate (Sutent) ; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide ; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide ; UX9356900 ; MFCD08282795 ; GA2360000 ; MFCD00038725 ; PDGF TK antagonist ; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid ; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide ; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-keto-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide ; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-3-indolinylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide ; D06402 ; UNII-LVX8N1UT73 ; Sunitinib (Malate) ; N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-2-hydroxybutanedioic acid (1:1) salt ; SU112248 ; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide and (2S)-2-hydroxybutanedioic acid ; UNII:LVX8N1UT73 ; SU 11248 ; Sutent ; SU-11248 ; Sunitinib ; Sunitinib Malate (Sunitinib L-Malate) ; LVX8N1UT73 ; "
166,118.0,"622387-85-3 ; 3-(1-Methylindol-3-ylmethylene)-2-oxo-2,3-dihydroindole-5-sulfonic acid amide ; 1H-Indole-5-sulfonamide ; 2,3-dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2-oxo- ; (3Z)-3-[(1-methyl-1H-indol-3-yl)methylidene]-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide ; 3-[1-(1-Methyl-1H-indol-3-yl)-meth-(Z)-ylidene]-2-oxo-2,3-dihydro-1H-indole-5-sulfonic acid amide ; Syk Inhibitor ; (3Z)-3-[(1-Methyl-1H-indol-3-yl)methylene]-2-oxo-5-indolinesulfonamide ; 3-(1-METHYLINDOL-3-YLMETHYLENE)-2-OXO-2,3-DIHYDROINDOLE-5-SULFONICACIDAMIDE ; 2,3-dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2-oxo-1H-indole-5-sulfonamide ; CHEMBL104279 ; spleen tyrosine kinase inhibitor ; K00564a|spleen tyrosine kinase inhibitor ; 3-[(1-METHYLINDOL-3-YL)METHYLIDENE]-2-OXO-1H-INDOLE-5-SULFONAMIDE ; 3-[(1-methyl-3-indolyl)methylidene]-2-oxo-1H-indole-5-sulfonamide ; Not available ; [622387-85-3] ; OXSI 2 ; (3Z)-3-[(1-methylindol-3-yl)methylidene]-2-oxo-1H-indole-5-sulfonamide ; 1956296-96-0 ; MFCD07776820 ; "
167,119.0,227449-73-2 ; 2-(2-Aminoethylamino)-4-(3-trifluoromethylanilino)-pyrimidine-5-carboxamide ; Dihydrochloride ; Dihydrate ; 5-Pyrimidinecarboxamide ; 2-[(2-aminoethyl)amino]-4-[[3-(trifluoromethyl)phenyl]amino]- ; hydrochloride ; hydrate (1:2:2) ; 2-[(2-Aminoethyl)amino]-4-{[3-(trifluoromethyl)phenyl]amino}-5-pyrimidinecarboxamide dihydrochloride dihydrate ; 
168,120.0,"MNS ; 1485-00-3 ; 1,3-Benzodioxole ; 5-nitrovinyl- ; 3,4-Methylenedioxy-.beta.-nitrostyrene ; 3,4-Methylenedioxy-.omega.-nitrostyrene ; 3,4-Methylenedioxy-beta-nitrostyrene ; Styrene ; 3,4-methylenedioxy-beta-nitro- ; 1,3-Benzodioxole ; 5-(2-nitroethenyl)- ; 1,3-Benzodioxole ; 5- (2-nitroethenyl)- ; Styrene ; 3,4-methylenedioxy-.beta.-nitro- ; 22568-48-5 ; 5-(2-nitrovinyl)-1,3-benzodioxole ; T56 BO DO CHJ G1U1NW ; 000-000-0 ; 1-(3,4-Methylenedioxy)phenyl-2-nitroethene ; 5-19-01-00545 ; 5-[(Z)-2-nitroethenyl]-1,3-benzodioxole ; 5-[(E)-2-Nitrovinyl]-1,3-benzodioxole ; 1,3-Benzodioxole ; 5-[(E)-2-nitroethenyl]- ; 5-[(E)-2-Nitrovinyl]-1,3-benzodioxol ; 1,3-Benzodioxole ; 5-[(1E)-2-nitroethenyl]- ; 5-((1E)-2-nitrovinyl)-2H-benzo[d]1,3-dioxolane ; 5-[(E)-2-nitroethenyl]-2H-1,3-benzodioxole ; 5-(2-nitroethenyl)-1,3-benzodioxole ; 3,4-Methylenedioxy-b-nitrostyrene ; 192350 ; 5-(2-Nitrovinyl)benzo[d][1,3]dioxole ; 5-(2-nitroethenyl)-2H-1,3-benzodioxole ; Syk Inhibitor III ; 1,3-Benzodioxole,5-(2-nitroethenyl)- ; 1,3-Benzodioxole,5-[(1E)-2-nitroethenyl]- ; (E)-5-(2-nitrovinyl)benzo[d][1,3]dioxole ; MFCD00014575 ; 1-(2-Nitrovinyl)-3,4-methylenedioxybenzene ; 3,4-(Methylenedioxy)-beta-nitrostyrene ; 3,4-Methylenedioxy-1-(2-nitrovinyl)benzene ; Styrene ; 3,4-(methylenedioxy)-b-nitro- ; Ethene ; 1-(3,4-methylendioxyphenyl)-2-nitro- ; Benzene ; 2-nitroethenyl ; 3,4-methylenedioxy ; [1485-00-3] ; WL5270000 ; 5-[(E)-2-nitroethenyl]-1,3-benzodioxole ; SBB007833 ; NSC 10120|NSC 105303|NSC 170724|SBB007833 ; 5-(2-Nitro-vinyl)-benzo[1,3]dioxole ; 5-[(E)-2-nitroethenyl]-1,3-dioxaindane ; 5-(2-NITRO-VINYL)-BENZO(1,3)DIOXOLE ; MNS|5-(2-nitroethenyl)-1,3-benzodioxole ; MDBN ; 5-(2-nitroethenyl)-1,3-dioxaindane ; "
169,155.0,"5-chloro-2-N-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-4-N-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine ; 5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine ; 761439-42-3 ; NVP-TAE684 ; TAE684 ; NVP-TAE684 - TAE 684 ; 5-Chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-2,4-pyrimidinediamine ; Kinome_1205 ; NVP TAE 684 ; TAE684 (NVP-TAE684) ; TAE 684 ; 5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-pyperidinyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-2,4-Pyrimidinediamine ; 2,4-Pyrimidinediamine ; 5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]- ; 2,4-Pyrimidinediamine,5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]- ; TAE-684 ; MFCD11977634 ; NVP-TAE 684 ; 5-chloro-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine ; CHEMBL509032 ; 5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine ; [5-chloro-4-[(2-isopropylsulfonylphenyl)amino]pyrimidin-2-yl]-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)-1-piperidyl]phenyl]amine ; 5-chloro-N'-(2-isopropylsulfonylphenyl)-N-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]pyrimidine-2,4-diamine ; 5-chloro-N'-(2-isopropylsulfonylphenyl)-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)-1-piperidyl]phenyl]pyrimidine-2,4-diamine ; 5-chloro-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-N'-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine ; UNII-EH1713MN4K ; NVP-TAE 684|TAE-684|TAE684 ; [761439-42-3] ; NVP TAE684 ; UNII:EH1713MN4K ; TAE684 ; NVP TAE684 ; 5-CHLORO-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL]PHENYL}-N4-[2-(PROPANE-2-SULFONYL)PHENYL]PYRIMIDINE-2,4-DIAMINE ; GUI ; nv--tae684 ; EH1713MN4K ; 5-â€‹chloro-â€‹N2-â€‹[2-â€‹methoxy-â€‹4-â€‹[4-â€‹(4-â€‹methyl-â€‹1-â€‹piperazinyl)â€‹-â€‹1-â€‹piperidinyl]â€‹phenyl]â€‹-â€‹N4-â€‹[2-â€‹[(1-â€‹methylethyl)â€‹sulfonyl]â€‹phenyl]â€‹-2,â€‹4-pyrimidinediamine ; "
170,151.0,"Tenovin-6 ; 1011557-82-6 ; N-[[[4-[[5-(dimethylamino)-1-oxopentyl]amino]phenyl]amino]thioxomethyl]-4-(1,1-dimethylethyl)-benzamide ; Benzamide ; N-[[[4-[[5-(dimethylamino)-1-oxopentyl]amino]phenyl]amino]thioxomethyl]-4-(1,1-dimethylethyl)- ; N-[(4-{[5-(Dimethylamino)pentanoyl]amino}phenyl)carbamothioyl]-4-(2-methyl-2-propanyl)benzamide ; 4-tert-butyl-N-[(4-{[5-(dimethylamino)pentanoyl]amino}phenyl)carbamothioyl]benzamide ; 4-tert-butyl-N-[[4-[5-(dimethylamino)pentanoylamino]phenyl] carbamothioyl]benzamide ; 4-tert-butyl-N-(4-(5-(dimethylamino)pentanamido)phenylcarbamothioyl)benzamide ; MFCD11976906 ; Tenovin 6 ; Tnv 6 ; 4-tert-butyl-N-[[4-[5-(dimethylamino)pentanoylamino]phenyl]carbamothioyl]benzamide ; 4-tert-butyl-N-[[4-[[5-(dimethylamino)-1-oxopentyl]amino]anilino]-sulfanylidenemethyl]benzamide ; 4-(tert-butyl)-N-((4-(5-(dimethylamino)pentanamido)phenyl)carbamothioyl)benzamide ; [1011557-82-6] ; Tenovin6 ; Tenovin 6;Tenovin6 ; N-(((4-((5-(DIMETHYLAMINO)-1-OXOPENTYL)AMINO)PHENYL)AMINO)THIOXOMETHYL)-4-(1,1-DIMETHYLETHYL)-BENZAMIDE ; N-[4-({[(4-TERT-BUTYLPHENYL)FORMAMIDO]METHANETHIOYL}AMINO)PHENYL]-5-(DIMETHYLAMINO)PENTANAMIDE ; Untitled Document ; "
171,139.0,"K00243 ; 1-(3-Ethyl-5-methoxy-3H-benzothiazol-2-ylidene)-propan-2-one ; 1-[3-Ethyl-5-methoxy-3H-benzothiazol-(2Z)-ylidene]-propan-2-one ; (Z)-1-(3-ethyl-5-methoxy-2 ; 3-dihydrobenzothiazol-2-ylidene) propan-2-one ; (1Z)-1-(3-ethyl-5-methoxy-1,3-benzothiazol-2(3H)-ylidene)propan-2-one ; 2-Propanone ; 1-(3-ethyl-5-methoxy-2(3H)-benzothiazolylidene)- ; (1Z)-1-(3-Ethyl-5-methoxy-1,3-benzothiazol-2(3H)-ylidene)acetone ; Cdc2-Like Kinase Inhibitor ; TG003 ; 300801-52-9 ; TG 003 ; 719277-26-6 ; (1Z)-1-(3-Ethyl-5-methoxy-2(3H)-benzothiazolylidene)-2-propanone ; 1-(3-ethyl-5-methoxy-2(3H)-benzothiazolylidene)-2-propanone ; (Z)-1-(3-ethyl-5-methoxybenzo[d]thiazol-2(3H)-ylidene)propan-2-one ; TG-003 ; MFCD00624584 ; (1Z)-1-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one ; CHEMBL408982 ; Cdc2-like kinase inhibitor ; Clk inhibitor ; Clk inhibitor|TG 003|TG-003|TG003 ; [300801-52-9] ; [719277-26-6] ; (Z)-1-(3-Ethyl-5-methoxy-2,3-dihydrobenzothiazol-2-ylidene)propan-2-one ; TG 003;TG-003 ; Not available ; 1-(3-Ethyl-5-methoxybenzo[d]thiazol-2(3H)-ylidene)propan-2-one ; "
172,140.0,"Torin 1 ; 1222998-36-8 ; 1-[4-[4-(1-Oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)-benzo[h]-1,6-naphthyridin-2(1H)-one ; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one ; Torin1 ; CGS 14824A | ; Benzo[h]-1,6-naphthyridin-2(1H)-one ; 1-[4-[4-(1-oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)- ; 1-[4-(4-Propionyl-1-piperazinyl)-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)benzo[h][1,6]naphthyridin-2(1H)-one ; Benzo[h][1,6]naphthyridin-2(1H)-one ; 1-[4-[4-(1-oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)- ; 1-[4-[4-(1-Oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)benzo[h]-1,6-naphthyridin-2(1H)-one ; 1-[4-(4-propanoylpiperazin-1-yl)-3-(trifluoromethyl)phenyl]-9-quinolin-3-ylbenzo[h][1,6]naphthyridin-2-one ; 1-[4-(4-propanoylpiperazin-1-yl)-3-(trifluoromethyl)phenyl]-9-(quinolin-3-yl)-1H,2H-benzo[h]1,6-naphthyridin-2-one ; [1222998-36-8] ; 1-[4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl]-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one ; Torin-1 ; CHEMBL1256459 ; MFCD18782653 ; 1-(4-(4-Propionylpip erazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzoh1,6naphthyridin-2(1H)-one ; 1-4-(4-Propanoylpiperazin-1-yl)- ; 1-4-4-(1-Oxopropyl)-1-piperazinyl-3-(trifluoromethyl)phenyl-9-(3-quinolinyl)-benzoh-1,6-naphthyridin-2(1H)-one ; Torin1;Torin-1 ; 1-[4-(4-Propanoylpiperazin-1-yl)-3-(trifluoromethyl)phenyl]-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one ; 1-[4-(4-PROPANOYLPIPERAZIN-1-YL)-3-(TRIFLUOROMETHYL)PHENYL]-9-(QUINOLIN-3-YL)BENZO[H]1,6-NAPHTHYRIDIN-2-ONE ; Not available ; "
173,141.0,"418805-02-4 ; PYR-41 ; Benzoic acid ; 4-[(4Z)-4-[(5-nitro-2-furanyl)methylene]-3,5-dioxo-1-pyrazolidinyl]- ; ethyl ester ; Ethyl 4-{(4Z)-4-[(5-nitro-2-furyl)methylene]-3,5-dioxo-1-pyrazolidinyl}benzoate ; 4-(4-(5-Nitro-furan-2-ylmethylene)-3,5-dioxo-pyrazolidin-1-yl)-benzoic acid ethyl ester ; ethyl 4-[(4Z)-4-[(5-nitrofuran-2-yl)methylidene]-3,5-dioxopyrazolidin-1-yl]benzoate ; PYR41 ; [418805-02-4] ; MFCD01469983 ; PYR41;PYR 41 ; ethyl (Z)-4-(4-((5-nitrofuran-2-yl)methylene)-3,5-dioxopyrazolidin-1-yl)benzoate ; 4-[4-[(5-nitro-2-furanyl)methylene]-3,5-dioxo-1-pyrazolidinyl]-benzoic acid ; ethyl ester ; (Z)-ethyl 4-(4-((5-nitrofuran-2-yl)methylene)-3,5-dioxopyrazolidin-1-yl)benzoate ; atoms 27 bonds 29 ; "
174,142.0,"N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine ; 7-Hydroxystaurosporine ; 112953-11-4 ; 8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)triinden-1-one ; 2,3,9,10,11,12-hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)- ; 9,13-Epoxy-1H,9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-1-one ; 2,3,10,11,12,13-hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)- ; (3-alpha,9-beta,10-alpha,11-alpha,13-beta)-(+)- ; 9,13-Epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one ; 2,3,10,11,12,13-hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)- ; (3R,9S,10R,11R,13R)- ; UCN-02 ; 6,10-Epoxy-6H,16H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-16-one ; 7,8,9,10,17,18-hexahydro-18-hydroxy-7-methoxy-6-methyl-8-(methylamino)- ; (6S,7R,8R,10R,18R)- ; 339526-74-8 ; Methyl alpha-D-glucoside [VAN] ; -Methyl-3-methyl-4-phosphonophenylglycine ; 9,13-Epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo [3,4-j][1,7]-benzodiazonin-1-one ; 2,3,10,11,12,13- hexahydro-3-hydroxy-10-methoxy-9-methyl- 11-(methylamino)- ; [3R-(3.alpha. ; 9.beta. ; 10.alpha.,11.alpha. ; 13.beta.)]- ; 9,13-Epoxy-1H,9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-1-one ; 2,3,10,11,12,13-hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)- ; (3-alpha,9-beta,10-alpha,11-alpha,13-beta)-(+)-NSC 638850 ; KRX-0601 ; UCN 01|UCN-01 ; (3R,9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one ; 12953-11-4 ; (5S,6R,7R,9R,16R)-16-hydroxy-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-14(5H)-one ; MFCD26960886 ; "
175,259.0,"109511-58-2 ; U-0126 ; Bis{amino[(2-aminophenyl)sulfanyl]methylene}succinonitrile ; Butanedinitrile ; 2,3-bis[amino[(2-aminophenyl)thio]methylene]- ; 2,3-bis[amino-[(2-aminophenyl)thio]methylidene]butanedinitrile ; Butanedinitrile,2,3-bis[amino[(2-aminophenyl)thio]methylene]- ; MFCD11046040 ; BIS({AMINO[(2-AMINOPHENYL)SULFANYL]METHYLIDENE})BUTANEDINITRILE ; "
176,315.0,"755038-65-4 ; BI-6727 ; Benzamide ; N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy- ; N-{trans-4-[4-(Cyclopropylmethyl)-1-piperazinyl]cyclohexyl}-4-{[(7R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-5,6,7,8-tetrahydro-2-pteridinyl]amino}-3-methoxybenzamide ; BI6727 (Volasertib) ; Volasertib ; 755038-65-4 ; 946161-17-7 (3HCl) ; BI 6727 (Volasertib) ; N-((trans)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)-4-((R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-ylamino)-3-methoxybenzamide ; BI 6727 ; N-((1r,4R)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)-4-(((R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)amino)-3-methoxybenzamide ; MFCD20926414 ; UNII-6EM57086EA ; N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide ; [755038-65-4] ; BI6727 ; UNII:6EM57086EA ; BI 6727;BI-6727;BI6727 ; 4-{[(7R)-7-ethyl-5-methyl-6-oxo-8-(propan-2-yl)-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxy-N-[(1r,4r)-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl]benzamide ; IBI ; N-{trans-4-[4-(Cyclopropylmethyl)piperazin-1-Yl]cyclohexyl}-4-{[(7r)-7-Ethyl-5-Methyl-8-(1-Methylethyl)-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxybenzamide ; BI6727(VOLASERTIB) ; volasertib (bi 6727) ; volasertib (bi-6727) ; volasertib(bi6727) ; 6EM57086EA ; 9228 ; volasertib(bi-6727) ; "
177,169.0,"Desmethylmisonidazole ; 13551-92-3 ; VX6 ; MK-0457VX-680 ; N-[4-({4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl}sulfanyl)phenyl]cyclopropanecarboxamide ; Cyclopropanecarboxamide ; N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]- ; 639089-54-6 ; Tozasertib ; N-[4-({4-(4-Methylpiperazin-1-yl)-6-[(3-methyl-1H-pyrazol-5-yl)amino]pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide ; cyclopropanecarboxamide ; N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(3-methyl-1H-pyrazol-5-yl)amino]-2-pyrimidinyl]thio]phenyl]- ; cyclopropyl-N-(4-{6-(4-methylpiperazinyl)-4-[(5-methylpyrazol-3-yl)amino]pyrimidin-2-ylthio}phenyl)carboxamide ; VX-680(Tozasertib) ; MK-0457 ; Tozasertib ; N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide ; N-[4-({4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide ; MK-045 ; VX-68 ; VX-680 (MK-0457)(Tozasertib) ; N-(4-(4-(3-methyl-1H-pyrazol-5-ylamino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-ylthio)phenyl)cyclopropanecarboxamide ; VX-680 (MK-0457 ; Tozasertib) ; Cyclopropanecarboxamide,N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]- ; 936915-58-1 ; MK 0457 ; Tozasertib ; Cyclopropanecarboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-1H-pyrazol-3-ylamino)-pyrimidin-2 ; -ylsulfanyl]-phenyl}-amide ; N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]-Cyclopropanecarboxamide ; N-(4-((4-((5-methyl-1H-pyrazol-3-yl)amino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)thio)phenyl)cyclopropanecarboxamide ; N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide ; MFCD10565966 ; N-£¿[4-£¿[[4-£¿(4-£¿methyl-£¿1-£¿piperazinyl)-£¿6-£¿[(5-£¿methyl-£¿1H-£¿pyrazol-£¿3-£¿yl)amino]-£¿2-£¿pyrimidinyl]thio]phenyl]-£¿cyclopropanecarboxamide ; Cyclopropanecarboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-1H-pyrazol-3-ylamino)-pyrimidin-2 ; -ylsulfanyl]-phenyl}-amide ; N-[4-({4-(4-Methyl-1-piperazinyl)-6-[(3-methyl-1H-pyrazol-5-yl)amino]-2-pyrimidinyl}sulfanyl)phenyl]cyclopropanecarboxamide ; Cyclopropane carboxylic acid{4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidin-2-ylsulphanyl]-phenyl}-amide ; VX-680(MK-0457) ; N-[4-({4-[(3-methyl-1H-pyrazol-5-yl)amino]-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide ; MFCD13185152 ; N-[4-[[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]thio]phenyl]cyclopropanecarboxamide ; UNII-234335M86K ; MK 0457|VX 680 ; 1010423-95-6 ; N-(4-((4-((3-methyl-1H-pyrazol-5-yl)amino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)thio)phenyl)cyclopropanecarboxamide ; [639089-54-6] ; MK0457 ; Tozasertib(MK-0457,VX-680) ; VX-680 (Tozasertib ; MK-0457) ; UNII:234335M86K ; MK-0457;VX-680;MK0457;VX680;VX 680;MK 0457 ; MK 0457 | Tozasertib | ; GZ1037000 ; VX-680 (MK-0457,Tozasertib) ; Cyclopropanecarboxylic Acid {4-[4-(4-Methyl-Piperazin-1-Yl)-6-(5-Methyl-2h-Pyrazol-3-Ylamino)-Pyrimidin-2-Ylsulfanyl]-Phenyl}-Amide ; Cyclopropanecarboxylic Acid {4-[4-(4-Methyl-Piperazin -1-Yl)-6-(5-Methyl-2h-Pyrazol-3-Ylamino)-Pyrimidin-2-Ylsulfanyl]-Phenyl}-Amide ; tozasertib(vx-680) ; 234335M86K ; 9007 ; N-[4-({4-[(5-METHYL-2H-PYRAZOL-3-YL)AMINO]-6-(4-METHYLPIPERAZIN-1-YL)PYRIMIDIN-2-YL}SULFANYL)PHENYL]CYCLOPROPANECARBOXAMIDE ; tozasertib (vx-680 ; mk-0457) ; tozasertib；vx680；mk0457 ; vx-680 ; mk-0457 ; tozasertib ; VX 680|Tozasertib ; Tozasertib (VX-680 ; MK-0457 ; "
178,263.0,"2-Chloro-5-fluoropyrimidine ; 5-(2,6-dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6h-pyrimido(1,6-b)pyridazin-6-one ; 6H-Pyrimido(1,6-b)pyridazin-6-one ; 5-(2,6-dichlorophenyl)-2-((2,4-difluorophenyl)thio)- ; 209410-46-8 ; 62802-42-0 ; 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenylthio)-6H-pyrimido[1,6-b]pyridazin-6-one ; 6H-Pyrimido[1,6-b]pyridazin-6-one ; 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]- ; 5-(2,6-Dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one ; 5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido[1,6-b]pyridazin-6-one ; 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenylthio)-9-hydropyrimidino[1,6-e]pyridazin-6-one ; Kinome_3767 ; VX 745 ; 5-(2,6-Dichlorophenyl)-2-[2,4-difluorophenyl)thio]-6H-pyrimido[1,6-b]pyridazin-6-one ; VX-745,VX745 ; 6BIO | ; 5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)-thio)-6H-pyrimido[1,6-b]pyridazin-6-one ; MFCD09834070 ; cid_3038525 ; BR-44905 ; 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfanyl-pyrimido[1,6-b]pyridazin-6-one ; VX745 ; 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfanylpyrimido[1,6-b]pyridazin-6-one ; 5-(2,6-Dichloro-phenyl)-2-(2,4-difluoro-phenylsulfanyl)-1,7,8a-triaza-naphthalen-6-one ; VX-745 ; 5-(2,6-Dichlorophenyl)-2-(2,4-difluorophenylsulfanyl)-6H-pyrimido[3,4-b]pyridazin-6-one ; 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]-6-pyrimido[1,6-b]pyridazinone ; 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfanylpyridazino[6,1-f]pyrimidin-6-one ; 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfanyl-pyridazino[6,1-f]pyrimidin-6-one ; 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]-6-pyridazino[6,1-f]pyrimidinone ; 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]pyridazino[6,1-f]pyrimidin-6-one ; 6H-Pyrimido[1,6-b]pyridazin-6-one,5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]- ; 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]-6H-pyrimido[1,6-b]pyridazin-6-one ; [209410-46-8] ; 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]pyrimido[1,6-b]pyridazin-6-one ; VX 745;VX745 ; Neflamapimod ; 10527 ; "
179,205.0,"Withaferine A ; Withaferin A ; WITHAFERIN DERIV JPR ; IOWA U. COMPOUND ; 5119-48-2 ; 5.beta.-Ergosta-2,24-dien-26-oic acid ; 5,6.beta.-epoxy-4.beta.,22 ; 27-trihydroxy-1-oxo- ; .delta.-lactone ; (20S,22R)- ; Ergosta-2,24-dien-26-oic acid ; 5,6-epoxy-4,22 ; 27-trihydroxy-1-oxo- ; .delta.-lactone ; (4.beta.,5.beta.,6.beta. ; Ergosta-2,24-dien-26-oic acid ; 5,6-epoxy-4,22,27-trihydroxy-1-oxo- ; .delta.-lactone ; (4.beta.,5.beta.,6.beta.,22R)- ; 4b,27-Dihydroxy-1-oxo-5b,6b-epoxywitha-2,24-dienolide ; 5,6-Epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dien-26-oic Acid d-Lactone ; (4b,5b,6b,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dien-26-oic acid d-lactone ; (4beta,5beta,6beta,22R)-4,27-Dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione ; Ergosta-2,24-diene-1,26-dione ; 5,6:22,26-diepoxy-4,27-dihydroxy- ; (4beta,5beta,6beta,22R)- ; [5119-48-2] ; WITHAFERINA ; (4ß,5ß,6ß,22R)-4,27-Dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione ; 4beta,27-dihydroxy-1-oxo-5beta,6beta-epoxywitha-2,24-dienolide ; 5.beta.-Ergosta-2,24-dien-26-oic acid ; 5,6.beta.-epoxy-4.beta.,22,27-trihydroxy-1-oxo- ; .delta.-lactone ; (20S,22R)- ; (4S,4aR,5aR,6aS,6bS,9R,9aS,11aS,11bR)-4-hydroxy-9-((S)-1-((R)-5-(hydroxymethyl)-4-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-9a,11b-dimethyl-5a,6,6a,6b,7,8,9,9a,10,11,11a,11b-dodecahydrocyclopenta[ ; 1,2]phenanthro[8a,9-b]oxiren-1(4H)-one ; MFCD10687098 ; WFA ; 5Î²,6Î²-epoxy-4Î²,22R,27-trihydroxy-1-oxo-Î´-lactone-ergosta-2,24-dien-26-oic acid ; 4beta,5beta,6beta,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxo-ergosta-2,24-dien-26-oic acid delta-lactone ; Withaferine ; 5,6-Epoxy-4,27-dihydroxy-1-oxowitha-2,24-dienolide ; withaferin a standard ; "
180,122.0,"Wortmannin ; Wartmannin ; Antibiotic SL-2052 ; (1alpha,11alpha)-11-(Acetyloxy)-1-(methoxymethyl)-2-oxaandrosta-5,8-dieno(6,5,4-bc)furan-3,7,17-trione ; 19545-26-7 ; 200-835-2 ; 3H-furo[4,3,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione ; 11-(acetyloxy)-1, ; 2-Oxaandrosta-5,8-dieno[6,5,4-bc]furan-3,7,17-trione ; 11-(acetyloxy)-1-(methoxymethyl)- ; (1.alpha.,11.alpha.)- ; 3H-Furo[4,3,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione ; 11-(acetyloxy)-1,6b,7,8,9a,10,11,11b- ; 6b,7,8,9a,10,11,11b-octahydro-1-(methoxymethyl)-9a,11b-dimethyl- ; (1S,6bR,9aS,11R,11bR)- ; octahydro-1-(methoxymethyl)-9a,11b-dimethyl- ; [1S-(1alpha,6baalpha,9abeta,11alpha,11bbeta)]- ; (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE ; KY12420 ; Wortmannin ; from Penicillium funiculosum ; 67676 ; (1S,6bR,9aS,11R,11bR)-9a,11b-dimethyl-1-[(methyloxy)methyl]-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3H-furo[4,3,2-de]indeno[4,5-h]isochromen-11-yl acetate ; Wortmannin,Penicillium wortmannin ; (1S,6bR,9aS,11R,11bR)-1-(Methoxymethyl)-9a,11b-dimethyl-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3H-furo[4,3,2-de]indeno[4,5-h]isochromen-11-yl acetate ; 3H-Furo[4,3,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione ; 11-(acetyloxy)-1,6b,7,8,9a,10,11,11b-octahydro-1-(methoxymethyl)-9a,11b-dimethyl- ; (1S,6bR,9aS,11R,11bR)- ; (1R,6bR,9aS,11R,11bR)-1-(methoxymethyl)-9a,11b-dimethyl-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b- decahydro-3H-furo[4,3,2-de]indeno[4,5-h]isochromen-11-yl acetate ; [19545-26-7] ; CB9641000 ; (1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-6,11,16-trioxo-13,17-dioxapentacyclo[10.6.1.02,10.05,9.015,19]nonadeca-2(10),12(19),14-trien-3-yl acetate ; (1S,6bR,9aS,11R,11bR)-1-(methoxymethyl)-9a,11b-dimethyl-3,6,9-trioxo-3,6,6b,7,8,9,9a,10,11,11b-decahydro-1H-furo[4,3,2-de]indeno[4,5-h]isochromen-11-yl acetate ; ACon0_000951 ; BSPBio_001232 ; KY-12420 ; MEGxm0_000446 ; NCGC00163485-01 ; UNII-XVA4O219QW ; antibiotic SL-2052|KY 12420 ; Wortmannin ; from Penicillium funiculosum ; MFCD00133927 ; UNII:XVA4O219QW ; SL-2052;KY-12420 ; WORTMANIN ; 3H-Furo[4,3,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione,11-(acetyloxy)-1,6b,7,8,9a,10,11,11b-octahydro-1-(methoxymethyl)-9a,11b-dimethyl-,(1S,6bR,9aS,11R,11bR)- ; 606-337-5 ; XVA4O219QW ; 509095-08-3 ; Wortmannin solution ; Wortmannin ; Penicillium funiculosum ; "
181,123.0,"Y-27632 ; Y27632 ; (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyridyl)cyclohexanecarboxamide dihydrochloride ; (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyridyl)cyclohexanecarboxamide ; (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE ; Cyclohexanecarboxamide ; 4-[(1R)-1-aminoethyl]-N-4-pyridinyl- ; trans- ; Y27 ; 146986-50-7 ; Y-27632 2HCl ; Cyclohexanecarboxamide ; 4-(1-aminoethyl)-N-4-pyridinyl- ; trans- ; trans-4-(1-Aminoethyl)-N-(4-pyridinyl)cyclohexanecarboxamide ; (R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide ; 4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexane-1-carboxamide ; trans-4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexanecarboxamide ; trans-4-[(1R)-1-Aminoethyl]-N-(4-pyridinyl)cyclohexanecarboxamide ; (1R)-4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexane-1-carboxamide ; (1R,4r)-4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexane-1-carboxamide ; ROCK Inhibitor ; Y-27632 ; ROCK Inhibitor ; Y-27632|Y-27632 ; UNII:0X370ROP6H ; Y 27632 ; Y27632 ; (1R,4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexanecarboxamide ; MFCD03093855 ; 0X370ROP6H ; (R)-Trans-4-(1-Aminoethyl)-N-(4-Pyridyl)cyclohexanecarboxamide ; (1R,4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexane-1-carboxamide ; "
182,340.0,"200-835-2 ; iron sulfide (FeS) ; 215-268-6 ; FES ; 1317-37-9 ; 5975-78-0 ; Zearalenone ; 17924-92-4 ; 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione ; 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl- ; Zenone ; trans-zearalenone ; mycotoxin f2 ; (S)-Zearalenone ; (-)-Zearalenone ; Compound F-2 ; F-2 Toxin ; (S)-(-)-Zearalenone ; 241-864-0 ; 6-(10-hydroxy-6-oxo-trans-1-undecenyl)-beta-resorcylic acid lactone ; (S-(E))-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione ; 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione ; 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl- ; (3S,11E)- ; 6-(10-Hydroxy-6-oxo-trans-1-undecenyl)-b-resorcylic Acid Lactone ; [S-(E)]-3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione ; (3S,11E)-14,16-Dihydroxy-3-methyl-3,4,5,6,9,10-hexahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione ; benzoxacyclotetradecin-1,7(8H)-dione ; fusarium toxin ; ZON ; Zearalenone solution ; (10S)-zearalenone ; (3S)-14,16-dihydroxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-1H-2-benzoxacyclotetradecine-1,7-dione ; (E)-(S)-2,4-Dihydroxy-7-methyl-7,8,9,10,13,14-hexahydro-12H-6-oxa-benzocyclotetradecene-5,11-dione ; Zearalenone from Fusarium graminearum ; [17924-92-4] ; (S,E)-14,16-dihydroxy-3-methyl-3,4,5,6,9,10-hexahydro-1H-benzo[c][1]oxacyclotetradecine-1,7(8H)-dione ; (3S,11E)-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione ; 14,16-Dihydroxy-3-methyl-3,4,5,6,9,10-hexahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione ; Corrosive Solid ; N.O.S. (Zearalenone) ; (S)-()-zearalenone ; Zer ; 6-(10-Hydroxy-6-oxo-trans-1-undecenyl)-beta-resorcylic acid-N-lactone ; (2E,11S)-15,17-dihydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(14) ; 2,15,17-tetraene-7,13-dione ; (3S,11E)- ; 18695288 ; DM2550000 ; UN1759 ; CHEMBL454173 ; (4S)-16,18-dihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraene-2,8-dione ; (4S)-16,18-dihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraene-2,8-quinone ; (4S,12E)-16,18-dihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(18),12,14,16-tetraene-2,8-dione ; (4S,12E)-16,18-dihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(18),12,14,16-tetraene-2,8-quinone ; BCBcMAP01_000203 ; BSPBio_003581 ; LMPK01000020 ; NCGC00038520-03 ; SMP1_000322 ; SPECTRUM1505290 ; ST5320101 ; UNII-5W827M159J ; (2E,11S)-15,17-dihydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(14),2,15,17-tetraene-7,13-dione ; MFCD00133085 ; UNII:5W827M159J ; Zearalenone Standard Solution ; MFCD00564673 ; 5W827M159J ; 1350216 ; (3S,11E)-3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-,1H-2-benzoxacyclotetradecin-1,7(8H)-dione ; Zearalenone Ready Made Solution ; F-2 toxinZON200-835-2MFCD00133085 ; "
